Академический Документы
Профессиональный Документы
Культура Документы
the 39th Annual Meeting of the ESC Working Group on Cardiac Cellular Electrophysiology
BUILDING
FLOOR PLAN
Function
Space 8
Function
Space 7
Function
Space 6
MEZZANINE
Function
Space 5
To Level 2
Function
Space
Function Function
Space
Space
CAGLIARI
To Mezzanine
BARI
VENEZIA
Speaker
Service
Centre
ROMA
MILANO
BOLOGNA
To
Level 1
LEVEL 2
To
Exam
Room
FIRENZE
LEVEL 1
REGISTRATION
To
Levels 0 & 2
ENTRANCE
To
Level 0
EHRA
Members
Lounge
To
Exam Room
Business
Centre
ATM
LEVEL 0
AGORA
NAPOLI
TORINO
Charging
Point
POSTERS
Consult the
programme
EXHIBITION
First Aid
Information
Point
To
Level 1
To
Levels 1 & 2
Cloakroom
PALERMO
The PACE
GENOVA
Google Play
Apple Store
The EHRA Key Messages Mobile App is supported in the form of an unrestricted educational grant by:
www.escardio.org/EHRA
TABLE
OF CONTENTS
Welcome Address................................................................................................................................................................................................................................................................................................................................................................................................................................................................1
Special Events..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................2
Organising Committees....................................................................................................................................................................................................................................................................................................................................................................................................................................3
Congress Resources........................................................................................................................................................................................................................................................................................................................................................................................................................................................4
Congress Timetable.........................................................................................................................................................................................................................................................................................................................................................................................................................................................5
EHRA Members Benefits.........................................................................................................................................................................................................................................................................................................................................................................................................................6
Highlights On...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................7
Useful Information.................................................................................................................................................................................................................................................................................................................................................................................................................................................................8
Programme at a Glance.....................................................................................................................................................................................................................................................................................................................................................................................................................................9
Contact Details.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................14
Acknowledgements.......................................................................................................................................................................................................................................................................................................................................................................................................................................................15
Sunday
Morning Sessions......................................................................................................................................................................................................................................................................................................................................................................................................................................................17
Lunchtime Sessions...........................................................................................................................................................................................................................................................................................................................................................................................................................................27
Afternoon Sessions..........................................................................................................................................................................................................................................................................................................................................................................................................................................29
Evening Sessions..........................................................................................................................................................................................................................................................................................................................................................................................................................................................38
Poster Sessions.................................................................................................................................................................................................................................................................................................................................................................................................................................................................39
Monday
Morning Sessions......................................................................................................................................................................................................................................................................................................................................................................................................................................................57
Lunchtime Sessions...........................................................................................................................................................................................................................................................................................................................................................................................................................................66
Afternoon Sessions..........................................................................................................................................................................................................................................................................................................................................................................................................................................70
Evening Sessions..........................................................................................................................................................................................................................................................................................................................................................................................................................................................81
Poster Sessions.................................................................................................................................................................................................................................................................................................................................................................................................................................................................82
Tuesday
Morning Sessions......................................................................................................................................................................................................................................................................................................................................................................................................................................................97
Lunchtime Sessions........................................................................................................................................................................................................................................................................................................................................................................................................................................107
Afternoon Sessions.......................................................................................................................................................................................................................................................................................................................................................................................................................................109
Poster Sessions...............................................................................................................................................................................................................................................................................................................................................................................................................................................................119
Wednesday
Morning Sessions...................................................................................................................................................................................................................................................................................................................................................................................................................................................131
Poster Sessions..............................................................................................................................................................................................................................................................................................................................................................................................................................................................137
Sessions by topic....................................................................................................................................................................................................................................................................................................................................................................................................................................................................145
Chairpersons & Judges.....................................................................................................................................................................................................................................................................................................................................................................................................................................146
Speakers...............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................148
Authors...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................151
WELCOME
ADDRESS
Dear Colleagues,
I am delighted to welcome you to EHRA EUROPACE CARDIOSTIM 2015, organised by the European Heart Rhythm
Association (EHRA) in collaboration with Cardiostim and the Working Groups on Cardiac Cellular Electrophysiology
and e-Cardiology.
The scientific content throughout the congress is exciting to say the least. The programme committee, expertly lead
by Prof. Cecilia Linde, Prof. Michael Glikson and Dr. Philippe Ritter, worked from a comprehensive list of topics that
really highlight the multidisciplinary and translational approach in modern electrophysiology, diagnosis of arrhythmias
and conduction disturbance. This excellent programme has been put together by leading experts from around the
world, and has been augmented by its alignment to the strategy of EHRA through the inclusion of sessions from the
Innovation, Young EP and Women in EP communities.
For the third edition in a row we have received more than 1 500 abstract submissions, and to celebrate this remarkable
result we have put a real emphasis on abstract presentations. The Best Abstracts have been given the visibility they
deserve by being on display for the whole congress, as well as a new format for the presentation of oral abstracts to
facilitate communication and encourage discussion. Also, there will be two Young Investigator Award sessions, with
winners announced during the Awards and Closing Ceremony. These sessions are a great opportunity to network
and exchange knowledge with both the abstract presenters and the rest of the audience.
The EHRA - ESC stand (B300) in the exhibition area is well worth a visit. EHRA membership gives delegates benefits
such as exclusive access to EHRA Members only sessions, entry to the Members Lounge where you can stop
for a coffee and meet with the EHRA Executive Board and get discounts on the congress registration fees. More
information is available on the EHRA - ESC stand as well as from the EHRA booths located throughout the congress
centre, including one in the registration area.
We also have a great selection of industry partners attending the congress, bringing with them examples of cutting
edge technology and medical advancements. Make sure to go and see them in the exhibition area.
As well as taking in all that the congress has to offer, allow yourself some time to explore Milan. Dating back 26
centuries, it is one of the oldest cities in Europe; it really is a fascinating city.
Thank you for being here with us in Milan, I wish you all a great congress and hope that you are able to make the most
of all the opportunities it brings you to learn and share.
SPECIAL
EVENTS
Inaugural
session
Sunday 21 June 2015
18:15 - 19:15 in room Milano
Performance
Welcome addresses
EHRA EUROPACE - CARDIOSTIM 2015 Highlights
Opening Address
Performance
The European Heart Rhythm Association is pleased
to invite you to the Networking reception
in the exhibition area directly after the Inaugural session.
All attendees are encouraged to view the Best Abstracts which will be on display
in the poster area during the Networking reception and will remain in place throughout the whole congress.
ORGANISING
COMMITTEES
Ex-officio
Editor-in-Chief of EP-Europace
President-Elect
Prof. G. Hindricks
Past President
Prof. A. Auricchio
Secretary
Prof. C. Leclercq
Treasurer
Prof. B. Merkely
MEMBERS
Prof. Jean-Jacques Blanc
CONGRESS
RESOURCES
CME Accreditation
e-Library
Industry Programme
Presenter
Day & time
Available on www.escardio.org/EUROPACE
CONGRESS
TIMETABLE
8:00
7:30
9:00
8:30
10:00
9:30
11:00
10:30
12:00
11:30
13:00
12:30
14:00
13:30
15:00
14:30
16:00
15:30
17:00
18:00
16:30
17:30
19:00
18:30
20:00
19:30
20:30
Saturday 20 June
REGISTRATION
Sunday 21 June
REGISTRATION
EXHIBITION
POSTERS
MP
SESSIONS
POSTERS
SESSIONS
SATELLITE
SYMPOSIA
MP
SESSIONS
SESSIONS
INAUGURAL
SESSION
NETWORKING
RECEPTION
SESSIONS
SATELLITE
SYMPOSIA
SESSIONS
SATELLITE
SYMPOSIA
Monday 22 June
REGISTRATION
EXHIBITION
POSTERS
MP
SESSIONS
POSTERS
SESSIONS
SATELLITE
SYMPOSIA
MP
SESSIONS
Tuesday 23 June
REGISTRATION
EXHIBITION
POSTERS
MP
SESSIONS
POSTERS
SESSIONS
SATELLITE
SYMPOSIA
SESSIONS
MP
GA
Wednesday 24 June
REGISTRATION
EXHIBITION
POSTERS
SESSIONS
8:00
7:30
9:00
8:30
MP
10:00
9:30
SESSIONS
11:00
10:30
12:00
11:30
CLOSING
&
AWARDS
13:00
12:30
14:00
13:30
15:00
14:30
MP
Moderated Posters
GA
16:00
15:30
17:00
16:30
18:00
17:30
19:00
18:30
20:00
19:30
20:30
EHRA MEMBERS
BENEFITS
EHRA MEMBERSHIP
EHRA membership is open to specialist cardiologists with expertise in arrhythmias and electrophysiology, as well as
to basic scientists, members of allied professions, and general cardiologists.
Join EHRA on www.escardio.org/EHRA to get access!
The benefits of EHRA membership:
Exclusive access to dedicated scientific sessions
during EHRA EUROPACE - CARDIOSTIM 2015
and to online resources
Access to the EHRA Lounge level 1 providing all
members the opportunity to meet with EHRA
Executive Board
Discount on EHRA education including:
Special rate on registration fee for EHRA courses
Free online webinars
Reduced fees on EHRA booklets
EHRA members attending this years congress will benefit from members only sessions:
Programming a primary prevention implantable cardioverter defibrillator
Sunday 21 June 16:30-18:00, Torino - lecture room
Management of channellopathies in children, adolescents & young adults.
Monday 22 June 16:30-18:00, Cagliari - lecture room
Devices may not be forever? Can ongoing ICD or CRT therapy become unnecessary?
Tuesday 23 June 11:00-12:30, Torino - lecture room
The EHRA Members Lounge is an exclusive area at level 1 providing all EHRA members 2015 with a pleasant and
intimate environment to meet with the EHRA Executive Board (Profs. Kuck, Hindricks, Auricchio, Camm, Merkely
and Leclercq). This allows you to address specific but also more general questions to the EHRA leadership team as
well as to meet with colleagues, check emails or simply enjoy a cup of coffee.
HIGHLIGHTS ON
TRACKS
HONORARY LECTURES
These sessions will be held in the purposely designed area AGORA next to the poster area. Each presenter will
have 5 minutes to present their work followed by a Question & Answer period of 3 minutes animated by experts
chairing the session.
USEFUL
INFORMATION
@ Internet Corner
Language
The official language of the congress is English. With the
exception of two Nurse and Allied Professional sessions
in Italian, all lectures and presentations will be held in
English only.
Lost and Found
Lost and found items can be recovered from the
registration area.
No Smoking
EHRA EUROPACE - CARDIOSTIM 2015 is a non
smoking congress. Smoking is strictly prohibited
throughout the building.
Prayer Room
A prayer room is available. For more information please
ask at any information point.
Programme
The congress Mobile App contains the most up to date
programme and is the fastest way to search sessions,
speakers and topics.
There is no printed Final Programme.
iPads to consult the programme via the Mobile
App are available on levels 0, 1 and 2.
Registration
Registration to EHRA EUROPACE - CARDIOSTIM
2015 entitles delegates to the following:
A copy of the Programme at a Glance and the
Industry Programme
Access to the scientific sessions (with the exception
of three EHRA Members only sessions)
Access to the exhibition and The PACE
Refreshment breaks each day from Sunday 21 to
Wednesday 24 June.
All delegates are cordially invited by the President of the
European Heart Rhythm Association (EHRA) to attend
the Inaugural session and Networking reception on
Sunday 21 June.
Visual Reproduction
Photographing or filming scientific sessions or meetings
is strictly prohibited (except with prior permission
of the ESC). The ESC reserves the right to video all
presentations of the EHRA EUROPACE - CARDIOSTIM
2015 Congress.
PROGRAMME
AT A GLANCE
SUNDAY 21 JUNE 2015
08:30 - 10:00
Atrial fibrillation and heart failure: advances
and gaps in knowledge in the elderly.................................................................................................................................ROMA
Cardiac pacing troubleshooting I: indications........................................................................NAPOLI
Reducing shocks in implantable
cardioverter-defibrillator recipients.......................................................................................................................TORINO
Difficult accessory pathway ablations....................................................................................................... PALERMO
Management of catecholaminergic
polymorphic ventricular tachycardia..................................................................................................................GENOVA
Antiarrhythmic gene and pharmacological
therapy...............................................................................................................................................................................................................................................................................BOLOGNA
Novel aspects of ventricular repolarisation
assessment..........................................................................................................................................................................................................................................................................FIRENZE
Global approach to heart rhythm management.................................................. VENEZIA
Allied professionals (Italian): Remote monitoring
and remote treatment................................................................................................................................................................................................................................BARI
Cancer treatment and cardiotoxicity......................................................................................................... CAGLIARI
Who said theres nothing new in 12-LEAD-ECG?
New lessons....................................................................................................................................................................................................................................................................AGORA
11:00 - 12:30
Recorded
12:45 - 13:45
How to optimise the mitral regurgitation treatment
of your heart failure patients with TMVR?
Sponsored by Abbott Vascular..............................................................................................................................................................NAPOLI
AF - New Tools for an Old Disease
Sponsored by Biosense Webster..........................................................................................................................................GENOVA
Present and future of advanced mapping
Sponsored by St.Jude Medical................................................................................................................................................BOLOGNA
14:00 - 15:30
lecture..................................................................................................................................................................................................................................MILANO
of atrial fibrillation: time for
something completely different?..........................................................................................................................................................ROMA
Why and how to implant a leadless pacemaker..........................................................NAPOLI
The subcutaneous defibrillator in practice.................................................................................. TORINO
AVNRT ablation.................................................................................................................................................................................................................................PALERMO
Advanced pharmacological and molecular
therapies for inherited arrhythmias.......................................................................................................................GENOVA
Post-extrasystolic potentiation and
myocardial Ca2+ homeostasis..........................................................................................................................................................FIRENZE
Atrial fibrillation and stroke in 2015...................................................................................................................... VENEZIA
Four interesting cases (interactive session)
in implantable cardioverter defibrillator care.............................................................................................BARI
From bench to personalised therapy with
antiarrhythmic drugs........................................................................................................................................................................................................CAGLIARI
Atrial fibrillation: risk factors, fibrosis and
outcomes.....................................................................................................................................................................................................................................................................................AGORA
Honorary
Management
16:30 - 18:00
Upstream
PROGRAMME
AT A GLANCE
MONDAY 22 JUNE 2015
08:30 - 10:00
Management of atrial fibrillation new ideas for 2015............................ROMA
The pericardium and the electrophysiologist........................................................................NAPOLI
Troubleshooting stored data in ICDs: is it VT,
SVT, both or neither? Part 1..................................................................................................................................................................TORINO
Arrhythmogenic right ventricular cardiomyopathy
(ARVC) from genes to bedside.................................................................................................................................................GENOVA
Cardiac ion channels and their macromolecular
complexes: electrophysiology and beyond...................................................................BOLOGNA
Emerging smartphone application for cardiac
evaluation.................................................................................................................................................................................................................................................................................FIRENZE
New developments in technology for arrhythmia
nursing...........................................................................................................................................................................................................................................................................................................................BARI
Antiarrhythmic drugs and devices during pregnancy................. CAGLIARI
Risk predictors beyond LVEF + ECG.......................................................................................................................AGORA
10:15 - 10:45
State-of-the-art: ablation in patients on NOACs
Sponsored by Boehringer Ingelheim................................................................................................................................AGORA
11:00 - 12:30
Live session.....................................................................................................................................................................................................................................................................MILANO
Rotors and atrial fibrillation: experimental
and clinical aspects.........................................................................................................................................................................................................................................ROMA
Lead extraction in practice................................................................................................................................................................................NAPOLI
Troubleshooting stored data in ICDs: is it VT,
SVT, both, or neither? Part 2...............................................................................................................................................................TORINO
Catheter ablation of complex ventricular arrhythmias.... PALERMO
Hypertrophic cardiomyopathy: from genetics
to electrical therapies......................................................................................................................................................................................................GENOVA
Integrating remote monitoring of cardiac implantable
electronic devices into daily clinical practice.........................................................................FIRENZE
Remote monitoring to impact morbidity
and mortality.........................................................................................................................................................................................................................................................VENEZIA
Professional and training issues for nurses
and allied professionals..............................................................................................................................................................................................................................BARI
Practical approach to devices and ablation in adults
with repaired congenital heart disease.................................................................................................CAGLIARI
ICD therapy: clinical data and new concepts..........................................................................AGORA
12:45 - 13:45
Improving outcomes in Paroxysmal and Persistent
AF Ablation - Sponsored by Medtronic................................................................................................................ROMA
Atrial high rate episodes and stroke prevention - An update.
Organised by AFNET, supported by an unrestricted
educational grant from Daiichi Sankyo Europe......................................................................NAPOLI
Can the new Generation of Contact Force catheter
make AF Ablation more simple?
Sponsored by Biosense Webster.............................................................................................................................................TORINO
Leadless pacing, Advancing Standard of Care
Sponsored by St.Jude Medical.......................................................................................................................................................PALERMO
The subcutaneous defibrillator: are we ready for
a paradigm shift?
Sponsored by Boston Scientific....................................................................................................................................................GENOVA
Extending the Boundaries in Managing Heart Failure
Patients - Sponsored by Sorin Group CRM................................................................BOLOGNA
10
12:45 - 13:45
Left atrial appendage closure: which of your AF patients
benefit most? - Sponsored by Boston Scientific............................................................FIRENZE
Controversies and advances in management of Atrial
Fibrillation - Special session organised by EPIC Alliance,
supported by an unrestricted educational grant from
BIOTRONIK..............................................................................................................................................................................................................................................................VENEZIA
14:00 - 15:30
Breaking Trial...........................................................................................................................................................................................................................MILANO
Achieving permanent lesions in atrial fibrillation...............................................................ROMA
Unanswered questions in lead management.............................................................................NAPOLI
Cardiac resynchronisation therapy (CRT)
in the near future: what developments?..................................................................................................TORINO
Defining the outcome of a VT ablation............................................................................................. PALERMO
Troubleshottoting in surface ECG..............................................................................................................................GENOVA
Carmeliet-Coraboeuf-Weidmann lecture......................................................................BOLOGNA
Health technology assessment of device remote
monitoring...........................................................................................................................................................................................................................................................................FIRENZE
Arrhythmias and device problems in acute
cardiac care..................................................................................................................................................................................................................................................................VENEZIA
Organising care for arrhythmia patients:
what can we learn from different models?..............................................................................................................BARI
New approaches to arrhythmias in repaired
congenital heart disease.....................................................................................................................................................................................CAGLIARI
How to improve procedural outcomes following
atrial fibrillation ablation................................................................................................................................................................................................AGORA
Late
15:30 - 16:30
on CCE General Assembly.............................................................................................................................BOLOGNA
WG
16:30 - 18:00
session - Basic ablation and complex
implantable cardioventer-defibrillator therapy
in paediatric practice...............................................................................................................................................................................................................MILANO
Persistent atrial fibrillation ablation: the quest
for a tailored approach to each patient...................................................................................................................ROMA
Managing infected devices......................................................................................................................................................................................NAPOLI
What is needed to provide cardiac resynchronisation
therapy for all European patients?...................................................................................................................................TORINO
Non-ischaemic cardiomyopathies............................................................................................................................ PALERMO
EHRA activities in the field of EP Wires, patient
and snap-shot surveys. Up-to-date 2015.........................................................................................GENOVA
Evolving picture of cardiac arrhythmias.....................................................................................BOLOGNA
Patient management systems - best use of medical
technologies..................................................................................................................................................................................................................................................................FIRENZE
TRP channels and cardiac electric activity................................................................................... VENEZIA
Psychosocial care of patients with arrhythmia........................................................................................BARI
Management of channellopathies in children,
adolescents & young adults...................................................................................................................................................................CAGLIARI
New ablation technology: ready for prime time?..................................................AGORA
Recorded
18:15 - 19:15
ablation management: Therapy, stroke
prevention and monitoring
Sponsored by Medtronic..................................................................................................................................................................................PALERMO
AF
PROGRAMME
AT A GLANCE
TUESDAY 23 JUNE 2015
08:30 - 10:00
Management of atrial fibrillation in patients
with left ventricular systolic dysfunction.............................................................................................................ROMA
Start up of a lead extraction program at my center....................................NAPOLI
Cardiac resynchronisation therapy (CRT)
in heart failure: indication or not?...................................................................................................................................TORINO
How to approach the unstable ventricular
tachycardia patient.....................................................................................................................................................................................................................PALERMO
Argue with experts - case based discussions...................................................................GENOVA
Device registries - quality of care in daily
clinical practice?..............................................................................................................................................................................................................................BOLOGNA
New understanding of syncope..................................................................................................................................................... FIRENZE
Myocardial ischaemia, necrosis and arrhythmias................................................ VENEZIA
Quality of life in living with a device......................................................................................................................................................BARI
Innovation in EP: achievements and pitfalls........................................................................... CAGLIARI
Lead management and syncope........................................................................................................................................................AGORA
11:00 - 12:30
session.......................................................................................................................................................................................................................................................................MILANO
Post atrial fibrillation ablation management............................................................................................ROMA
Devices may not be forever? Can ongoing ICD
or CRT therapy become unnecessary?........................................................................................................TORINO
VT ablation in ischaemic cardiomyopathies....................................................................... PALERMO
Best of young research in 2014...................................................................................................................................................GENOVA
Clinical value of registries related to sudden death...................BOLOGNA
New management strategies of syncope................................................................................................ FIRENZE
The right ventricle in arrhythmogenic remodelling................................. VENEZIA
Monitoring arrhythmias in-hospital: Are we getting
it right?............................................................................................................................................................................................................................................................................................................................BARI
EHRA and Cardiostim inventors Awards................................................................................... CAGLIARI
Molecular pathology and therapy of arrhytmias:
novel insights from experimental studies.................................................................................................AGORA
Live
12:45 - 13:45
Improving
14:00 - 15:30
aspects on stroke prevention in atrial
fibrillation - what to do in 2015?
This session is supported by Boehringer Ingelheim
in the form of an unrestricted educational grant.......................................................................ROMA
Transcatheter aortic valve implantation induced
conduction disorders - How to manage?..................................................................................................NAPOLI
Tips and tricks at CRT implant.......................................................................................................................................................TORINO
The ECG in arrhythmogenic syndromes............................................................................................GENOVA
Atrial fibrillation registries - of clinical use
in daily clinical practice?.................................................................................................................................................................................BOLOGNA
Postural orthostatic tachycardia syndrome,
inappropriate sinus tachycardia and vasovagal syncope:
toward a consensus on diagnosis and therapy.................................................................FIRENZE
Re-remodelling by cardiac resynchronisation................................................................. VENEZIA
Treatment of arrhythmias in female patients..................................................................................................BARI
Young Investigator Award session Basic Science.......................................... CAGLIARI
Its not all about ablation: electrophysiological
insights from left atrial intervention...............................................................................................................................AGORA
Practical
15:30 - 16:30
EHRA General Assembly...........................................................................................................................................................................FIRENZE
16:30 - 18:00
session..................................................................................................................................................................................................................................MILANO
Stroke prevention for atrial fibrillation Europe,
Far East or USA, nice or not?..........................................................................................................................................................................ROMA
New devices for heart failure - when, which device
and in whom...................................................................................................................................................................................................................................................................NAPOLI
Antithrombotic management of patients
undergoing electrophysiological procedures.......................................................................TORINO
International CRT implantation practice:
are we in Sync? Rationale for the CRT Survey II
a HFA EHRA initiative..............................................................................................................................................................................................PALERMO
Special ECG diagnostics..........................................................................................................................................................................................GENOVA
Update of registries and EP wire in heart
rhythm management................................................................................................................................................................................................BOLOGNA
Syncope and sudden death prevention:
special considerations in the elderly.........................................................................................................................FIRENZE
Sinus node dysfunction: how can basic science
improve clinical management?........................................................................................................................................................VENEZIA
Challenges in ablation of complex arrhythmias...................................................................................BARI
Young Investigator Award session - Clinical................................................................... CAGLIARI
Who said theres nothing new in cardiac pacing?!...............................................AGORA
Recorded
11
PROGRAMME
AT A GLANCE
WEDNESDAY 24 JUNE 2015
08:30 - 10:00
New EHRA Scientific Documents-1..........................................................................................................................NAPOLI
Emerging molecular strategies in antiarrhythmic
therapy..............................................................................................................................................................................................................................................................................................TORINO
Opportunities to prevent sudden death
in sports...............................................................................................................................................................................................................................................................................PALERMO
The art of the ECG. Part 1........................................................................................................................................................................GENOVA
Prediction of response to crt and patient
outcomes.....................................................................................................................................................................................................................................................................................AGORA
11:00 - 12:30
New EHRA Scientific Documents-2..........................................................................................................................NAPOLI
Cardiac resynchronisation therapy (CRT):
difficult decisions in complex patients............................................................................................................TORINO
Non-lethal arrhythmic challenges in athletes............................................................ PALERMO
The art of the ECG. Part 2........................................................................................................................................................................GENOVA
Complications of af ablation: avoidance,
recognition and management...................................................................................................................................................................AGORA
12:45 - 13:45
and Closing Ceremony............................................................................................................................................NAPOLI
Awards
POSTER SESSIONS
SUNDAY IN THE POSTER AREA
Best Abstracts Poster session
08:30 - 18:00
10:00 - 11:00
14:00 - 15:30
15:30 - 16:30
19:00 - 20:00
08:30 - 18:00
10:00 - 11:00
11:00 - 12:30
15:30 - 16:30
08:30 - 18:00
10:00 - 11:00
15:30 - 16:30
12
08:30 - 12:30
10:00 - 11:00
CONTACT
DETAILS
ORGANISER
MEETING OF
IN COLLABORATION WITH
CARDIOSTIM
A subsidiary of Reed Expositions France
Website: www.cardiostim.com
JOINT WITH
ESC Working Group on Cardiac Cellular Electrophysiology
Email: workinggroups@escardio.org
Website: www.escardio.org/ewgcce
ESC Working Group on e-Cardiology
Email: workinggroups@escardio.org
Website: www.escardio.org/e-cardiology
VENUE
07:30 - 18:30
07:30 - 18:30
07:30 - 18:30
07:30 - 12:30
Rehearsal: in the SSC, a demonstration computer will be representative of what is supplied in the lecture room.
We strongly recommend that all speakers familiarise themselves with the mouse control.
14
ACKNOWLEDGEMENTS
(AS OF 12/05/2015)
The European Heart Rhythm Association (EHRA) wishes to express its sincere appreciation to all exhibitors, industry
partners and sponsors mentioned below, who have contributed to the success of EHRA EUROPACE - CARDIOSTIM
2015 in a variety of ways and initiatives.
Abbott Electrophysiology
Abbott Vascular
Fysicon B.V.
HAGMED
Arrhythmia Alliance
Hansen Medical
AtriCure
Baylis Medical
Manta
Biosense Webster
MEDICO SPA
Medtronic
Boehringer Ingelheim
MERIT MEDICAL
MicroPort EP MedTech
OSYPKA AG
CardioFocus, Inc.
Schwarzer Cardiotek
Cardiostim
Siemens Healthcare
Cook Medical
CVRx, Inc.
EBIT
St.Jude Medical
Stereotaxis Inc.
EHRA Plaza
ERCULES
Eumaco Srl
FIAB SPA
15
Symposium
ROMA
Atrial fibrillation and heart failure: advances and gaps in knowledge in the elderly
Chairpersons: W.K. Shen (Scottsdale, US); P. Mabo (Rennes, FR)
Atrial Fibrillation track
08:30 - 10:00
How-to Session
1
2
3
4
NAPOLI
Participants should learn how to apply the ESC Guidelines on Cardiac Pacing and Cardiac Resynchronisation Therapy in difficult situations where
different options may apply.
08:30
08:52
09:15
09:37
Pacing indication in sinus node disease: symptom-rhythm correlation, drug-induced bradycardia, bradycardia at night.
G. Marinskis (Vilnius, LT)
How to distinguish between intrinsic and extrinsic AV block.
J.-C. Deharo (Marseille, FR)
What to do in syncope and bundle branch block.
M. Brignole (Lavagna, IT)
What to do with rate-response function in pacing.
S. Tzeis (Maroussi, GR)
08:30 - 10:00
Main Session
5
6
7
WEDNESDAY
TUESDAY
08:30 State of the art lecture: atrial fibrillation: why age matters, from mechanism to practice guidelines.
C. Torp-Pedersen (Aalborg, DK)
08:52 Case 1: 82 year-old woman has HTN, Diabetic, cr 1.9 with paroxysmal atrial fibrillation; what would you recommend for
anticoagulation?
G.Y.H. Lip (Birmingham, GB)
09:15 Case 2: 87 year-old man has persistent atrial fibrillation with rapid ventricular rate, HTN, class II-III HF and COPD:
would you ablate the AVN? What pacemaker would you recommend?
J.C. Daubert (Rennes, FR)
09:37 Case 3: 85 year-old man runs marathon, has HTN, sinus bradycardia, and symptomatic recurrent persistent atrial fibrillation;
wants a cure: what would you recommend, ablation, anticoagulation?
P. Friedman (Rochester, US)
MONDAY
Upon conclusion of this Europace - Cardiostim Joint Symposium, participants should be able to:
Assess and manage older patients with atrial fibrillation for stroke prevention using warfarin and new oral anticoagulants
Describe the current practice in managing elderly patients with heart failure and atrial fibrillation, particularly recognizing the role of AVN
ablation and pacemaker therapy
Recognize the advances and knowledge gaps in atrial fibrillation ablation in the very elderly
SUNDAY
08:30 - 10:00
TORINO
To review the latest advances and techniques for the reduction of inappropriate and unnecessary shocks in patients with ICDs.
08:30
08:52
09:15
09:37
9
10
11
12
17
MONDAY
SUNDAY
08:30 - 10:00
TUESDAY
PALERMO
08:30 - 10:00
WEDNESDAY
Main Session
13
14
15
16
Symposium
GENOVA
The management of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is complex. The objective is to guide practicing cardiologists
in taking the most rationale approach to prevent sudden death while preserving quality of life.
08:30
08:52
09:15
09:37
08:30 - 10:00
Symposium
17
18
19
20
BOLOGNA
18
Antiarrhythmic gene therapy - (when) will biologicals replace catheters and drugs?
D. Thomas (Heidelberg, DE)
Genetic and pharmacological rescue of LQT syndrome in hiPSC-derived cardiomyocytes.
L. Sala (Leiden, NL)
Antiarrhythmic principle of SK channel inhibition in atrial fibrillation.
T. Jespersen (Copenhagen, DK)
The pentamidine analogue PA-6 selectively blocks inward rectifier potassium current IK1 in human atrial myocytes.
A.P. Khan (Essen, DE)
Correlating the effect of dofetilide derivatives in HEK cells and in human induced pluripotent stem cell derived cardiomyocytes.
P. Saxena (Vienna, AT)
21
22
23
24
25
Symposium
FIRENZE
To provide the electrophysiological basis and the clinical utility of established and new techniques for the evaluation of ventricular repolarisation
and its abnormalities, for both experimental and clinical cardiologists
The ionic and genetic bases of ventricular repolarisation.
S.G. Priori (Pavia, IT)
QT interval and its rate and autonomic control.
M. Malik (Purley, GB)
Beat to beat T wave changes.
H.V. Huikuri (Oulu, FI)
Sympathetic activity-associated periodic repolarisation dynamics
A. Bauer (Munich, DE)
08:30 - 10:00
Symposium
26
27
28
29
VENEZIA
31
32
33
34
Symposium
BARI
Monitoraggio remoto e trattamento remoto - Allied professionals (Italian):Remote monitoring and remote treatment
Chairpersons: C. Giannessi (Pisa, IT); S. Colosio (Brescia, IT)
Nurses and Allied Professional track
Local Track
WEDNESDAY
08:30 - 10:00
30
TUESDAY
MONDAY
08:30
08:52
09:15
09:37
SUNDAY
08:30 - 10:00
35
36
37
38
19
MONDAY
SUNDAY
08:30 - 10:00
TUESDAY
WEDNESDAY
CAGLIARI
Cancer treatment may lead to cardiotoxicity. More and more data become available on type of drugs, their influence on cardiac function, the
prevalence and possible surveillance during and after cancer treatment.The same holds for radiotherapy.
08:30
08:52
09:15
09:37
08:30 - 10:00
20
Main Session
39
40
41
42
AGORA
Each speaker will present and discuss their research during the session.
After the session finishes each speaker will have a dedicated screen next to the Agora in the Abstract Discussion Zone in order to further
discuss and display their presentation and facilitate in-depth dialogue with interested parties.
08:30
08:39
08:48
08:57
09:06
09:15
The features of cardiac electrical and structural remodeling in elite soccer athletes.
43
J.B. Kim, M.S. Ahn, J.S. Woo, H.S. Kim, W. Kim, W.S. Kim, K.S. Kim (Seoul and Wonju, KR)
Electrocardiographic findings in unselected Chinese adolescents during preparticipation screening
44
L. Wenling, W. Liu, Y. Zhou, G. Zhou (Beijing, CN)
Prognostic significance of an automated ECG QRS score quantifying myocardial scar burden in patients presenting with
symptoms suggestive of acute myocardial infarction
45
T. Reichlin, R. Twerenbold, R. Abaecherli, C. Sticherling, S. Osswald, C. Mueller (Basel, CH)
The usefulness of a fragmented QRS complex in patients with myocardial ischemia
(W) 46
M.H. Bae, C.Y. Kim, N.K. Kim, J.H. Kim, S.Y. Jang, S.H. Park, W.S. Choi, J.H. Lee, D.H. Yang, Y. Cho (Daegu, KR)
Clinical importance of lead aVR in arrhythmogenic cardiomyopathy.
47
S. Peters (Salzgitter, DE)
Fragmented QRS complexes in patients with hypertrophic cardiomyopathy: a marker of myocardial fibrosis detected by cardiac
magnetic resonance imaging with gadolinium enhancement
48
E. Tulumen, P. Ehlermann, C. Doesch, B. Rudic, V. Liebe, S. Roeger, J. Kuschyk, H.A. Katus, T. Papavassiliu, M. Borggrefe
(Mannheim and Heidelberg, DE)
09:24 Electrocardiographic features of disease progression in arrhythmogenic right ventricular cardiomyopathy/dysplasia
49
A.M. Saguner, S.H. Baldinger, L.M. Haegeli, T. Wolber, J. Steffel, N. Krasniqi, S.A. Mueller-Burri, C. Brunckhorst, F. Duru
(Zurich and Bern, CH)
09:33 Prevalence and prognosis role of wide QRS and of QRS narrower than normal
50
P. Maury, E. Lematte, J.B. Ruidavet, A. Rollin, A. Duparc, P. Mondoly, C. Cardin, M. Sadron, V. Bongard, J. Ferrieres (Toulouse, FR)
09:42 Electrocardiographic features in patients presenting with non-ischaemic cardiomyopathy and ventricular tachycardias
51
G. Santagostino, T. Oloriz, G. Peretto, H.J.J. Wellens, P. Della Bella (Milan, IT; Maastricht, NL)
09:51 Electrocardiographic criteria and outcome in patients with arrhythmogenic right ventricular cardiomyopathy.
52
S. Peters (Salzgitter, DE)
Moderated Posters
POSTER AREA
Temporal changes in patient characteristics and comorbidities in primary and secondary prevention ICD implantations - Insight
from nationwide Danish registries
A.C. Huth Ruwald, M. Vinther, G.H. Gislason, J.B. Johansen, J.C. Nielsen, H.H. Petersen, O.D. Joergensen, S. Riahi, C. Jons
(Gentofte, Odense, Aarhus, Copenhagen and Aalborg, DK)
Ventricular antitachycardia pacing therapy in heart failure patients with cardiac resynchronization therapy defibrillator:
efficacy, safety and impact on heart failure hospitalizations and mortality.
R.P. Ricci, M. Landolina, M. Lunati, G. Boriani, E. Daleffe, R. Rordorf, M. Maines, A. Rossillo, M. Gasparini, A. Proclemer
(Rome, Crema, Milan, Bologna, Udine, Pavia, Rovereto, Mestre-Venice and Rozzano, IT)
Fragmented left bundle branch block predicts efficacy of antithachycardia pacing theraphy in implantable cardioverter
desfibrillator carriers
E. Rodriguez Gonzalez, C. Pham Trung, V. Castro Urda, J. Toquero Ramos, M. Sanchez Garcia, A. Ragab, J. Goirigolzarri Artaza,
M.A. Restrepo Cordoba, J. Vazquez Lopez Ibor, I. Fernandez Lozano (Madrid, ES)
Incidence of Slow Ventricular Tachycardia, ATP efficacy and clinical outcome in CRT-D population
A. Bauer, F. Bode, F. Legal, F. Francesci, A. Duparc, J. Sahu, D. Mueller, R. Luise, M. Martino, A. Deplagne (Schwbisch Hall,
Luebeck, Bad Bevensen and Mnchen, DE; Poitiers, Marseille, Toulouse and Bordeaux, FR; Sheffield, GB; Chieti, IT)
Baroreflex activation therapy (BAT) safely coexists with cardiac rhythm management devices in patients with heart failure and
reduced ejection fraction
J. Mueller-Ehmsen, C. Butter, M. Halbach, R. Wachter, M. Senni, D. Klug, A. Ducharme, N. Madershahian, E. Lovett, V. Swarup
(Hamburg, Bernau bei Berlin, Cologne and Gottingen, DE; Bergamo, IT; Lille, FR; Montreal, CA; Minneapolis and Phoenix, US)
Evaluation of implantable cardioverter-defibrillator leads: a long term follow-up study
L. Leite, R. Providencia, N. Antonio, M. Ventura, J. Cristovao, L. Elvas, M. Pego (Coimbra, PT; London, GB)
Eligibility of hypertrophic cardiomyopathy patients for subcutaneous ICD: results of postural & exercise ECG screening
N.T. Srinivasan, K. Patel, P.D. Lambiase (London, GB)
Twelve-month CIED infection rate in ICD and CRT replacements using the antibacterial envelope: results of the CITADEL
and CENTURION studies
C. Henrikson, M.R. Sohail, G.R. Simons, D.J. Lerner, S. Sisk (Portland, Rochester, Englewood, NJ and Monmouth Junction, NJ, US)
The subcutaneous-ICD for patients with Brugada syndrome: a viable option for everybody?
N. Monteforte, A. Mazzanti, N. Maurizi, R. Bloise, M. Morini, P. Gambelli, C. Napolitano, S.G. Priori (Pavia, IT)
Longevity of the subcutaneous implantable defibrillator: long-term follow-up of the European Regulatory Trial cohort
D.A.M.J. Theuns, I.G. Crozier, G.S. Barr, M.A. Hood, R. Cappato, R.E. Knops, A.H. Maass, L.V.A. Boersma, L. Jordaens (Rotterdam,
Amsterdam, Groningen and Nieuwegein, NL; Christchurch and Auckland, NZ; Dudley, GB; San Donato Milanese, IT; Ghent, BE)
P53
P54
P55
P56
P57
WEDNESDAY
TUESDAY
Moderated Posters must be set up between 08:00 and 08:30, removed between 12:30 and 13:00 and be on display from 08:30 until 12:30. The
presenter should be present throughout the coffee break (10:00 - 11:00) in order to discuss the poster.
The following abstracts were chosen for their high quality and will be discussed during the Moderated Poster session animated by two
Chairpersons between 10:00 - 11:00. Each presenter will have 5 minutes to present and discuss their research in front of the audience and the
chairpersons
MONDAY
10:00 - 11:00
SUNDAY
P58
P59
P60
P61
P62
21
MONDAY
SUNDAY
11:00 - 12:30
TUESDAY
WEDNESDAY
MILANO
Recorded session-Robotics and technologies to facilitate atrial fibrillation ablation and device implantation
Chairpersons: J.L. Merino (Madrid, ES); C. Blomstrom-Lundqvist (Uppsala, SE)
- To be familiar with technologies which reduce fluoroscopic exposure during ablation and device implantation procedures.
- To learn the basic principles of second generation remote navigation systems, specially for ablation in patients with complex anatomical
peculiarities.
11:00
11:30
12:00
11:00 - 12:30
Main Session
63
64
65
ROMA
11:00 - 12:30
How-to Session
66
67
68
69
NAPOLI
Which routines will help minimising device related infections both acutely and long term . Putting patient safety in focus
11:00
11:22
11:45
12:07
22
Special Session
Main Session
TORINO
SUNDAY
11:00 - 12:30
To provide an up to date perspective on risk stratification for sudden cardiac death in patient being considered for primary prevention ICDs
Are the results of SCD-HeFT and MADIT-2 applicable to todays primary prevention patients?
M. Zabel (Gottingen, DE)
How to approach risk in patient groups when theres no trial data?
H.U. Klein (Munich, DE)
Can we prevent SCD in the first 6 weeks after MI?
G. Steinbeck (Starnberg, DE)
Can biomarkers be useful for risk stratification?
I. Goldenberg (Ramat Gan, IL)
11:00 - 12:30
How-to Session
74
75
76
77
PALERMO
The session proposal aims at providing an update to the best medical practice of fluoroscopy reduction in the EP lab.
11:00 - 12:30
Symposium
78
79
80
81
GENOVA
One gene, different phenotypes: how is it possible? Lessons from mixed phenotypes in Brugada syndrome.
Chairpersons: S. Viskin (Tel Aviv, IL); S.G. Priori (Pavia, IT)
Basic and genetic track
WEDNESDAY
TUESDAY
11:00
11:22
11:45
12:07
MONDAY
11:00
11:22
11:45
12:07
This section will provide fascinating data on mixed phenotypes. Different members of unique families carrying the same mutation present with
different phenotypes. How is this possible?
11:00
11:22
11:45
12:07
82
83
84
85
23
MONDAY
SUNDAY
11:00 - 12:30
TUESDAY
BOLOGNA
11:00 - 12:30
WEDNESDAY
Symposium
Symposium
FIRENZE
To learn clinical and research possibilities offered by novel Holter analyses including the possibilities of simultaneous recordings of different signals.
11:00
11:22
11:45
12:07
11:00 - 12:30
91
92
93
94
Symposium
VENEZIA
Differences in electrophysiology between Europe and Japan: do they really matter? An update of clinically relevant information
Joint session with the Japanese Heart Rhythm Society (JHRS)
Chairpersons: K. Okumura (Hirosaki, JP); A. Goette (Paderborn, DE)
Joint Session
11:00
11:22
11:45
12:07
24
95
96
97
98
Symposium
BARI
Problemi e competenze di interesse infermieristico nella cure delle Aritmie - Nursing issues and skills in arrhythmia care
Chairpersons: P. Raffagnato (Rovigo, IT); A. Porfili (Roma, IT)
Nurses and Allied Professional track
Local Track
SUNDAY
11:00 - 12:30
100
101
102
CAGLIARI
11:00
11:22
11:45
12:07
Mechanisms of atrial fibrillation - potential targets for prevention of AF and practical tips.
H.J.G.M. Crijns (Maastricht, NL)
Upstream therapies for AF including lifestyle - is there really evidence
P. Sanders (Adelaide, AU)
New antiarrhythmic drugs - will they really replace the old one's
I.C. Van Gelder (Groningen, NL)
Does the genotype influence response to antiarrhythmic drugs?
D. Dawood (Nashville, US)
103
104
105
WEDNESDAY
Antiarrhythmic drugs still are the cornerstone for prevention of AF. Upstream therapies still are incompletely studied and the role of the
genotype and efficacy of antiarrhythmic drugs is still in its infancy
TUESDAY
11:00 - 12:30
99
MONDAY
11:00
11:22
106
25
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
26
11:00 - 12:30
AGORA
Each speaker will present and discuss their research during the session.
After the session finishes each speaker will have a dedicated screen next to the Agora in the Abstract Discussion Zone in order to further
discuss and display their presentation and facilitate in-depth dialogue with interested parties.
11:00
11:09
11:18
11:27
11:36
11:45
11:54
12:03
12:12
12:21
Rivaroxaban and dabigatran versus warfarin in patients with high risk of stroke and embolism undergoing electrical
cardioversion with persistent and long-acting atrial fibrillation
O. Kalejs, A. Strelnieks, M. Kovalova, I. Sime, N. Pontaga, M. Zabunova, M. Berzina, I. Cgojeva, A. Lejnieks, A. Erglis (Riga, Jelgava,
Liepaja and Daugavpils, LV)
Predictive ability of bleeding risk scores for stratification of bleeding events in elderly patients with atrial fibrillation.
L. Fauchier, A. Banerjee, I. Lagrenade, N. Clementy, A. Bernard, D. Angoulvant, D. Babuty, G.Y.H. Lip (Tours, FR; Birmingham, GB)
A multicentre experience of percutaneous left atrial appendage occlusion (LAAO) using different device technologies,
with focus on long term outcome
T.R. Betts, M. Leo, S. Panikker, P. Kanagaratnam, D. Hildick-Smith, D. Todd, D. Fox, C. Pepper, J. Foran, T.R. Wong (Oxford, London,
Brighton, Liverpool, Manchester and Leeds, GB)
Early detection and treatment of supraventricular arrhythmia by remote monitoring prevents its progression in pacemaker
patients: the randomized, multicenter SETAM trial
W. Amara, C. Montagnier, S. Cheggour, M. Boursier, C. Barnay, F. Georger, A. Deplagne, S. Fromentin, M. Mlotek, J. Taieb
(Montfermeil, Vannes, Avignon, Ars-Laquenexy, Aix-en-Provence, Bziers, Libourne, Montbliard and Saint-Etienne, FR)
The influence of remote monitoring on long-term cardiovascular outcomes after cardioverter-defibrillator implantation
G. Portugal, M. Oliveira, P.S. Cunha, B. Valente, A. Lousinha, S. Alves, A.S. Delgado, R. Pimenta, J. Feliciano, R. Ferreira (Lisbon, PT)
Radiation exposure during cardiac device implantation: the RayPace registry
P. Bru, A. Dompnier, W. Amara, G. Haddad, G. Galuscan, P. Sagnol, M. Steinbach, C. Montagnier, J. Taieb, A. Milhem
(La Rochelle, Annecy, Montfermeil, La Roche sur Yon, versailles, Chalon s/Sane, Haguenau, Vannes and Aix-en-Provence, FR)
Is early reoperation after a CIED procedure associated with mortality after 6 months? Results from a complete, nationwide
cohort in Denmark
R. Kirkfeldt, J.B. Johansen, E.A. Nohr, O.D. Joergensen, J.C. Nielsen (Aarhus and Odense, DK)
Polish registry of electrical storm and recurrent ventricular tachycardia RECOVERY- preliminary results.
R. Sierpinski, J. Stepinska, Z. Kalarus, G. Opolski, K. Wranicz, S. Stec, P. Derejko, P. Urbanek, M. Bilinska, L. Szumowski
(Warsaw, Zabrze, Lodz and Rzeszow, PL)
Predictors of mortality following ventricular tachycardia ablation: data from the German multicenter ablation registry
R.R. Tilz, J. Senges, L. Eckardt, S. Willems, S. Kaab, T. Deneke, T. Lewalter, C. Reithmann, J. Brachmann, K.H. Kuck (Hamburg,
Ludwigshafen, Mnster, Munich, Bad Neustadt a.d. Saale and Coburg, DE)
After-PCI serious arrhythmias associated with worse short-term prognosis in stable patients with NSTE-ACS undergoing
successful early PCI
F. Cordeiro, S. Leao, P. Magalhaes, A. Baptista, C. Ferreira, A. Ferreira, P.S. Mateus, J.I. Moreira (Vila Real, PT)
107
108
109
110
111
112
113
114
115
116
SUNDAY
12:45 - 13:45
Learn about how the Medtronic Transcatheter Pacing System was developed, how to implant the device with tips and tricks and finally what the
first clinical results are.
Introduction.
M.G. Bongiorni (Pisa, IT)
Innovation by collaboration between physicians and industry.
P. Ritter (Pessac, FR)
Implantation of a Transcatheter Pacing System.
C. Steinwender (Linz, AT)
First clinical experience and results.
L. Mont (Barcelona, ES)
Conclusions and discussion.
T.A. Simmers (Eindhoven, NL)
Satellite Symposium
118
119
120
121
NAPOLI
How to optimise the mitral regurgitation treatment of your heart failure patients with TMVR?
Sponsored by Abbott Vascular
Chairperson: K.H. Kuck (Hamburg, DE)
- Raise awareness on TMVR for optimizing the treatment of Mitral Regurgitation in Heart Failure patients
- Investigates and discuss current clinical practices
Introduction.
K.H. Kuck (Hamburg, DE)
WHO can benefit from Transcatheter Mitral Valve Repair?
A. Vahanian (Paris, FR)
WHY should you refer your patient to Transcatheter Mitral Valve Repair?
F. Gustafsson (Copenhagen, DK)
WHEN should I consider TMVR for treating my patient?
C. Butter (Bernau/Berlin, DE)
Take home messages.
K.H. Kuck (Hamburg, DE)
12:45 - 13:45
Satellite Symposium
122
123
124
125
126
WEDNESDAY
12:45
12:48
13:01
13:14
13:41
TUESDAY
12:45 - 13:45
117
MONDAY
12:45
12:50
13:05
13:20
13:35
GENOVA
Clinical data on efficiency and efficacy of Multi ablation Technology in treating Atrial Fibrillation. Standardized workflow and how it adds value to
your clinical practice.
12:45
13:00
13:15
13:30
127
128
129
130
27
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
28
12:45 - 13:45
Satellite Symposium
BOLOGNA
The session will present optimized methods to improve the diagnosis and treatment of complex atrial and ventricular arrhythmias. These methods
include advanced mapping techniques and contact force guided ablation.
12:45
13:05
13:25
131
132
133
Special Session
MILANO
Honorary lecture
Chairpersons: G. Hindricks (Leipzig, DE); A.J. Camm (London, GB)
14:00
14:45
14:00 - 15:30
Symposium
134
135
ROMA
MONDAY
Intercontinental Lecture:
Newer diagnostic and treatment options for patients with Arrhythmogenic Right Ventricular dysplasia.
M.M. Scheinman (San Francisco, US)
Einthoven Lecture: Atrial fibrillation from mechanisms to improved care
G. Breithardt (Munster, DE)
SUNDAY
14:00 - 15:30
To inform on newly discovered mechanisms involved in the pathogenesis of atrial fibrillation and evaluate their translational potential
Atrial fibrillation genomics: Time to take the next step.
S. Kaab (Munich, DE)
MicroRNAs: are they realistic therapeutic targets in atrial fibrillation?
J.R. Ehrlich (Frankfurt, DE)
Targeting atrial fibrosis: the holy grail for the treatment of atrial fibrillation?
R.P. Martins (Rennes, FR)
Fat chance: adipose tissue talks to the atrial myocardium.
S. Hatem (Paris, FR)
How-to Session
137
138
139
NAPOLI
Participants should learn why and how to implant these new devices
14:00
14:22
14:45
15:07
Why should I implant a leadless pacemaker? Clinical cases of complications with traditional pacing devices.
P. Ritter (Pessac, FR)
How to implant a leadless pacemaker with screw-in fixation?
F.V.Y. Tjong (Amsterdam, NL)
How to implant a leadless pacemaker with fixation by hook-mechanism?
L. Mont (Barcelona, ES)
The Future: What can we expect (or hope) will come in leadless pacing.
J.M. Morgan (Southampton, GB)
140
WEDNESDAY
14:00 - 15:30
136
TUESDAY
14:00
14:22
14:45
15:07
141
142
143
29
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
14:00 - 15:30
Main Session
TORINO
14:00 - 15:30
144
145
146
147
Main Session
PALERMO
AVNRT ablation
Chairpersons: L. Jordaens (Gent, BE); C. Wolpert (Ludwigsburg, DE)
Ablation track
Symposium
148
149
150
151
GENOVA
This section will provide thorough information on the future of therapy in inherited arrhythmogenic disease. Cardiologists will have cutting edge
information on the therapeutic strategies that will be entering in the clinical arena in a near future.
14:00
14:22
14:45
15:07
30
152
153
154
155
Poster Session
POSTER AREA
Symposium
FIRENZE
SUNDAY
14:00 - 15:30
14:00 - 15:30
Symposium
156
157
158
159
VENEZIA
14:00
14:20
14:40
15:00
15:20
14:00 - 15:30
Symposium
160
161
162
163
WEDNESDAY
TUESDAY
14:00
14:22
14:45
15:07
MONDAY
To understand how the physiology and pathophysiology of myocardial Ca2+ homeostasis is linked to post-extrasystolic potentiation, which can
be easily measured in patients to assess the contractile status of their heart.
164
BARI
Clinical case: ICD for life? Decisions at device- and patient end-of-life
J.B. Johansen (Odense M, DK)
Clinical case: Brugada Syndrome and ICD
D.H. Lau (Adelaide, AU)
Clinical case: explantation of LVAD and ICD.
T. Ben Gal (Ramat Hasharon, IL)
Clinical case: implantable cardioverter defibrillator shocks, what do people feel.
I. Morken (Stavanger, NO)
165
166
167
168
31
MONDAY
SUNDAY
14:00 - 15:30
TUESDAY
WEDNESDAY
CAGLIARI
Antiarrhythmic drugs are still the cornerstone for treatment of arrhythmias. However, ablation is performed more and more. In this session we
will discuss the mechanism of antiarrhytmhic drugs and the role of antiarrhythmic drugs
14:00
14:22
14:45
15:07
14:00 - 15:30
32
Main Session
169
170
171
172
AGORA
Each speaker will present and discuss their research during the session.
After the session finishes each speaker will have a dedicated screen next to the Agora in the Abstract Discussion Zone in order to further
discuss and display their presentation and facilitate in-depth dialogue with interested parties.
14:00 Type of atrial fibrillation and pre-existing heart failure: impact on adverse clinical outcomes
173
K. Senoo, G. Lip, D. Lane, H. Buller, D. Kotecha (Birmingham, GB; Amsterdam, NL)
14:09 The dangerous embrace between atrial fibrillation and diabetes mellitus: the EURObservational Research Programme - Atrial
Fibrillation (EORP-AF) General Pilot Registry
174
S. Fumagalli, S. Said, C. Laroche, D. Gabbai, N. Marchionni, G. Boriani, A. Maggioni, M. Popescu, H. Crijns, G. Lip (Florence and
Bologna, IT; Hengelo and Maastricht, NL; Sophia-Antipolis, FR; Oradea, RO; Birmingham, GB)
14:18 Functional remodeling of both atria is associated with occurrence of stroke in patients with atrial fibrillation: lessons from
dynamic computed tomographic analysis of cardiac chamber
(W) 175
H.-M. Tsao, W.C. Hu, P.-H. Tsai, C.-L. Lee, H.-H. Wang, S.-A. Chen (Yi-Lan, Chung-Li and Taipei, TW)
14:27 Cerebral blood flow is improved after cardioversion of atrial fibrillation
176
M. Gardarsdottir, S. Sigurdsson, T. Aspelund, V.A. Gardarsdottir, V. Gudnason, D.O. Arnar (Reykjavik and Kopavogur, IS)
14:36 Pattern of left atrial remodeling at computed tomography in patients with paroxysmal, persistent and without atrial fibrillation 177
M. Brunelli, A. Grosse, S. Raffa, A. Madaffari, A. Cima, M. Frommhold, T. Daehne, J.C. Geller (Bad Berka, DE)
14:45 Comparison of atrial low voltage extent between persistent and paroxysmal atrial fibrillation
178
J. Sorrel, H. Lehrmann, J. Schiebelling, R. Weber, J. Allgeier, T. Arentz, A. Jadidi (Bad Krozingen, DE)
14:54 Relationship between diastolic ventricular dysfunction and subclinical sleep-disordered breathing in atrial fibrillation ablation
candidates
179
K. Kaitani, N. Onishi, Y. Hayama, H. Kondo, C. Izumi, Y. Nakagawa (Tenri, JP)
15:03 Obstructive respiratory events and premature atrial contractions after cardioversion
180
D. Linz, M. Hohl, K. Wirth, H.R. Neuberger, M. Boehm (Homburg, DE)
15:12 Modelling the effects of fibrosis-associated electrical heterogeneity in atrial fibrillation
181
R. Morgan, M.A. Colman, H. Chubb, M. Varela, O.V. Aslanidi (London and Manchester, GB)
15:21 Effects of different fibrotic patterns in the maintenance of atrial fibrillation: a simulation study.
182
M. Mase, S. Pelloni, A. Cristoforetti, F. Ravelli (Trento, IT)
Moderated Posters
POSTER AREA
WEDNESDAY
PVI by an endoscopically guided laser balloon: learning curve results after 12-month evaluation in 110 patients
P183
D.Q. Nguyen, S. Wilke, L. Lichtenberg, W. Fehske (Cologne, DE)
Superiority of irrigated multipolar catheter over conventional catheters in atrial fibrillation ablation
P184
S.H. Chin, S.S. Varanasi, G.S. Chu, S. Siddiqui, S.H. Man, R. Somani, A.J. Sandilands, P.J. Stafford, G.A. Ng (Leicester, GB)
Pulmonary vein isolation for symptomatic atrial fibrillation with 2nd generation cryoballoon in patients over 75 years of age P185
A. Pott, C. Bothner, M. Iturbe, M. Messemer, K. Petscher, W. Rottbauer, T. Dahme (Ulm, DE)
Comparison of cooled-tip radiofrequency vs laser balloon for pulmonary vein isolation in patients with atrial fibrillation,
a prospective evaluation
P186
J. Osca Asensi, O. Cano, A. Andres, P. Alonso, M.J. Sancho Tello, J. Olague, L. Martinez Dolz, A. Salvador (Valencia, ES)
12-month clinical outcomes following pulmonary vein isolation using the arctic front advance second-generation cryoballoon:
results from the multi-center STOP AF post approval study
P187
B.P. Knight, P.G. Novak, R. Sangrigoli, J. Champagne, M. Dubuc, S.W. Adler, V. Essebag, S.K. Jain, R.M. John, M. Mansour (Chicago,
Doylestown, St Paul, Pittsburgh and Boston, US; Victoria, Quebec and Montreal, CA)
A single four-minutes freeze with adenosine provocation versus standard procedure with bonus freeze for cryoballoon ablation:
15-months follow-up in 192 patients
P188
J. Tebbenjohanns, C. Hoefer, L. Bergmann, M. Dedroogh, D. Gaudin, A. Von Werder, K. Ruehmkorf (Hildesheim, DE)
Reliable, fast and safe: the first results with the novel gold multi-electrode ablation catheter for atrial fibrillation
P189
P. Gal, T. Buist, J.J.J. Smit, A. Adiyaman, A.R. Ramdat Misier, P.P.H.M. Delnoy, A. Elvan (Zwolle, NL)
Pilot results of independent approach to rotor targeted catheter ablation of persistent atrial fibrillation
P190
P. Kuklik, B. Schaeffer, B.A. Hoffmann, D. Schreiber, J.M. Moser, R.O. Akbulak, D. Steven, L. Pison, U. Schotten, S. Willems
(Hamburg and Cologne, DE; Maastricht, NL)
Pulmonary vein orientation significantly impacts pulmonary vein isolation results in multi-electrode ablation
P191
T.J. Buist, P. Gal, J.J.J. Smit, A.R. Ramdat Misier, P.P.H.M. Delnoy, J.P. Ottervanger, P.L. Jager, A.R. Elvan (Zwolle, NL)
Nine months outcomes following focal impulse and rotor modulation for the treatment of atrial fibrillation using the novel
P192
64-electrode basket catheter
R.R. Tilz, T. Lin, A. Rillig, L. Scholz, C.H. Heeger, A. Metzner, S. Mathew, E. Wissner, F. Ouyang, K.H. Kuck (Hamburg, DE)
TUESDAY
MONDAY
Moderated Posters must be set up between 13:30 and 14:00, removed between 18:00 and 18:30 and be on display between 14:00 and 18:00.
The presenters should be present throughout the break (15:30 - 16:30) in order to discuss the poster.
The following abstracts were chosen for their high quality and will be discussed during the Moderated Poster session animated by two
chairpersons between 15:30 - 16:30. Each presenter will have 5 minutes to present and discuss their research in front of the audience and the
chairpersons.
SUNDAY
15:30 - 16:30
33
MONDAY
SUNDAY
16:30 - 18:00
TUESDAY
WEDNESDAY
ROMA
Review of clinical trials targeting signalling pathways upstream of the atrial ionic/structural changes that provide a substrate for AF
16:30
16:52
17:15
17:37
16:30 - 18:00
193
194
195
196
Symposium
NAPOLI
Which strategies should be used when MRI is performed in pacemaker (and ICD) patients
16:30
16:52
17:15
17:37
16:30 - 18:00
Debate Session
197
198
199
200
TORINO
34
Main Session
DFT testing at the time of ICD implant for primary prevention is obsolete - Pro.
J. Healey (Hamilton, CA)
DFT testing at the time of ICD implant for primary prevention is obsolete - Contra.
J.M. Morgan (Southampton, GB)
DFT testing at the time of ICD implant for primary prevention is obsolete - Rebuttal Pro.
J. Healey (Hamilton, CA)
DFT testing at the time of ICD implant for primary prevention is obsolete - Rebuttal Contra.
J.M. Morgan (Southampton, GB)
Conclusion.
J. Healey (Hamilton, CA); J.M. Morgan (Southampton, GB)
Programming ATP at the time of ICD implant for primary prevention is obsolete and may even be harmful - Pro.
P. Lambiase (London, GB)
Programming ATP at the time of ICD implant for primary prevention is obsolete and may even be harmful - Contra.
M. Gasparini (Rozzano, IT)
201
202
203
204
205
206
207
17:45
17:50
17:55
TORINO
Programming ATP at the time of ICD implant for primary prevention is obsolete and may even be harmful - Rebuttal Pro.
P. Lambiase (London, GB)
Programming ATP at the time of ICD implant for primary prevention is obsolete and may even be harmful - Rebuttal Contra.
M. Gasparini (Rozzano, IT)
Conclusion.
P. Lambiase (London, GB); M. Gasparini (Rozzano, IT)
Main Session
209
210
PALERMO
16:30 - 18:00
Symposium
211
212
213
214
GENOVA
This section will offer practical information on the role of new genetic knowledge for risk stratification. The speaker will provide a critical
assessment of the possibilities and limitation of genetic association studies and next generation sequencing.
Genetics of the normal human electrocardiogram.
C.R. Bezzina (Amsterdam, NL)
Genetic association studies in rare diseases: do we have enough power?
S. Kaab (Munich, DE)
Genetic modifiers for risk stratification and therapy.
J. Schwartz (Milan, IT)
The role of next generation sequencing in the clinical setting.
E. Behr (London, GB)
215
WEDNESDAY
16:30
16:52
17:15
17:37
TUESDAY
16:30
16:52
17:15
17:37
MONDAY
16:30 - 18:00
208
SUNDAY
16:30 - 18:00
216
217
218
35
MONDAY
SUNDAY
16:30 - 18:00
TUESDAY
BOLOGNA
Transcription factors and microRNAs are novel modulators of ion channel expression in the sinoatrial node.
H. Dobrzynski (Manchester, GB)
The role of CTGF in cardiac remodeling upon pressure overload.
M.S.C. Fontes (Utrecht, NL)
Suberoylanilide Hydroxamic acid (SAHA) affect functional properties of HL-1 cardiomyocytes.
S. Suffredini (Bozen, IT)
Exosomes from human cardiac progenitor cells preserve cardiac function after long-term myocardial infarction.
L. Barile (Lugano, CH)
Thyroid stimulating hormone directly modulates cardiac electrical activity.
O. Casis (Vitoria, ES)
16:30 - 18:00
WEDNESDAY
Symposium
Main Session
219
220
221
222
223
FIRENZE
To understand complex CRT ECGs: Lead location, lead dislodgement, fusion, pseudofusion, oversensing, undersensing, etc.
16:30
16:52
17:15
17:37
16:30 - 18:00
Symposium
224
225
226
227
BARI
Discuss new ESC guidelines and see what is relevant for Nurses and Allied Professionals
16:30
16:52
17:15
17:37
36
228
229
230
231
Main Session
CAGLIARI
Ventricular arrhythmias occur predominantly in the setting of (non)ischaemic cardiomyopathy but may also occur in patients with a normal left
ventriular function in the setting of a channelopathy. In patients with ICDs and CRTs antiarrhythmic drugs wwarrant special.
Antiarrhythmic drugs for ventricular arrhythmias in patients with electrical heart disease.
N.A.M. Estes (Boston, US)
Antiarrhythmic drugs for ventricular arrhythmias in patients with structural heart disease.
S.H. Hohnloser (Frankfurt, DE)
Effect of antiarrhythmic drugs on stimulation and defibrillation threshold.
M.R. Gold (Charleston, US)
Optimised antiarrhythmic drug therapy in CRT patients.
K. Vernooy (Valkenburg Aan De Geul, NL)
16:30 - 18:00
232
233
234
235
AGORA
Each speaker will present and discuss their research during the session.
After the session finishes each speaker will have a dedicated screen next to the Agora in the Abstract Discussion Zone in order to further
discuss and display their presentation and facilitate in-depth dialogue with interested parties.
WEDNESDAY
The role of fractionated potentials in non-macro reentrant atrial tachycardia post atrial fibrillation ablation
236
Y.C. Wang, L.B. Shi, A. De Bortoli, L.Z. Sun, P.I. Hoff, E. Solheim, P. Schuster, O.J. Ohm, J. Chen (Bergen, NO)
Does left atrial appendage closure improve the success of pulmonary vein isolation? results of a randomized clinical trial
237
A. Romanov, E. Pokushalov, S. Artemenko, A. Yakubov, I. Stenin, E. Kretov, O. Krestianinov, I. Grazhdankin, D. Risteski, A. Karaskov
(Novosibirsk, RU; Skopje, MK)
16:48 Radiofrequency ablation of intra-atrial reentrant tachycardia in lateral tunnel Fontan circuits: the isthmus is often within
the tunnel
238
A. Porta Sanchez, K. Viswanathan, B. King, N. Jackson, V. Ezzat, A. Alqubany, L. Harris, E. Downar, K. Nair (Toronto, CA)
16:57 Determining the optimal ablation site for outflow tract ventricular arrhythmia in patients with and without a discrete
coronary cusp prepotential
239
H. Hachiya, K. Hirao, Y. Yamauchi, H. Taniguchi, S. Miyazaki, H. Nakamura, T. Takagi, J. Iwasawa, N. Ichihara, Y. Iesaka (Tsuchiura-shi,
Ibaraki-ken, Tokyo and Musashino-shi, Tokyo, JP)
17:06 Isolated epicardial RVOT scar: A typical substrate for VT in endurance athletes without evidence for inherited cardiomyopathy 240
J. Venlet, S.R.D. Piers, G.F.L. Kapel, M. De Riva Silva, M.J. Schalij, K. Zeppenfeld (Leiden, NL)
17:15 Infarct transmurality as a criterion for first-line endo-epicardial substrate-guided ventricular tachycardia ablation in ischemic
cardiomyopathy
241
J. Acosta Martinez, J. Fernandez-Armenta, D. Penela, D. Andreu, R. Borras, R.J. Perea, T. De Caralt, L. Mont, J. Brugada, A. Berruezo
(Barcelona, ES)
17:24 Ablation of ventricular tachycardia with extracorporeal membrane oxygenation hemodynamic support
242
F. Baratto, G. Santagostino Baldi, F. Pappalardo, G.D.angelo, M. Evangelista, A. Di Prima, S. Silvietti, P. Della Bella (Milan, IT)
17:33 Short- and long-term outcome after ventricular fibrillation ablation
243
K. Masuda, A. Nogami, K. Kuroki, T. Machino, M. Igarashi, Y. Sekiguchi, K. Aonuma (Tsukuba, JP)
17:42 Technological, procedural and patient characteristics determine the risk for silent cerebral events in patients undergoing atrial
fibrillation ablation
244
T. Deneke, P. Mueller, P. Halbfass, A. Szoelloesi, M. Roos, A. Schade, J. Krug, R. Schmitt, G. Christopoulos, K. Nentwich
(Bad Neustadt a.d. Saale, DE)
17:51 Resolution of inconsistent local activation time determination from bipolar electrograms using novel omnipolar catheter
technology and signal processing
245
R. Balachandran, D.C. Deno, S. Masse, K. Nanthakumar (St Paul, US; Toronto, CA)
TUESDAY
16:30
16:39
MONDAY
16:30
16:52
17:15
17:37
SUNDAY
16:30 - 18:00
37
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
38
18:15 - 19:15
Special Event
Inaugural session
Chairperson: K.H. Kuck (Hamburg, DE)
Welcome address by the EHRA President
K.H. Kuck (Hamburg, DE)
Welcome address by the ESC President.
F.J. Pinto (Lisbon, PT)
Welcome address by the Local hosts.
G.L. Botto (Como, IT); L. Padeletti (Florence, IT)
EHRA EUROPACE - CARDIOSTIM 2015 Highlights from the Chairperson Scientific Programme Committee.
C. Linde (Stockholm, SE)
EHRA EUROPACE - CARDIOSTIM 2015 Highlights from the Vice-Chairperson Scientific Programme Committee.
M. Glikson (Ramat Gan, IL)
EHRA EUROPACE - CARDIOSTIM 2015 Highlights from the ESC Working Group on e-Cardiology.
M. Malik (Purley, GB)
EHRA EUROPACE - CARDIOSTIM 2015 Highlights from the ESC Working Group on Cardiac Cellular Electrophysiology.
P.G.A. Volders (Maastricht, NL)
EHRA EUROPACE - CARDIOSTIM 2015 Highlights from the Chairperson Cardiostim.
P. Ritter (Pessac, FR)
Opening Address.
K.H. Kuck (Hamburg, DE)
MILANO
246
247
248
249
250
251
252
253
254
POSTER AREA
Poster must be set up on Sunday between 08:00 and 12:30 and should remain on display for the whole congress
The presenter is required by the poster during the Networking reception that follows the Inaugural session on the evening of Sunday 21 June,
between 19:00 and 20:00
Removed on Wednesday between 12:30 and 13:00
The outstanding quality of the following abstracts meant they received the highest grades; accordingly they have been given full visibility for the
entire congress.
P255
P256
P257
TUESDAY
WEDNESDAY
MONDAY
SUNDAY
08:30 - 18:00
P266
P267
P268
39
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
Devices (Pacing)
Cardiac implantable electronic devices adverse events reporting system (CIED_AERS): rationale and preliminary results
P270
K.R. Silva, L.B.A. Alves, T.S. Kawauchi, C.M.M. Albertini, J.V. Barros, I.C. Maurino, G. Melo, M. Martinelli, R. Costa (So Paulo and
Sao Paulo, BR)
Early electrical performance of a novel leadless transcatheter pacemaker system. Data from the Micra clinical study
P271
C. Steinwender, P. Ritter, G. Duray, K. Soejima, L. Chinitz, O. Razali, L. Mont, T. Sheldon, K. Stromberg, D. Reynolds (Linz, AT; Bordeaux, FR;
Budapest, HU; Tokyo, JP; New York, Mounds View, MN and Oklahoma City, Oklahoma, US; Kuala Lumpur, MY; Catalonia, ES)
Minimized ventricular pacing to prevent the first onset of AF in pacemaker patients without atrial arrhythmia history: results from the
ANSWER study
P272
S. Boveda, P. Defaye, J. Moreno, G. Macaluso, G. Jauvert, M. Burban, J. Noack, E. Garcia Campo, P.H. Siot, M.O. Stockburger
(Toulouse, Grenoble, Marseille, Neuilly sur Seine, Nantes and Clamart, FR; Madrid and Vigo, ES; Hamburg and Berlin, DE)
Indications & Results (Pacing)
Heart rhythm conduction disturbances in patients who underwent transcatheter aortic valve implantation - TAVI
B. Sredniawa, K. Mitrega, P. Chodor, Z. Kalarus, M. Zembala (Zabrze, PL)
Prevalence and clinical significance of LBBB according to classical or strict definition criteria in permanent pacemaker patients.
A. Mazza, M.G. Bendini, M. Lovecchio, S. Valsecchi, U. Riva, M. Leggio, R. De Cristofaro (Orvieto, Milan and Rome, IT)
Prevalence of indication for cardiac resynchronization therapy: effect of evolving clinical guidelines
M. Stahlberg, B. Svennblad, C. Linde, F. Braunschweig, U. Dahlstrom, M. Edner, L.H. Lund (Stockholm, Uppsala and Linkoping, SE)
The effect of using floseal on reducing the incidence of pocket hematoma formation in patients requiring pacemaker or implantable
cardioverter-defibrillator with concomitant dual antiplatelet therapy.
O. Al-Razo, E. Gonzalez, J.A. Blazquez, L. Sartor, A. Hurtado, J. Silvestre, J.M. Mesa (Madrid, ES)
Use of CoreValve and prolonged PQ and QRS times are associated with pacemaker dependence in patients with a new LBBB after
transcatheter aortic valve implantation
V.J. Nijenhuis, S.M. Chaldoupi, J.C. Balt, M.C.E.F. Wijffels, L.V.A. Boersma, J.M. Ten Berg (Nieuwegein, NL)
P273
P274
P275
P276
P277
Leadless (Pacing)
How robust is the Micra transcatheter pacemaker fixation?
P278
T.A. Simmers, M.D. Bonner, F.A.L.E. Bracke, M.D. Eggen, P. Ritter, D. Reynolds (Eindhoven, NL; Mounds View MN and Oklahoma City, US;
Bordeaux, FR)
Technical and imaging aspects (Resynchronisation therapy)
Imaging guided left ventricular lead placement improves clinical response in cardiac resynchronization therapy: a randomized
controlled trial
(W) P279
A. Sommer, M.B. Kronborg, B.L. Norgaard, S.H. Poulsen, H.K. Jensen, J.M. Jensen, J. Kristensen, C. Gerdes, P.T. Mortensen, J.C. Nielsen
(Aarhus, DK)
Service life of implantable cardioverter-defibrillators for cardiac resynchronization therapy: an analysis of determinants in current
clinical practice.
P280
M. Landolina, A. Curnis, G. Morani, A. Vado, E. Ammendola, A.D. Onofrio, G. Stabile, M. Crosato, M. Gasparini (Crema, Brescia, Verona,
Cuneo, Naples, Treviso and Rozzano, IT)
Indications & Results (Resynchronisation therapy)
Left ventricular endocardial pacing across the interventricular septum - medium-term results
J.H.P. Gamble, M. Ginks, K. Rajappan, Y. Bashir, T.R. Betts (Oxford, GB)
Left ventricular lead position and outcome in CRT - a large nationwide cohort study.
M.B. Kronborg, J.B. Johansen, S. Riahi, H.H. Petersen, J. Haarbo, O.D. Jorgensen, J.C. Nielsen (Aarhus, Odense, Aalborg and
Copenhagen, DK)
Lead management - extractions and recalls
Characteristics and failure rate of the Biotronik Linox implantable cardioverter defibrillator lead
F. Demirel, A. Adiyaman, P.P. Delnoy, J.J.J. Smit, A.R. Ramdat Misier, A. Elvan (Zwolle, NL)
40
P269
P281
P282
P283
Anticoagulation
Prognosis in patients with atrial fibrillation and CHA2DS2-VASc score = 1 in a community based cohort study.
L. Fauchier, C. Lecoq, N. Clementy, D. Angoulvant, D. Babuty, G.Y.H. Lip (Tours, FR; Birmingham, GB)
P286
P287
P288
P289
P290
TUESDAY
P285
MONDAY
P284
SUNDAY
Different outcomes between high and low volume centres performing transvenous lead extraction in the ELECTRa registry
M.G. Bongiorni, C. Kennergren, C. Butter, J.C. Deharo, A. Kutarski, C.A. Rinaldi, A.P. Maggioni, C. Blomstrom-Lundqvist, A. Auricchio,
K.H. Kuck (Pisa, IT; Gothenburg and Uppsala, SE; Bernau bei Berlin and Hamburg, DE; Marseille and Sophie Antipolis, FR; Lublin, PL;
London, GB; Lugano, CH)
Transvenous removal of pacing and ICD leads: single italian referral center experience.
M.G. Bongiorni, E. Soldati, L. Segreti, G. Zucchelli, A. Di Cori, S. Viani, L. Paperini, G. Branchitta, D. Andreini (Pisa, IT)
WEDNESDAY
41
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
42
08:30 - 12:30
Poster Session
POSTER AREA
Poster session 1
Posters must be set up between 08:00 - 08:30, removed between 12:30 - 13:00, to be on display between 08:30 - 12:30.
The presenter should be available by the poster during the coffee break (10:00 to 11:00) in order to discuss the research with the audience.
Clinical and epidemiological aspects (Atrial Fibrillation)
Cost and efficiency benefits of a single modality imaging strategy for pre-procedural workup of atrial fibrillation catheter ablation
P291
P. Bhagirath, A.W.M. Van Der Graaf, E. Van Dongen, S. Ghoerbien, V.J.H.M. Van Driel, H. Ramanna, N.M.S. De Groot, M.J.W. Gotte
(The Hague and Rotterdam, NL)
Left atrial appendage closure using the novel Coherex Wavecrest device - initial single center experience
P292
K.J. Chun, S. Bordignon, L. Perrotta, A. Fuernkranz, D. Dugo, A. Konstantinou, B. Schmidt (Hamburg and Frankfurt am Main, DE)
Neuropreventive effect of sitagliptin after atrial fibrillation related ischemic stroke in type 2 Diabetic Patients: a nationwide cohort
study
P293
T.H. Chen, L.S. Lin, D.Y. Chen, S.H. Wang (Taipei, TW)
Arrhythmia progression is associated with development of cardiovascular disease in a population of patients with idiopathic atrial
fibrillation: a 5-year follow-up study
P294
E.A.M.P. Dudink, B. Weijs, R.J. Haest, J.A. Kragten, B.L. Kietselaer, J.E. Wildberger, H.J.G.M. Crijns (Maastricht, Geldrop and Heerlen, NL)
Effect on sleep and sleep apnea with cardioversion of atrial fibrillation
(W) P295
N. Hoglund, C. Sahlin, M. Kesek, S. Jensen, K. Franklin (Umea, SE)
Assessment of p wave signal-averaged ECG in patients with hypertension to investigate the preventive effect of eplerenone on atrial
P296
fibrillation
M. Kawasaki, T. Yamada, T. Morita, Y. Furukawa, S. Tamaki, Y. Iwasaki, A. Kikuchi, T. Kondo, M. Fukunami (Osaka, JP)
Categorizating patients with long-standing atrial fibrillation by evaluating exercise capacity helped in determining treatment strategy P297
T. Haruna, M. Funasako, I. Tanaka, M. Okano, T. Sekihara, Y. Kimura, H. Hayashi, M. Kimura, M. Inoko (Osaka, JP)
Mechanisms & Computer modelling (Atrial Fibrillation)
Hyperglycemia and oxidative stress stimulate abnormal proliferation of atrial fibroblast through NADPH oxidase/MAPK/MMP9
signal pathway
T. Liu, Q. Zhang, X. Wang, X. Liang, G. Li (Tianjin, CN)
Antiarrhythmic drugs (Atrial Fibrillation)
Effect of QT interval prolongation following antiarrhythmic drug therapy on left ventricular systolic and diastolic function.
K. Chouchoulis, J. Chiladakis, N. Koutsogiannis, P. Davlouros, D. Alexopoulos (Patras, GR)
P298
P299
MONDAY
TUESDAY
WEDNESDAY
SUNDAY
P322
Tools: catheters, sources, mapping, navigators (Catheter ablation / except atrial fibrillation)
Spot diagnosis by means of an ECG pattern: Inferior axis and positive concordant R pattern in the precordial leads are pathognomonic
for ventricular arrhythmias arising from the great cardiac vein
P323
H. Bogossian, G. Frommeyer, I. Ninios, F. Hasan, Q.S. Nguyen, Z. Karosiene, D. Mijic, B. Lemke, M. Zarse (Ldenscheid/ Witten-Herdecke,
Mnster and Luedenscheid, DE)
Assessment of ventricular tachycardia scar substrate by intracardiac echocardiography : comparison with contrast-enhanced cardiac MRI ( W) P324
I. Watanabe, Y. Okumura, K. Takahashi, K. Sonoda, A. Hirayama (Tokyo, JP)
A novel technique for simultaneous representation of multiple EP datasets with equivalent accuracy to color surface shading
P325
J. Whitaker, S. Williams, H. Chubb, M. Gabrawi, M.O.neill (London, GB)
P326
Peri-mitrotricuspid annulus atrial flutter: reentrant circuit delineation by entrainment mapping
E. Falconi, A. Bittner, M. Arceluz, R. Delgado, R. Altamirano, F. Cruz, M. Ortega, F. Larraya, J.L. Merino (Madrid, ES; Santiago, CL)
3D transcatheter cryoablation of slow pathway for treatment of atrio-ventricular nodal reentry tachycardia in children: acute success
obtained by a single focus cryolesion predicts a better outcome
P327
M.S. Russo, D. Righi, C. Di Mambro, M.S. Silvetti, R. Remoli, F.A. Saputo, F. Drago (Rome, IT)
43
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
P329
P330
P331
P332
P333
P334
P335
P336
P337
44
P328
P340
P341
P342
P343
P344
P346
P347
P348
P349
P353
P354
P355
P356
WEDNESDAY
TUESDAY
MONDAY
P345
SUNDAY
Leads (Pacing)
Intra-Hisian block: Stable distal His-Purkinje conduction at 3 years during permanent His bundle pacing
P. Vijayaraman, A. Naperkowski, G. Dandamudi, K.A. Ellenbogen (Wilkes Barre and Richmond, US)
Electrical performance and lead handling evaluation of a new active fixation left ventricular lead: results of an italian multicenter
experience
M. Biffi, R. Rordorf, G. Giannola, G. Luzzi, M.G. Bongiorni, G. Maglia, L. Bontempi, M. Ziacchi, M. Landolina, M. Lunati (Bologna, Pavia,
Cefalu, Bari, Catanzaro, Brescia and Milan, IT)
P357
P358
45
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
46
Syncope
Implantable loop recorder: a syncope unit experience
M. Rafanelli, A. Ceccofiglio, F. Tesi, G. Toffanello, V.M. Chisciotti, G. Rivasi, N. Marchionni, A. Ungar (Florence, IT)
Importance of coronary vasospasm in unexplained syncope
D.H. Shin, C.K. Lee, G.H. Sohn, J.W. Kim, S.Y. Yoo, S.S. Cheong (GangNeung, KR)
Mechanism (Basic Science in Arrhythmias)
Waveform characteristics of ventricular fibrillation in relation to clinical parameters and shock success: An electrocardiographic
study in ICD-patients
J.L. Bonnes, J. Thannhauser, M. Hermans, J. Nas, S.W. Westra, M.J. De Boer, M.A. Brouwer, J.L.R.M. Smeets (Nijmegen and Enschede, NL)
Measurement of ventricular effective refractory period by the extrastimulus technique: effect of baseline ventricular pacing versus
sinus rhythm.
S. Rossi, F. Cacciani, M. Zaniboni, S. Callegari, L. Carnevali, A. Sgoifo, M. Miragoli, E. Macchi (Parma, IT)
A microRNA blueprint for early atrial remodeling in a porcine model of paroxysmal atrial fibrillation
M. Torrado, D. Franco, E. Lozano-Velasco, F. Hernandez-Torres, R. Calvino, G. Aldama, A. Centeno, A. Castro-Beiras, A. Mikhailov
(La Coruna and Jaen, ES)
Galectin 3 in patients with atrial fibrillation and metabolic syndrome
V.A. Ionin, O.V. Listopad, S.E. Nifontov, A.V. Soboleva, D.I. Jatsuk, E.L. Zaslavskaya, O.D. Belyaeva, E.I. Baranova, E.V. Shlyakhto
(Saint Petersburg and Saint-Petersburg, RU)
Pharmacology (Basic Science in Arrhythmias)
Magnesium, an old but still fascinating antiarrhythmic: a comparative study of two doses
S. Myftiu, I. Sharka, A. Shkoza, G. Sulo, E. Sulo, X.H. Belshi, E. Saja (Tirana, AL; Bergen, NO)
Monitoring tools
Magnetocardiography provides beat-to-beat monitoring of fetal rhythm in unshielded clinical ambulatory setting at the 28th week of
gestation
D. Brisinda, A.R. Sorbo, A. Venuti, F. Fioravanti, R. Fenici (Rome, IT)
Clinical mechanisms (Cardiac arrhythmias, non invasive)
Electrophysiological observations of acute His bundle injury during permanent His bundle pacing
A. Naperkowski, G. Dandamudi, K.A. Ellenbogen, P. Vijayaraman (Wilkes Barre and Richmond, US)
Insight into the role of environmental triggers in J wave syndrome: results of 15 year-follow up.
A. Talib, N. Sato, K. Sumitomo, T. Nishiura, N. Sakamoto, Y. Tanabe, T. Takeuchi, Y. Kawamura, N. Hasebe (Asahikawa, JP)
ECG and eCardiology (Cardiac arrhythmias, non invasive)
Corrected PR interval after treatment optimisation: does it matter?
T. Nikolaidou, P. Pellicori, J. Zhang, A.L. Clark (Hull, GB)
Correlation between electrocardiographic abnormalities and scar location in patients with non-ischaemic cardiomyopathy and
ventricular tachycardia
G. Santagostino, T. Oloriz, G. Peretto, H.J.J. Wellens, P. Della Bella (Milan, IT; Maastricht, NL)
The lewis lead for P-wave detection during ventricular tachycardia
M. Huemer, H. Meloh, A. Wutzler, A.S. Parwani, P. Attanasio, H. Matsuda, F. Blaschke, L.H. Boldt, W. Haverkamp (Berlin, DE)
High risk electrocardiographic markers in Brugada syndrome
S. Georgopoulos, P. Korantzopoulos, M. Efremidis, K. Vlachos, N. Fragakis, P. Arsenos, K. Gatzoulis, A. Sideris, T. Liu, K. Letsas (Athens,
Ioannina and Thessaloniki, GR; Tianjin, CN)
Novel galvanised titanium-based ECG technology can reliably detect arrhythmias
F. Ara, C. Crockford, I. John, R.A. Kaba (Ashford and London, GB)
P363
P364
P365
P366
P367
P368
P369
P370
P371
P372
P373
P374
P375
P376
P377
P378
P379
Remote monitoring
Effectiveness of a management program for outpatient clinic or remote titration of beta-blockers in CRT patients: the RESTORE study.
A.D. Onofrio, P. Palmisano, E. Ammendola, L. Calo', A. Ruocco, A. Rapacciuolo, G. Del Giorno, V. Bianchi, M. Campari, M. Accogli
(Naples, Tricase, Rome and Milan, IT)
P383
P384
P385
P386
TUESDAY
P382
MONDAY
Anticoagulation
Initial european experience with a novel percutaneous epicardial suture delivery device for LAA exclusion.
R.R. Tilz, J. Foran, K. Bartus, T. Wong, S. Gafoor, T. Fink, J. Myc, R. Lee, H. Sievert, K.H. Kuck (Hamburg and Frankfurt am Main, DE;
London, GB; Krakow, PL; San Francisco, US)
Suitable PT-INR in Japanese is different from Caucasian from the base of coagulat and fibrinolytic makers
Y. Kobayashi, A. Ochi, K. Inokuchi, Y. Nakamura, K. Ogawa, Y. Onishi, Y. Munetsugu, Y. Minoura, N. Watanabe, E. Uchida (Tokyo, JP)
SUNDAY
Intermediate term outcome of thoracic sympathectomy in patients with diseased hearts and refractory ventricular tachycardia storms P380
P. Barwad, S. Devidutta, M. Shah, S. Joshi, S. Vichare, S. Shastri, M. Venkat, R. Motwani, S. Moolgaonkar, Y. Lokhandwala (Chandigarh
and Mumbai, IN)
Risk assessment in hypertrophic cardiomyopathy: the role of the emerging sudden cardiac death risk factors
P381
M.F. Mezni, A. Haggui, S. Mzoughi, H. Mahfoudhi, B. Jdaida, N. Ben Mansour, D. Lahidheb, N. Hajlaoui, W. Fehri, H. Haouala (Tunis, TN)
WEDNESDAY
47
SUNDAY
14:00 - 15:30
Poster Session
Posters must be set up between 08:00 - 08:30, removed between 18:00 - 18:30, to be on display between 08:30 - 18:00.
The presenter should be available by the poster (14:00-15:30) in order to discuss the research with the audience.
WEDNESDAY
TUESDAY
MONDAY
Modelling
Effects of mutations in HCN4 assessed with the Inada et al. human sinus node action potential model.
48
POSTER AREA
(W) P387
P388
P389
P390
P391
P392
P393
P394
P395
P396
P397
P398
Arrhythmias
Cardiac electrophysiological properties of Hey2+/- mice.
P399
S. Podliesna (Amsterdam, NL)
P400
Alteration of membrane distribution of Cav3 T78M induces cardiac arrhytmias by modulating ion channel properties.
A. Barbuti (Milan, IT)
A new KCNQ1 mutation that impairs its association with KCNE1 is responsible for short QT syndrome.
P401
C. Valenzuela (Madrid, ES)
Role of common polymorphism Q2958R on RyR2 function and propensity to cardiac arrhythmias.
P402
C. Valdivia (Ann Arbor, US)
Functional characterization of a mutation in KCNT1 gene related to non familial Brugada Syndrome.
P403
I. Rivolta (Monza, IT)
Functional characterization of a new cpvt-1 ryr2 mutation (r420q) in mouse ventricular myocytes
P404
R. Rizzetto, Y.Y. Wang, A. Zahradnikova Jr, F. Lefebvre, J.P. Benitah, A.M. Gomez (Chatenay-Malabry, FR)
In vivo modulation of the cardiac sodium channel by overexpression of a Brugada syndrome SCN5A mutation in mice using
viral vectors
P405
N. Doisne, M. Grauso, N. Mougenot, M. Clergue, A. Coulombe, P. Guicheney, N. Neyroud (Paris, FR)
Scn5a+/deltaQKP mice present late sodium current associated with long QT syndrome, dilated cardiomyopathy and ranolazine-sensitive
spontaneous ventricular arrhythmias
P406
N. Belbachir, J. Montnach, F. Chizelle, A. Carcouet, I. Baro, F. Charpentier (Nantes, FR)
P408
P409
P410
P411
P412
P413
P414
MONDAY
P415
P416
P417
P418
P419
TUESDAY
P420
P421
P422
P423
P424
WEDNESDAY
P407
SUNDAY
The role of -adrenoceptor activation in the frequency-dependence of triggered activity in catecholaminergic polymorphic
ventricular tachycardia.
M.K. Stokke (Oslo, NO)
Effect of hypercholesterolemia and ageing on TdP arrhythmia incidence in methoxamine sensitized rabbits.
L. Nalos (Pilsen, CZ)
Optical mapping sutdy of atrial fibrillation-induced reentry on perfused whole heart preparation in a large mammalian species.
C.E. Cros (Pessac, FR)
Cardiac remodeling in rat model volume overload.
D. Jarkovska (Plzen, CZ)
Heart rate variability in sepsis.
M. Stengl (Pilsen, CZ)
Not hypoxia alone but obstructive respiratory events disturb ventricular repolarisation by sympathatic activation
D. Linz, M. Hohl, K. Wirth, J.C. Reil, M. Boehm (Homburg, DE)
The study of EADs and the relation to Torsade de Pointes
N.V. Vandersickel, A.V.P. Panfilov (Ghent, BE)
Asymptomatic ventricular fibrillation in patient with implanted left ventricle assist device. A case report.
E. Gadula-Gacek, M. Tajstra, J. Pacholewicz, A. Kurek, M. Zakliczynski, P. Nadziakiewicz, M. Gasior, M. Zembala (Zabrze, PL)
Defective sinoatrial node function causes cardiac arrhythmias in diabetic mice
A.F. Lubberding, E. Soltysinska, T. Speerschneider, M. B Thomsen (Copenhagen, DK)
Pro-arrhythmic electrical rate of atrial conduction and distinct cardiac Cxs contribution in HL-1 cell line
M. Constantin, S. Dupuis, S. Chaigne, T. Desplantez (Bordeaux, FR)
Pulmonary vein isolation by laser balloon ablation: is energy delivered too deep into the vein?
M.R. Arceluz, F. Cruz, E. Falconi, O. Salvador, J. Figueroa, M. Ortega, R. Delgado, J. Caro, C. Vasquez, J.L. Merino (Madrid, ES)
The lack of Hemopexin causes cardiac heme retention and oxidative stress in C57BL/6 mice, resulting in reduction of fractional
shortening.
G. Ingoglia (Turin, IT)
Determined factors of long- term efficacy of persistent atrial fibrillation radiofrequency ablation: 5 years of follow-up
S.H.G. Nardaia, Z.R. Mustapaeva, F.G. Rzaev, A.S.H. Revishvili (Moscow, RU)
Electrical isolation of the superior vena cava by laser balloon ablation in patients with atrial fibrillation: initial experience.
M.R. Arceluz, P.F. Cruz, E. Falconi, O. Salvador, J. Figueroa, M. Ortega, R. Delgado, J. Caro, C. Vasquez, J.L. Merino (Madrid, ES)
Lower loop reentry. Entreintment characterization and ablation validation
P.F. Cruz, M. Arceluz, E. Falconi, S. Castrejon Castrejon, O. Salvador, J. Caro, R. Delgado, M. Ortega, C. Vazquez, J.L. Merino Llorens
(Madrid, ES)
Malignant mitral valve prolapse mixes up features of primary electrical disorder and mild structural heart disease
L. Bisch, S. Di Bernardo, P. Monney, P. Pascale, C.I. Park, E. Pruvot (Lausanne, CH)
Association of initial and terminal ventricular activation velocity ratio on 12-leads electrocardiography with myocardial scar presence
S. Priyantoro, K. Priyantoro, Y. Yuniadi, M. Kasim, A.M. Soesanto (Jakarta, ID)
Assessment of cardiac electrophysiology during deep hypothermia and rewarming in isolated Langendorff perfused rabbit hearts
K. Mcglynn, E.S. Dietrichs, A. Allan, F. Burton, T. Tveita, G.L. Smith (Glasgow, GB; Tromso, NO)
Panoramic measurements of ventricular activation and repolarisation in isolated rabbit hearts during bi-ventricular pacing
A. Allan, R. Myles, G. Smith, F. Burton (Glasgow, GB)
P425
P426
P427
P428
P429
P430
P431
P432
49
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
50
The TRPM4 non-selective cation channel participates in the rabbit Purkinje fiber action potential
T. Hof, R. Rouet, A. Manrique, L. Salle, R. Guinamard (Caen, FR)
Accurate co-expression ratio of Cx43:Cx45: influence on the gap junction channels make-up and properties
S. Dupuis, S. Chaigne, M. Constantin, T. Desplantez (Bordeaux, FR)
Electrical properties of gap junction channels: dependence on the ratio of co-expressed connexin 43 and connexin 40.
S. Chaigne, S. Dupuis, M. Constantin, T. Desplantez (Bordeaux, FR)
TRPM4 over-expression in HEK-293 cell line: comprehensive interpretation of functional data.
L.C. Ozhathil, V. Sottas, N. Syam, J.S. Rougier, B. Bianchi, H. Abriel (Bern, CH; Leuven, BE)
Bridging integrator 1 (BIN1) initiates t-tubule growth during cardiac development and disease
D.B. Lipsett, M. Frisk, N. Singh, J.M. Aronsen, W. Marszalec, O.M. Sejersted, I. Sjaastad, J.A. Wasserstrom, G. Christensen, W.E. Louch
(Oslo, NO; Chicago, US)
Slices of human neonatal and infantile myocardium: a novel experimental platform to study (patho)physiological properties at
a cellular level
T. Hannes, M. Haustein, M. Khalil, J. Hescheler, A. Kroener, G. Bennink, K. Brockmeier (Cologne and Giessen, DE)
Multiple roles of TRPM4 cation channel in cardiac electrophysiology
R. Guinamard, T. Hof, P. Bouvagnet, L. Salle (Caen and Lyon, FR)
The effect of beta3-adrenoceptors on Na/K pump modulation in noradrenaline-incubated cardiomyocytes
G. Kayki Mutlu, M. Rocchetti, V.M. Altan, A. Zaza (Ankara, TR; Milan, IT)
P433
P434
P435
P436
P437
P438
P439
P440
Poster Session
POSTER AREA
Poster session 2
Posters must be set up between 13:30 - 14:00, removed between 18:00 - 18:30, to be on display between 14:00 - 18:00.
The presenter should be available by the poster during the break (15:30 to 16:30) in order to discuss the research with the audience.
P448
P449
WEDNESDAY
P447
TUESDAY
MONDAY
SUNDAY
14:00 - 18:00
P450
P451
P452
P453
P454
P455
P456
51
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
Sequential unipolar and bipolar radiofrequency versus repeated unipolar radiofrequency ablation of paroxysmal atrial fibrillation
by nMARQ catheter
P457
P. Vergara, L. Capulzini, G. Paparella (Milan, IT; Brussels, BE)
Atrial fibrillation ablation with Amigo robotic arm: a comparison with manual navigation
P458
F. Moscoso Costa, R. Candeias, P. Adragao, D. Cavaco, P. Santos, E. Vaz, P. Carmo, F. Morgado, M. Mendes (Lisbon, PT)
Characteristics and efficacy of radiofrequency catheter ablation for symptomatic atrial premature contractions
P459
S. Aita, K. Kuroki, M. Igarashi, Y. Sekiguchi, A. Nogami, K. Aonuma (Ibaraki, JP)
Three-minute single shot versus three-minute double shot cryoballoon ablation for the treatment of atrial fibrillation
P460
J. Marti Almor, E. Valles, B. Benito, P. Ramos, S. Cabrera, A. Fageda, V. Bazan (Barcelona, ES)
Feasibility and safety of nurse-directed deep sedation
(W) P461
M. Namdar, L. Varotto, F. Mattey-Prevot, J. Lyvet, D. Marcelot, A. Eichenberger, P. Gentil-Baron, H. Sunthorn, H. Burri, D. Shah
(Geneva, CH)
FIRM only ablation in patients with persistent atrial fibrillation: acute and medium term results.
P462
A. Schade, P. Halbfass, P. Mueller, K. Nentwich, M. Roos, F. Steinborn, G.A. Szoelloesi, P. Pavlov, T. Deneke
(Erfurt and Bad Neustadt/ Saale, DE)
Does the size of isolation area after pulmonary vein isolation with balloon-based techniques really matter for the long term outcome? P463
G.M. Fassini, L. Cipolletta, G. Del Giorno, S. Conti, G. Vettor, A. Dello Russo, F. Tundo, B. Majocchi, V. Marino, C. Tondo (Milan, IT)
Feasibility of left atrial ablation for the treatment of atrial tachyarrhythmias in patients with left atrial appendage closure devices
P464
C.H. Heeger, A. Rillig, T. Lin, S. Mathew, M. Botros, A. Metzner, E. Wissner, K.H. Kuck, F. Ouyang, R.R. Tilz (Hamburg, DE)
Activation mapping during pulmonary vein pacing allows precise localization of conduction gaps in the wide circumferential ablation
lines to complete pulmonary vein isolation
P465
G. Monir, S. Pollak, E. Bassily, J. Pepe (Orlando, US)
Relationship between reduced left atrial function and electro-anatomical remodeling in patients undergoing atrial fibrillation ablation. P466
A.S. Parwani, D.A. Morris, N. Smolny, M. Huemer, A.S. Wutzler, P. Attanasio, F. Blaschke, W. Haverkamp, L.-H. Boldt (Berlin, DE)
Incidence and characteristics of pulmonary vein stenosis following catheter ablation of atrial fibrillation: insights from the
contemporary multicenter ADVICE trial
(W) P467
S. Gomes, P. Khairy, F.P. Mongeon, Z. Galvan, J. Andrade, S. Nattel, M. Talajic, S. Levesque, D. Roy, L. Macle (Montreal, CA)
Galectin-3 in patients with atrial fibrillation undergoing radiofrequency catheter ablation
P468
J. Kornej, J. Schmiedl, L. Ueberham, S. John, B. Dinov, G. Hindricks, V. Adams, D. Husser, A. Bollmann (Leipzig, DE)
P469
Optimal settings of VisiTag module for contact force-guided circumferential pulmonary vein isolation of atrial fibrillation
K. Nakamura, S. Naito, K. Minami, T. Sasaki, E. Goto, M. Nakano, S. Shimizu, T. Yano, K. Kumagai, S. Oshima (Maebashi, JP)
Characterization of endocardial voltage attenuation and pulmonary vein isolation following convergent epicardial ablation for
persistent atrial fibrillation
P470
B.G. Hook, T. Fitton (Burlington MA, US)
Surgery & Pacing (Atrial Fibrillation)
Excellent outcomes at long term follow-up following minimally invasive surgical ablation for stand-alone atrial fibrillation
C. Muneretto, G. Bisleri, F. Rosati, L. Di Bacco, L. Bontempi, M. Cerini, A. Curnis (Brescia, IT)
P471
Tools: catheters, sources, mapping, navigators (Catheter ablation / except atrial fibrillation)
An automated algorithm for the segmentation of the left atrial blood pool as a key step in the assessment and display of left atrial wall
thickness
P472
J. Whitaker, R. Karim, T. Fastl, R. Rajani, H. Chubb, S. Williams, M. Gabrawi, M. Wright, S. Niederer, M.O.neill (London, GB)
P473
Stereotactic radiosurgery in threatment of ventricular tachycardias
R. Neuwirth, J. Cvek, L. Knybel, L. Molenda, B. Otahal, J. Pindor, M. Fiala, D. Feltl, M. Branny (Trinec and Ostrava, CZ)
Experience with non-invasive mapping system (ECVUE) to guide ablation
P474
F. Gomez, K. Roy, L. Mantziari, D. Valeron, I. Horduna, J.R. Clague, S. Ernst (London, GB)
Direct pulmonary vein ablation with stenosis prevention therapy
(W) P475
C. Desimone, E. Ebrille, F. Syed, D. Ladewig, S. Suddendorff, E. Gilles, A. Danielsen, S. Kapa, D. Holmes, S. Asirvatham (Rochester and
Ann Arbor, US; Turin, IT)
P476
Use of electrical coupling index in typical atrial flutter ablation
M. Maines, D. Catanzariti, C. Angheben, M. Del Greco (Rovereto, IT)
Results (Catheter ablation / except atrial fibrillation)
The non-fluoroscopic navigation reduces significantly not only the x-ray exposure but the cumulative radiofrequency time as well
during radiofrequency catheter ablation of the cavo-tricuspid isthmus
T.N. Shalganov, M.K. Stoyanov, B.T. Kunev (Sofia, BG)
52
P477
Devices (Pacing)
Early impacts of right ventricular pacing on left ventricular strain and dyssynchrony
A. Algazzar, M.A. Moharram, A.A. Katta, G. Soltan, W. Abdelaziz (Cairo and Shebin El-kom, EG)
Intra-individual comparison of two algorithms for the reduction of ventricular pacing percentage in sick sinus syndrome:
twelve-month results from the VIPERS study
V. Calvi, E.C.L. Pisano', M. Brieda, V. Giudici, D. Melissano, B. Castaldi, G. Nigro, C. Guastaferro, M. Madalosso, A. Capucci (Catania,
Lecce, Pordenone, Seriate, Casarano, Isernia, Naples, Castellammare, Mestre-Venice and Ancona, IT)
Long-term single-center experience with subaxillary approach in cardiac defibrillators implantation in young patients population
M. Morosato, G. Morani, G. Silvestre, L. Tomasi, B. Bolzan, G. Mugnai, C. Vassanelli (Verona, IT)
Follow up cost of patients subjected to cardiac rhythm management device implantation
J. Fanourgiakis, E. Simantirakis, E. Kanoupakis, S. Chrysostomakis, N. Maniadakis, G. Kourlaba, G. Mpantouvakis, M. Touloupaki, E. Kouvidis,
P. Vardas (Heraklion and Athens, GR)
Leads (Pacing)
Long-term performance of a MRI-conditional ventricular lead: Beflex MRI RF46D (Ventricular) and RF45D (atrial).
J.A. Lapuerta Irigoyen, R. Bangueses, P. Vigil, J. Casares, C. Fernandez Cimadevilla, J. Garcia-Rubio (Gijon and Aviles, ES)
Low dislodgement and phrenic nerve stimulation (PNS) incidences observed in new straight quadripolar LV leads
M. Biffi, D. Gras, D. Exner, W.B. Johnson, A.C. Lin, A. Hussin, G. Giannola, S. Li, K. Holloman, G. Crossley (Bologna and Cefalu, IT;
Nantes, FR; Calgary, CA; Des Moines, Chicago, Minneapolis and Nashville, US; Kuala Lumpur, MY)
P485
P486
P487
P488
WEDNESDAY
Subcutaneous ICD
Prevalence of subcutaneous implantable defibrillator (S-ICD) related complications in patients with congenital heart disease:
results from a pooled analysis from the IDE study and EFFORTLESS registry
B.D.souza, Y.Y. Kim, M. Burke, J.M. Morgan, A.R. Leon, K.K. Patton, S.C. Agarwal, P.H. Belott, A.E. Epstein, M.J. Shah (Philadelphia,
Chicago, Atlanta, Seattle and La Mesa, US; Southampton and Newcastle upon Tyne, GB)
P484
TUESDAY
P483
MONDAY
Primary & Secondary prevention (Sudden cardiac death and implantable defibrillators)
long term follow up of victims of out of hospital cardiac arrest with first rhythm ventricular fibrillation treated with an ICD in
secondary prevention
M. Caputo, B. Adjibodou, F. Regoli, G. Conte, A. Del Bufalo, T. Moccetti, C. Klersy, M. Curti, A. Auricchio (Lugano, CH; Pavia, IT)
Prognostic value of the epinephrine test following thoracoscopic left cardiac sympathetic denervation in patients with inherited
arrhythmia syndrome
S.Y. Jang, Y. Cho, N.K. Kim, C.Y. Kim, J.H. Kim, M.H. Bae, J.H. Lee, D.H. Yang, H.S. Park, S.C. Chae (Daegu, KR)
Re-evaluation of the left ventricular ejection fraction before ICD generator replacement: time for a systematic approach?
J. Nas, D. Jilesen, J.L. Bonnes, S.W. Westra, J.L.R.M. Smeets, M.A. Brouwer, M.J. De Boer (Nijmegen, NL)
Outcomes of patients with valvular cardiomyopathy after prophylactic defibrillator implantation.
M. Rodriguez Manero, R.A.A.S. Rosa Alba Abellas-Sequellas, J.J.L. Jesus Jimenez-Lopez, J.F.A. Juan Fernandez-Armenta,
J.B.M. Juan Benezet-Mazuecos, A.F.C. Agustin Fernandez-Cisnal, J.M.A. Jose Moreno-Arribas, V.B.G. Vicente Bertomeu-Gonzalez,
R.F. Rafael Peinado, L.M.S. Luis Martinez-Sande (Santiago de Compostela, Toledo, Cadiz, Madrid, Seville and Alicante, ES)
SUNDAY
Are patients with Wolff-Parkinson-White pattern with syncope as the single symptom different from those completely symptom-free? P478
M.S. Ait Messaoudene, Y. Aoudia, R. Benkouar, F. Ahlouche, T. Boumedien, A. Boudrifa, T. Delassi, M.T. Chentir (Algiers, DZ)
Impact of automated template matching during PVC ablation: results of a randomized controlled trial
(W) P479
J. Luker, A. Sultan, K. Furst, H. Servatius, R.O. Akbulak, B. Schaffer, D. Schreiber, B.A. Hoffmann, S. Willems, D. Steven (Cologne and
Hamburg, DE; Bern, CH)
Efficacy of the renal denervation in patients with resistant hypertension and atrial fibrillation
P480
L. Plashchinskaya, D. Goncharik, A. Chasnoits, V. Barsukevich, A. Savchenko, V. Golenischa, A. Mrochek (Minsk, BY)
Distance to the origin, not the earliness activation or pacemap, determines a cure of ventricular tachyarrhythmias: a distinct
subgroup of outflow tachyarrhythmias.
P481
K. Hisazaki, K. Kaseno, D. Aoyama, K. Hasegawa, M. Yokokawa, N. Amaya, K. Ishida, K. Arakawa, H. Uzui, H. Tada (Fukui, JP)
The transseptal or transaortic approach for pediatric left sided accessory pathway ablation in era of NavX/Ensite? Comparison
of four apporaches.
P482
A. Baszko, K. Czyz, S. Stec, A. Lazniak, K. Deutch, J. Siedz, W. Bobkowski (Poznan, Rzeszow and Kielce, PL)
P489
P490
P491
P492
P493
P494
53
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
P501
P502
54
P500
P509
P510
P511
P512
P513
P514
P520
P521
P522
P523
P524
P525
P526
P527
WEDNESDAY
P519
TUESDAY
Monitoring tools
The lung impedance monitoring in treatment of chronic heart failure: results of the LIMIT-CHF study
G. Domenichini, T. Rahneva, I. Diab, O. Dhillon, V. Baker, R.J. Hunter, M.J. Earley, R.J. Schilling (London, GB)
P518
MONDAY
SUNDAY
P528
P529
P530
P531
P532
55
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
56
Anticoagulation
Bleeding risk in patients treated with dabigatran or vitamin K antagonist for non-valvular atrial fibrillation : a meta analysis of
matched analysis in routine care settings
L. Fauchier, W. Darwiche, T. Bejan Angoulvant, N. Clementy, D. Angoulvant, D. Babuty, F. Dievart (Tours, FR)
Influence of rivaroxaban in comparison to warfarin on the laboratory measurements of coagulation assays and the circadian variation
in patients with non-valvular atrial fibrillation
Y. Hitaka, M. Ogawa, S. Goto, Y. Nagata, J. Morii, S. Imaizumi, T. Yasuda, N. Matsumoto, A. Matsunaga, K. Saku (Fukuoka, JP)
Remote monitoring
Respirate Project-2: a telemedicine-based project for ICD-CRTD patients involving HF specialist and general practitioner
P. Rocca, L. Viscardi, P. Neri, A. Locatelli, M. Tespili, V. Giudici (Seriate, IT)
Registries and surveys
Gender differences in antithrombotic therapy in Europe: observations from the GLORIA-AF registry program
G.Y.H. Lip, H.-C. Diener, S.J. Dubner, J.L. Halperin, C.S. Ma, K.J. Rothman, K. Zint, A. Elsaesser, C. Teutsch, M.V. Huisman
(Birmingham, GB; Essen and Ingelheim, DE; Buenos Aires, AR; New York and Research Triangle Park NC, US; Beijing, CN;
Burlington, CA; Leiden, NL)
P533
P534
P535
P536
Symposium
ROMA
08:30 - 10:00
537
538
539
540
541
Symposium
NAPOLI
TUESDAY
To study the interface between pericardium and invasive electrophysiology , and the risk of pericardial complications of EP procedures
Management of cardiac tamponade the position statement.
M. Imazio (Torino, IT)
Pacemaker related pericardial disease acute and chronic.
M. Glikson (Ramat Gan, IL)
Contemporary management of recurrent pericarditis.
Y. Adler (Rannana, IL)
Pericardial anatomy - relevance to ablation performance and complications
Y.-M. Cha (Rochester, US)
08:30 - 10:00
542
543
544
545
TORINO
WEDNESDAY
08:30
08:52
09:15
09:37
MONDAY
08:30
08:48
09:06
09:24
09:42
SUNDAY
08:30 - 10:00
546
547
548
57
MONDAY
SUNDAY
08:30 - 10:00
TUESDAY
GENOVA
This section is aimed at update on ARVC with a specific focus on the pathophysiology and clinical management of ventricular arrhythmias. The
session has a translational approach that will walk the audience to gather a mechanistic approach to the disease phenotype.
08:30
08:52
09:15
09:37
08:30 - 10:00
WEDNESDAY
Symposium
Symposium
549
550
551
552
BOLOGNA
Cardiac ion channels and their macromolecular complexes: electrophysiology and beyond
39th Meeting of the ESC Working Group on Cardiac Cellular Electrophysiology
Chairpersons: G. Antoons (Maastricht, NL); D. DiFrancesco (Milan, IT)
08:30
08:48
09:06
09:24
09:42
The cardiac sodium channel interactomes: results from genetically-modified mouse models.
H. Abriel (Bern, CH)
Impact of DPP10 on native cardiac Ito and action potential in rat epicardial myocytes.
K. Metzner (Leipzig, DE)
Super-resolution imaging of Ryanodine Receptor cluster organization in normal and failing rat cardiac myocytes.
T. Kolstad (Oslo, NO)
End-Binding protein 1 is a modulator of cardiac conduction.
V. Portero (Amsterdam, NL)
Determinants of altered atrial Na+-Ca2+ exchanger function in patients with chronic atrial fibrillation
S. Ghezelbash, C. E Molina, L. Badimon, N. Voigt, J. Heijman, D. Dobrev (Essen, DE; Barcelona, ES)
08:30 - 10:00
Symposium
553
554
555
556
557
FIRENZE
To provide insight into the most relevant application that have been proposed to evaluate cardiovascular function from arrhythmias detection to
imaging
08:30
08:52
09:15
09:37
58
558
559
560
561
Symposium
BARI
SUNDAY
08:30 - 10:00
08:30 - 10:00
Main Session
562
563
564
565
CAGLIARI
Arrhythmias during pregnancy occur seldom. This session will give an overview on the types of arrhythmias, which drug can be instituted during
pregnancy and which drug not and gives some practical advised how to treat these patients.
08:30 - 10:00
566
567
568
569
AGORA
WEDNESDAY
TUESDAY
08:30
08:52
09:15
09:37
MONDAY
08:30
08:52
09:15
09:37
Each speaker will present and discuss their research during the session.
After the session finishes each speaker will have a dedicated screen next to the Agora in the Abstract Discussion Zone in order to further
discuss and display their presentation and facilitate in-depth dialogue with interested parties.
08:30
08:39
08:48
08:57
09:06
Can serologic markers of fibrosis predict future shocks in icd recipients with dilated cardiomyopathy?
E. Kanoupakis, J. Fanourgiakis, E. Kallergis, H. Mavrakis, G. Chlouverakis, P. Vardas (Heraklion, GR)
Left atrial fibrosis quantification by late gadolinium enhancement MRI: can we find the optimal normalized thresholds
E. Benito, A. Carlosena-Remirez, E. Guasch, A. Berruezo, R.J. Perea, S. Prat, J. Brugada, L. Mont (Barcelona, ES)
Identification of the arrhythmogenic substrate in acute phase of STEMI
J. Acosta, D. Penela, D. Andreu, J. Fernandez-Armenta, T. De Caralt, L. Mont, J.T. Ortiz, X. Bosch, J. Brugada, A. Berruezo
(Barcelona, ES)
Prognostic value of 18-fluorodeoxyglucose positron emission computed tomography scan in patients with unexplained
atrioventricular conduction block
A. Shelke, T. Danwade, D. Saggu, S. Yalagudri, C. Sridevi, C. Narasimhan (Hyderabad, IN)
Noninvasive epi/endocardial mapping of ventricular arrhythmias
A. Tsyganov, M. Chaykovskaya, M. Chmelevsky, S. Deiss, T. Maurer, M. Yakovleva, K.H. Kuck, E. Wissner (Moscow and
Saint Petersburg, RU; Hamburg, DE)
570
571
572
(W) 573
574
59
MONDAY
SUNDAY
08:30 - 10:00
09:15
09:24
09:33
09:42
09:51
AGORA
575
576
577
578
579
TUESDAY
WEDNESDAY
10:00 - 11:00
60
Moderated Posters
POSTER AREA
Moderated Posters must be set up between 08:00 and 08:30, removed between 12:30 and 13:00 and be on display from 08:30 until 12:30. The
presenter should be present throughout the coffee break (10:00 - 11:00) in order to discuss the poster.
The following abstracts were chosen for their high quality and will be discussed during the Moderated Poster session animated by two
chairpersons between 10:00 - 11:00. Each presenter will have 5 minutes to present and discuss their research in front of the audience and the
chairpersons
P580
P581
P582
P583
P584
P585
POSTER AREA
Long term performance of the tendril MRI leads: results from the tendril MRI lead observational study
R. Breedveld, J. Sperzel, G. Paulussen, M. Alberio, E. Pisano, D. Sergi, K. Timmermans, A. Oza (Leeuwarden and Heerlen, NL;
Bad Nauheim, DE; Como, Lecce and Rome, IT; Zaventem, BE; Sylmar, US)
Assessing response to biventricular pacing: non-invasive cardiac monitoring does not consistently detect acute response
J.H.P. Gamble, N. Herring, R. Khiani, P.W.X. Foley, M.R. Ginks, K. Rajappan, Y. Bashir, T.R. Betts (Oxford, Milton Keynes
and Swindon, GB)
Prognostic role of right ventricular function in patients with heart failure undergoing cardiac resynchronization therapy
S. Maffe', A. Rapacciuolo, E. Bertaglia, A.D. Onofrio, F. Esposito, U. Parravicini, A. Agresta, P. Paffoni, M. Campari, G. Stabile
(Borgomanero (NO), Naples, Padua and Milan, IT)
Characteristics of regions with poor acute hemodynamic response in cardiac resynchronization therapy
S. Ross, H.H. Odland, T. Edvardsen, T. Haaland, T. Fischer, L.O. Gammelsrud, R. Skaardal, E. Kongsgaard (Oslo, NO)
10:15 - 10:45
P586
P587
P588
P589
AGORA
MONDAY
SUNDAY
10:00 - 11:00
10:15
11:00 - 12:30
590
Special Session
MILANO
WEDNESDAY
Live session
Chairpersons: J.C. Silberbauer (London, GB); F. Leyva-Leon (Sutton Coldfield, GB)
Parallel case 1
Accurate substrate analysis during SR
Relation of SR findings and documented/induced VT to guide the selection of the ablation targets
Substrate ablation
VT ablation efficacy validation.
Parallel case 2
Presenting CRT candidate (preop echo)
Identify LV lead adequate location
Choosing LV lead (bipolar vs multipolar vs multipoint)
Evaluating inter and intraLV delays, and programming
11:00
11:00
TUESDAY
During this interactive session, speakers and attendees will discuss the current guidelines for performing ablation in NVAF patients on NOACs,
and how the safety and efficacy profile of NOACs demonstrated in clinical trials and in real-world practice relates to ablation. Delegates will then
be encouraged to explore how new clinical trials may impact on future practice.
591
592
61
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
11:00 - 12:30
ROMA
11:00 - 12:30
593
594
595
596
NAPOLI
11:00 - 12:30
597
598
599
600
TORINO
62
Main Session
Cases 1.
C.W. Israel (Bielefeld, DE)
Cases 2.
P. Ritter (Pessac, FR)
Cases 3.
B.A. Schaer (Basel, CH)
601
602
603
Symposium
PALERMO
11:00 - 12:30
Symposium
604
605
606
607
GENOVA
11:00 - 12:30
Poster Session
608
609
610
611
612
WEDNESDAY
11:00
11:18
11:36
11:54
12:12
TUESDAY
11:00
11:22
11:45
12:07
MONDAY
Catheter ablation of ventricular arrhythmias is among the most frequent indications for catheter ablation. In symptomatic patients ablation may be
performed as first line therapy. Thus, the procedure should be effective but also very safe. In this highly practical session the ablation procedure of
VT is explained in different types of substrates, showing the different techniques and approach in different pathologies (outflow tract, idioapathic,
ischaemic heart disease and Chagas disease). In their presentations the experts will particularly focus on potential problems and pitfalls and of
course give their recommendations how to prevent and handle
SUNDAY
11:00 - 12:30
POSTER AREA
63
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
11:00 - 12:30
Symposium
FIRENZE
Integrating remote monitoring of cardiac implantable electronic devices into daily clinical practice
Chairpersons: F. Braunschweig (Stockholm, SE); L. Guedon-Moreau (Lille, FR)
Non invasive and eCardiology track
To focus on practical aspects of remote monitoring in standard clinical practice: current use in different European countries; technology issues;
organisational models and patient acceptance; effectiveness of remote monitoring in patient management
11:00
11:22
11:45
12:07
11:00 - 12:30
Symposium
613
614
615
616
VENEZIA
11:00 - 12:30
617
618
619
620
Symposium
BARI
To present and discuss training and professional developments for nurses and allied professionals
11:00
11:22
11:45
12:07
64
The EHRA exam in cardiac pacing and ICDs for allied professionals.
J. Elders (Nijmegen, NL)
Advance practice roles for nurses and allied professionals; state of the art in Europe.
E. Kletsiou (Athens, GR)
Ethical issues in arrhythmia care.
J. Tagney (Bristol, GB)
Publishing by nurses and allied professionals.
T. Jaarsma (Norrkoping, SE)
621
622
623
624
How-to Session
CAGLIARI
Practical approach to devices and ablation in adults with repaired congenital heart disease
Chairpersons: J. Janousek (Prague, CZ); R. Fogelman (Petah Tikva, IL)
Practical approach to the management of arrhythmias in adults with repaired congenital heart disease.
This will include medical management, use of implanted devices and catheter ablation.
Recognition & management of acute arrhythmia in the adult congenital heart disease population
A. Stuart (Bristol, GB)
Catheter ablation of incisional atrial arrhythmias after congenital heart disease repair.
J. Hebe (Bremen, DE)
Transvenous pacemaker & defibrillator implantation in complex congenital heart disease.
E. Rosenthal (St Albans, GB)
Anatomical substrates and ablation for re-entrant ventricular tachycardias in repaired congenital heart disease.
K. Zeppenfeld (Leiden, NL)
11:00 - 12:30
625
626
627
628
AGORA
Each speaker will present and discuss their research during the session.
After the session finishes each speaker will have a dedicated screen next to the Agora in the Abstract Discussion Zone in order to further
discuss and display their presentation and facilitate in-depth dialogue with interested parties.
629
630
631
632
WEDNESDAY
11:27
11:36
11:45
11:54
12:03
12:12
12:21
ICD shocks. Risk factor or risk marker. Association between ICD intervention and mortality.
V. Castro Urda, M. Sanchez Garcia, J. Martinez Ferrer, A. Barrera Cordero, X. Vinolas Prat, A. Arenal Maiz,
J. Fernandez De La Concha, J.C. Rodriguez Perez, J.C. Villacastin Dominguez, I. Fernandez Lozano (Madrid, Vitoria, Malaga,
Barcelona, Badajoz and Las Palmas De Gran Canaria, ES)
Incidence of appropriate therapy after elective replacement of an uneventful first ICD.
B. Vandenberk, C. Garweg, G. Voros, V. Flore, T. Marynissen, J. Ector, R. Willems (Leuven, BE)
Prognostic significance of Non-sustained Ventricular Tachycardias occurring early after ICD implant among patients with left
ventricular dysfunction.
J. Jimenez-Candil, O. Duran, E. Garcia-Piney, J. Hernandez, J.L. Morinigo, P. Perdiguero, A. Martin, P.L. Sanchez (Salamanca, ES)
Atrial fibrillation and outcomes of patients implanted with cardioverter defibrillator or cardiac resynchronization therapy
in a real world setting
N. Teodorovich, Y. Kogan, I. Goldenberg, M. Swissa (Rehovot and Ramat Gan, IL)
Long-term follow-up of the Brugada syndrome: a single-centre experience
B. Rudic, E. Tueluemen, S. Roeger, K. Stach, C. Doesch, R. Schimpf, C. Veltmann, J. Kuschyk, T. Papavassiliu, M. Borggrefe
(Mannheim and Hannover, DE)
The shortening of the short refractory periods in short QT syndrome
A. Rollin, A. Duparc, P. Mondoly, C. Cardin, M. Sadron, E. Lematte, A. Bennadji, E. Thomson, P. Maury (Toulouse, FR)
Identifying patients with less potential to benefit from implantable cardioverter-defibrillator therapy
A. Kaura, I. Mann, R. Kamdar, E. Petzer, E. Silberbauer, N. Gall, F. Murgatroyd, P. Scott (London, GB)
Morphology of myocardial infarction scar, assessed by magnetic resonance imaging, is a better predictor of ventricular
arrhythmia than left ventricular ejection fraction
D. Voilliot, F. Odille, M. Andronache, B. Brembilla-Perrot, D. Mandry, P.Y. Marie, J. Felblinger, E. Aliot, N. Sadoul, C. De Chillou
(Nancy, FR)
Long term follow up of post-MI patients with relatively preserved left ventricular ejection fraction and non sustained VT:
Role of ce-CMR in identification of arrhythmogenic substrate
K. Yalin, E. Golcuk, A.K. Bilge, K. Adalet (Istanbul, TR)
Left cardiac sympathetic denervation made by a video assisted thoracoscopic approach could terminate electrical storm in
icd patients with brugada syndrome.
E. Hatzinikolaou-Kotsakou, M. Konstantinidou, E. Reppas, G. Moschos, T.H. Beleveslis (Thessaloniki, GR)
TUESDAY
11:00
11:09
11:18
MONDAY
11:00
11:22
11:45
12:07
SUNDAY
11:00 - 12:30
633
634
635
636
637
638
65
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
12:45 - 13:45
Satellite Symposium
ROMA
Learn about the clinical results with the second generation Cryoballoon in both paroxysmal and persistent atrial fibrillation ablation. Learn about
the technology of the second generation multi-electrode ablation catheters and the clinical results obtained with this technology.
12:45
12:50
13:05
13:20
13:35
Introduction.
M. Hocini (Pessac, FR)
Dosing considerations with the second generation Cryoballoon.
K.J. Chun (Frankfurt, DE)
Second-generation multi-electrode ablation technology: clinical results and future directions.
L.V.A. Boersma (Nieuwegein, NL)
Cryoballoon ablation for persistent atrial fibrillation.
S. Boveda (Toulouse, FR)
Conclusions and discussion.
K.H. Kuck (Hamburg, DE)
12:45 - 13:45
Satellite Symposium
639
640
641
642
643
NAPOLI
12:45 - 13:45
Satellite Symposium
644
645
646
647
TORINO
Can the new Generation of Contact Force catheter make AF Ablation more simple?
Sponsored by Biosense Webster
Chairperson: R. Schilling (London, GB)
Discuss the combination of Porous Tip with Contact Force Technology and its potential clinical impacts in the treatment of AF. Does an efficient
tracking of the ablation strategy adds value to your clinical practice?
12:45
13:00
13:15
13:30
66
648
649
650
651
Satellite Symposium
PALERMO
12:45 - 13:45
Satellite Symposium
652
653
654
655
656
657
GENOVA
TUESDAY
1) Learn about latest clinical data on the entirly subcutaneous implantable defibrillator to better understand the benefit for patients.
2) Learn about the evolution of subcutaneous defibrillator technology in the way we are protecting patients from sudden cardiac death.
3) Learn about risk stratification factors to guide patient selection for the subcutaneous defibrillator.
658
659
660
661
662
WEDNESDAY
MONDAY
12:45
12:50
13:05
13:20
13:35
13:40
SUNDAY
12:45 - 13:45
67
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
68
12:45 - 13:45
Satellite Symposium
BOLOGNA
Understand the clinical impact of the latest developments in device therapy for the prevention and treatment of HF and Central Sleep Apnea
Pacemakers, CRT and Phrenic Nerve Stimulation (PNS).
How important is it to adapt ventricular pacing in patients with intermittent AV block? What additional benefits do we expect from using multipoint or multi-lead stimulation in CRT? How to screen for Sleep Apnea?
How can PNS be used to treat Central Sleep Apnea in HF patients?
12:45
13:05
13:25
12:45 - 13:45
Satellite Symposium
663
664
665
FIRENZE
1) To learn which patients may benefit from left atrial appendage closure.
2) To understand how to best balance the risk of stroke and bleeding in specific patient groups.
3) To know the latest clinical evidence, guidelines and expert consensus recommendations on left atrial appendage closure.
12:45
12:55
13:07
13:10
13:22
13:25
13:37
13:40
666
667
668
669
670
671
672
673
VENEZIA
674
MONDAY
Special Session
SUNDAY
12:45 - 13:45
1) The participant will understand the role of risk factor modulation in AF patients
2) The participant will understand the studies regarding AF detection through remote monitoring and the implications for therapy
3) The participant will understand the risks and benefits of different approaches to AF ablation
12:45
13:00
13:15
13:30
675
676
677
TUESDAY
WEDNESDAY
69
TUESDAY
MONDAY
SUNDAY
14:00 - 15:30
WEDNESDAY
MILANO
Assessment of a standardized algorithm for cardiac pacing in older patients affected by severe unpredictable reflex syncopes
M. Brignole (Lavagna, IT)
Discussant: Pacing for reflex syncope
J.-C. Deharo (Marseille, FR)
ENHANCED ICD programming to reduce therapies and improve quality of life in Implantable Cardioverter Defibrillator
patients: a prospective, single-arm safety monitoring study
M.H. Mastenbroek (Utrecht, NL)
Discussant: ENHANCED-ICD study
F.D. Murgatroyd (London, GB)
Big data Characterization of Sex-Specific Survival Following CIED Implant
N. Varma (Cleveland, US)
Discussant: sex-specific survival following CIED implant
C. Linde (Stockholm, SE)
Cardiorespiratory Fitness Predicts Arrhythmia Recurrence in Patients with Symptomatic Atrial Fibrillation-CARDIO-FIT Study
R. Pathak (Adelaide, AU)
Discussant:.CARDIO-FIT Study
C. Herrera Siklody (Ludwigsburg, DE)
Early Performance of a Miniaturized Leadless Cardiac Pacemaker: The Micra Transcatheter Pacing Study
P. Ritter (Pessac, FR)
Discussant:.Micra Transcatheter Pacing Study: Early Performance
V. Reddy (New York, US)
14:00 - 15:30
70
Special Session
Main Session
678
679
680
681
682
683
684
685
686
687
ROMA
Creating permanent pulmonary vein isolation or bidirectional block of lines with a single ablation is still not guaranteed. This session would
investigate strategies to improve transmural lesion creation, to ultimately benefit patients.
14:00
14:18
14:36
14:54
15:12
How I try to improve lesion permanence with current tools: role of visi tag, contact force, adenosine, pacing the RF lesions
G. Michaud (Boston, US)
Real time ultrasound for creation of permanent lesions.
M.J. Wright (London, GB)
Energies, technologies, that may be associated with more durable lesions
V. Reddy (New York, US)
Lesion assessment using MRI.
R. Beinart (Ramat Gan, IL)
Visually guided laser ablation a single center experience.
J. Kautzner (Prague, CZ)
688
689
690
691
692
How-to Session
NAPOLI
14:00 - 15:30
693
694
695
696
Main Session
TORINO
14:00 - 15:30
697
698
699
700
701
Symposium
PALERMO
WEDNESDAY
14:00
14:18
14:36
14:54
15:12
TUESDAY
MONDAY
14:00
14:22
14:45
15:07
SUNDAY
14:00 - 15:30
702
703
704
705
71
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
14:00 - 15:30
GENOVA
706
707
708
709
710
711
Symposium
BOLOGNA
Carmeliet-Coraboeuf-Weidmann lecture
39th Meeting of the ESC Working Group on Cardiac Cellular Electrophysiology
Chairpersons: A. Zaza (Milan, IT); G.L. Smith (Glasgow, GB)
14:00 Atrial fibrillation: a dystrophinopathy of the heart
B. Casadei (Oxford, GB)
14:00 - 15:30
712
Main Session
FIRENZE
To have an overview on Health Technology assesment of device remote monitoring as a new standard for patient follow-up.
14:00
14:22
14:45
15:07
72
713
714
715
716
Symposium
VENEZIA
14:00 - 15:30
Symposium
717
718
719
720
BARI
To review different models of organising care and to discuss what migth be relevant for organisation of care in the arrhythmia patient
The AF clinic improves patients outcomes.
J.M.L. Hendriks (Sittard, NL)
How does the patient benefit from device clinics?
A. Metzner (Hamburg, DE)
How is a 'black out' clinic organised?
J. Mudd (Middlesbrough, GB)
Is partnership between EP and HF clinics feasible?
F. Braunschweig (Stockholm, SE)
722
723
724
Symposium
CAGLIARI
WEDNESDAY
14:00 - 15:30
721
TUESDAY
Organising care for arrhythmia patients: what can we learn from different models?
Chairpersons: J. Tagney (Bristol, GB); L. Morichelli (Roma, IT)
Nurses and Allied Professional track
14:00
14:22
14:45
15:07
MONDAY
14:00
14:22
14:45
15:07
SUNDAY
14:00 - 15:30
This symposium should give the audience an overview of recent advances in understanding the mechanism of arrhythmias, sudden cardiac death
prevention and cardiac resynchronisation in these complex patients
14:00
14:22
14:45
15:07
Anatomical and pathological substrate for arrhythmias after repair of congenital heart disease
N.M.S. de Groot (Beinsdorp, NL)
Primary ICD implantation in repaired congenital heart disease: Is it ever indicated?
T. Paul (Gottingen, DE)
Non-transvenous ICDs in congenital heart disease: techniques and results
F. Roses Noguer (Barcelona, ES)
Cardiac resynchronisation for the failing subpulmonary right ventricle: Is there a role?
J. Janousek (Prague, CZ)
725
726
727
728
73
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
14:00 - 15:30
AGORA
Each speaker will present and discuss their research during the session.
After the session finishes each speaker will have a dedicated screen next to the Agora in the Abstract Discussion Zone in order to further
discuss and display their presentation and facilitate in-depth dialogue with interested parties.
14:00
14:09
14:18
14:27
14:36
14:45
14:54
15:03
15:12
15:21
Comparison of contact force sensing radiofrequency catheter and new generation cryoballoon ablation of pulmonary veins
in patients with paroxysmal atrial fibrillation. 1 year follow up.
A. Kardos, Z. Kis, Z. Som, Z. Nagy, C. Foldesi (Budapest, HU)
Adenosine in atrial firillation ablation: does it improve the outcome?
F. Moscoso Costa, D. Cavaco, P. Carmo, P. Santos, S. Carvalho, T. Teixeira, A. Soares, M. Marques, L. Parreira, P. Adragao (Lisbon, PT)
Ipsilateral pulmonary vein isolation using new force-power-time formula in atrial fibrillation patients
P. Taghji, M. Duytschaever, Y. Vandekerckhove, T. Phlips, R. Choudhury, R. Tavernier, H. Nakagawa (Bruges, BE; Oklahoma City, US)
Tissue contact monitoring with an electrical coupling index during radiofrequency energy pulmonary venous isolation
- a prospective randomised control trial
M.A. Jones, K.C.K. Wong, C. Hayes, D. Webster, M. Ginks, Y. Bashir, K. Rajappan, T.R. Betts (Oxford, GB)
Robotic catheter ablation provides stable contact force during pulmonary vein isolation
B. Kreidieh, S. Ibarra, P. Schurmann, A.S. Dave, M. Valderrabano (Houston, US)
Good 2 year outcomes in patients with adverse features undergoing convergent hybrid AF ablation for persistent AF
S.B.L. Claridge, N. Child, C.A. Rinaldi, J. Gill, P. Taggart (London, GB)
Simultaneous renal sympathetic denervation and pulmonary veins isolation in patients with paroxysmal atrial fibrillation and
hypertension
A.S. Vorobyoff, V.N. Bibikov, S.V. Korolev, A.V. Geraschenko, A.V. Sveshnikov (Moscow, RU)
Pulmonary vein reconnection: is contact force the main problem?
P. Adragao, F. Moscoso Costa, D. Cavaco, L. Parreira, P. Santos, P. Carmo, S. Carvalho, T. Teixeira, A. Soares, M. Abecasis
(Lisbon, PT)
Appropriate waiting time to confirm dormant pulmonary vein conduction in patients with atrial fibrillation
K. Kato, K. Ejima, M. Shoda, T. Manaka, D. Yagishita, R. Henmi, K. Suwa, T. Mizuki, M. Imai, N. Hagiwara (Tokyo, JP)
Differences in the prevalence, characteristics, and predictors of pulmonary vein reconnections between contact force-guided
and conventional circumferential pulmonary vein isolation
K. Nakamura, S. Naito, T. Sasaki, E. Goto, K. Minami, M. Nakano, S. Shimizu, T. Yano, K. Kumagai, S. Oshima (Maebashi, JP)
15:30 - 16:30
WG on CCE General Assembly
74
Special Event
729
730
731
732
733
734
735
736
737
738
BOLOGNA
Moderated Posters
POSTER AREA
16:30 - 18:00
Special Session
P739
P740
P741
P742
P743
P744
P745
P746
P747
P748
MILANO
WEDNESDAY
Risk prediction in atrial fibrillation. comparison between the CHADS2, CHA2DS2-VASC score in a large contemporary
cohort of patients with incident non-valvular atrial fibrillation
M. Haim, M. Hoshen, O. Reges, Y. Rabi, M. Leibowitz, R. Balicer (Beer Sheva and Tel Aviv, IL)
Causes of death and influencing factors in unselected patients with atrial fibrillation.
L. Fauchier, O. Villejoubert, N. Clementy, B. Pierre, A. Bernard, D. Angoulvant, D. Babuty (Tours, FR)
New onset of atrial fibrillation following transcatheter aortic valve replacement: the prevalence, predictive factor and
prognostic value
W. Kong, E. Tay, J. Yip (Singapore, SG)
Association between serum parathyroid hormone and prevalent atrial fibrillation in a Korean population: the Dong-gu study
K.H. Lee, H.W. Park, N.S. Yoon, J.G. Cho, J.S. Kim, M.H. Shin, S.S. Kweon, Y.H. Lee, S.S. Kim (Gwangju and Iksan, KR)
The impact of free thyroxine on the outcomes of left atrial ablation procedures
P. Sousa, R. Providencia, S. Combes, N. Combes, S. Boveda, J.P. Albenque (Toulouse, FR)
Natriuretic propeptides as markers of atrial fibrillation burden and recurrence: insights from the AMIO-CAT trial
S. Darkner, J.P. Goetze, X. Chen, K. Henningsen, S. Pehrson, J.H. Svendsen (Copenhagen, DK)
Atrial fibrillation in patients with obstructive sleep apnea: triggers and atrial structural remodeling
J. Li, F. Contreras Valdes, C. Tschabrunn, E. Anter (Boston, US)
Relationship between elft atrial wall thickness and intracardiac electrogram characteristics during atrial fibrillation and sinus
rhythm
I. Watanabe, Y. Okumura, K. Takahashi, A. Hirayama (Tokyo, JP)
Relation of biomarkers of inflammation, oxidative stress and endothelial dysfunction with the development of cardiovascular
disease in lone atrial fibrillation
M. Polovina, M.C. Ostojic, T. Potpara (Belgrade, RS)
Twenty-four hours holter monitoring predictors for new onset atrial fibrillation in a non-selected population
S. Cabrera, E. Valles, B. Benito, P. Ramos, J. Bruguera, J. Marti-Almor (Barcelona, ES)
TUESDAY
MONDAY
Moderated Posters must be set up between 13:30 and 14:00, removed between 18:00 and 18:30 and be on display between 14:00 and 18:00.
The presenter should be present throughout the break (15:30 - 16:30) in order to discuss the poster.
The following abstracts were chosen for their high quality and will be discussed during the Moderated Poster session animated by two
chairpersons between 15:30 - 16:30. Each presenter will have 5 minutes to present and discuss their research in front of the audience and the
chairpersons.
SUNDAY
15:30 - 16:30
Recorded session - Basic ablation and complex implantable cardioverter-defibrilator therapy in paediatric practice.
Chairpersons: J.M. Morgan (Southampton, GB); A. Goette (Paderborn, DE)
16:30
17:00
17:30
749
750
751
75
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
16:30 - 18:00
Main Session
ROMA
Persistent atrial fibrillation ablation: the quest for a tailored approach to each patient
Chairpersons: M. ONeill (London, GB); J. Steinberg (New York, US)
Atrial Fibrillation track
The session proposal aims at providing an update on the recent developments on the methods and techniques for substrate characterisation in
AF. The audience will learn the different approaches targeting AF substrate thus improving ablation outcome.
16:30
16:48
17:06
17:24
17:42
Phase mapping: principle and comparison to activation mapping, results in surgery patients
P. Kuklik (Maastricht, NL)
Contact phase mapping to guide persistent AF ablation: methods, end point, results
P. Wang (Stanford, US)
Non contact phase mapping to guide persistent AF ablation: methods, end point, results
S. Knecht (Brugge, BE)
Origin of CFAE: a marker of arrhythmogenic substrate or something else?
L. Saghy (Szeged, HU)
MRI imaging in AF ablation.
N. Marrouche (Salt Lake City, US)
16:30 - 18:00
How-to Session
752
753
754
755
756
NAPOLI
16:30 - 18:00
757
758
759
760
Main Session
TORINO
What is needed to provide cardiac resynchronisation therapy for all European patients?
Chairpersons: R. Hatala (Bratislava, SK); A. Raviele (Mestre, IT)
EHRA Members only session
Device track
76
761
762
763
764
765
Symposium
PALERMO
Non-ischaemic cardiomyopathies
Chairpersons: T. Oloriz (Zaragoza, ES); A. Grace (Cambridge, GB)
Ablation track
ECG and the assessment of scar localisation: mechanistic and prognostic implications.
J. Kautzner (Prague, CZ)
Electrocardiographic imaging to enhance substrate localisation.
F. Sacher (Bordeaux Pessac, FR)
Multimodality imaging.
F.J. Pinto (Lisbon, PT)
Should myocardial biopsy become part of the standard pre-operative assessment of patients undergoing ablation?
S. Sala (Milan, IT)
16:30 - 18:00
Symposium
766
767
768
769
GENOVA
MONDAY
16:30
16:52
17:15
17:37
SUNDAY
16:30 - 18:00
EHRA activities in the field of EP Wires, patient and snap-shot surveys. Up-to-date 2015
Chairpersons: M.G. Bongiorni (Pisa, IT); H. Estner (Munchen, DE)
16:30 - 18:00
Symposium
770
771
772
773
774
BOLOGNA
WEDNESDAY
TUESDAY
16:30
16:48
17:06
17:24
17:42
775
776
777
778
779
77
MONDAY
SUNDAY
16:30 - 18:00
TUESDAY
FIRENZE
To explore the use of monitoring technologies for prevention of heart failure hospitalisations and sudden cardiac death
16:30
16:52
17:15
17:37
16:30 - 18:00
WEDNESDAY
Main Session
Symposium
780
781
782
783
VENEZIA
Many transient receptor potential (TRP) channels are expressed in cardiac cells. The main learning objective of this symposium is to review the
roles of some of them in normal and pathological electrophysiology.
16:30
16:52
17:15
17:37
16:30 - 18:00
Symposium
784
785
786
787
BARI
78
788
789
790
791
Debate Session
CAGLIARI
SUNDAY
16:30 - 18:00
Management of channelopathies remains contentious in the adolescent and young adult population 2 debates will highlight these issues
792
793
794
795
796
797
798
799
800
801
TUESDAY
EP studies are mandatory in children & adolescents with Brugada syndrome - Pro
J. Brugada Terradellas (Barcelona, ES)
EP studies are mandatory in children & adolescents with Brugada syndrome - Contra
N. Blom (Leiden, NL)
EP studies are mandatory in children & adolescents with Brugada syndrome - Rebuttal Pro.
J. Brugada Terradellas (Barcelona, ES)
EP studies are mandatory in children & adolescents with Brugada syndrome - Rebuttal Contra.
N. Blom (Leiden, NL)
Conclusion.
J. Brugada Terradellas (Barcelona, ES); N. Blom (Leiden, NL)
Sports restrictions are no longer needed in all young patients with LQTS - Pro.
S. Viskin (Tel Aviv, IL)
Sports restrictions are no longer needed in all young patients with LQTS - Contra.
R. Fogelman (Petah Tikva, IL)
Sports restrictions are no longer needed in all young patients with LQTS - Rebuttal Pro.
S. Viskin (Tel Aviv, IL)
Sports restrictions are no longer needed in all young patients with LQTS - Rebuttal Contra.
R. Fogelman (Petah Tikva, IL)
Conclusion.
S. Viskin (Tel Aviv, IL) ; R. Fogelman (Petah Tikva, IL)
MONDAY
16:30
16:45
17:00
17:05
17:10
17:15
17:30
17:45
17:50
17:55
WEDNESDAY
79
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
80
16:30 - 18:00
AGORA
Each speaker will present and discuss their research during the session.
After the session finishes each speaker will have a dedicated screen next to the Agora in the Abstract Discussion Zone in order to further
discuss and display their presentation and facilitate in-depth dialogue with interested parties.
16:30
16:39
16:48
16:57
17:06
17:15
17:24
17:33
17:42
17:51
Non-septal localization of late potentials in post-myocardial infarction patients undergoing ventricular tachycardia ablation
802
D. Tsiachris, J. Silberbauer, G. Maccabelli, T. Oloriz, H. Mizuno, C. Bisceglia, A. Marzi, N. Sora, S. Sala, P. Della Bella (Milan, IT)
Feasibility of combined unipolar and bipolar voltage maps to improve sensitivity of endomyocardial biopsy
803
F. Pizzamiglio, M. Casella, A. Dello Russo, C. Carbucicchio, G. Fassini, S. Riva, P.F. Notarstefano, M. Pieroni, L. Bolognese,
C. Tondo (Milan and Arezzo, IT)
Electroanatomic mapping system allows zero fluoroscopy in cryo and radiofrequency ablation of accessory pathways
in children
804
E. Ebrille, C. Raimondo, R. De Vito, F. Di Clemente, D. Caponi, P. Di Donna, F. Gabbarini, M. Morosato, F. Gaita, M. Scaglione
(Turin, Siena, Asti and Verona, IT)
Usefulness of contact force maps to predict ablation gaps in catheter ablation of atrial fibrillation
805
D. Andreu, F. Gomez-Pulido, M. Calvo, E. Benito, A. Carlosena-Remirez, E. Arbelo, J.M. Tolosana, A. Berruezo, J. Brugada, L. Mont
(Barcelona, ES)
Needle-based intracardiac echocardiography for transseptal puncture guidance
806
M.C. Finlay, C.A. Mosse, R. Colchester, S. Noimark, E. Zhang, D. Nikitichev, I. Papakonstantinou, P. Beard, R.J. Schilling,
A. Desjardins (London, GB)
Real-time magnetic resonance-guided ablation of typical right atrial flutter using active catheter tracking and passive catheter
(W) 807
imaging
S. Hilbert, P. Sommer, G. Hindricks, M. Gutberlet, M. Grothoff (Leipzig, DE)
Epicardial impedance mapping in surgical theater : pilot study for fat detection to facilitate epicardial radiofrequency catheter
ablation for ventricular tachycardia
808
H. Mizuno, G. Maccabelli, F. Alamanni, P. Della Bella (Suita, JP; Milan, IT)
Feasibility of fully MR-guided ablation with active tracking: from pre-clinical to clinical application
809
H. Chubb, J. Harrison, S.E. Williams, J. Whitaker, S. Weiss, S. Krueger, G. Stenzel, T. Schaeffter, R. Razavi, M.O. Neill (London, GB)
Resynchronization therapy implant procedures with a novel sensor-based electromagnetic tracking system: more
than just reduction in radiation exposure.
810
B. Thibault, B. Montdesert, M. Dubuc, K. Dyrda, L. Rivard, D. Roy, M. Talajic, S. Venier, R. Tadros, L. Macle (Montreal, CA)
Cardiac radiosurgery: non-invasive ablation and initial patient outcomes
811
P.C. Zei, P.J. Maguire, R. Schilling, D.W. Davies, E.A. Gardner, T.J. Fogarty, J.M. Assad (Stanford, California and Mountain View, US;
London, GB; Monterrey, MX)
Satellite Symposium
PALERMO
SUNDAY
18:15 - 19:15
Learn about atrial fibrillation ablation using the latest Cryoballoon technologies. Learn how to prevent atrial fibrillation related stroke using novel
oral anticoagulation. Learn how continuous monitoring for atrial fibrillation around the ablation procedure can help to optimize treatment
Introduction.
C. Blomstrom-Lundqvist (Uppsala, SE)
Individualising OAC for stroke prevention in AF: What factors are important?
G.Y.H. Lip (Birmingham, GB)
AF ablation results with the second generation Cryoballoon.
G.B. Chierchia (Jette, BE)
State of the art monitoring around AF ablation.
J. Schreieck (Tuebingen, DE)
Conclusions and discussion.
A.J. Camm (London, GB)
812
813
814
815
MONDAY
18:15
18:20
18:35
18:50
19:05
816
TUESDAY
WEDNESDAY
81
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
82
08:30 - 12:30
Poster Session
POSTER AREA
Poster session 3
Posters must be set up between 08:00 - 08:30, removed between 12:30 - 13:00, to be on display between 08:30 - 12:30.
The presenter should be available by the poster during the coffee break (10:00 to 11:00) in order to discuss the research with the audience.
Clinical and epidemiological aspects (Atrial Fibrillation)
Phenotypic profiling to determine individuals at risk for atrial fibrillation: A latent class clustering analysis of the PREVEND cohort
M. Rienstra, B. Geelhoed, J.E. Siland, R.A. Vermond, P. Van Der Harst, H.L. Hillege, I.C. Van Gelder (Groningen, NL)
P wave duration/morphology and left atrial volume at computed tomography in patients without and with (paroxysmal or persistent)
atrial fibrillation
A. Cima, M. Brunelli, S. Raffa, A. Grosse, M. Frommhold, T. Daehne, A. Madaffari, C. Lindemann, J.C. Geller (Bad Berka, DE)
Prediction of atrial arrhythmia after transcatheter closure of atrial septal defect
J.K. Hwang, K.M. Park, S.J. Park, Y.K. On, J.S. Kim, S.W. Park, I.S. Kang, J.Y. Song, J. Huh (Seoul, KR)
Clincial response predictors in patients undergoing Cardiac Resyncrhonization Therapy (CRT): 7 years follow up.
R. Ramirez Rodriguez, A.M. Ramirez Rodriguez, A. Delgado Espinosa, A. Medina Fernandez-Aceytuno, E. Hernandez Ortega,
A. Garcia Quintana, M. Blanco Nuez (Las Palmas G.C. ES)
Investigation of the frequency of spontaneous echo contrast and the predictors of left atrial appendage sludge or thrombus formation
in patients with atrial fibrillation/flutter.
R. Takeuchi, M. Ishida, K. Kodama, N. Hosoya, S. Kageyama, H. Sugiyama, Y. Watanabe, K. Murata, R. Nawada, T. Onodera (Shizuoka, JP)
Cardiovasal interconnections depending on Cystatin C in CHF patients with permanent atrial fibrillation
N. Koziolova, Y. Shilova, E. Polyanskaya, J. Nikonova (Perm, RU)
Mechanisms & Computer modelling (Atrial Fibrillation)
Association between red blood cell distribution width and postoperative atrial fibrillation after cardiac surgery: a prospective
observational study
P. Korantzopoulos, N. Sontis, T. Liu, S. Siminelakis, E. Apostolakis (Ioannina, GR; Tianjin, CN)
P817
P818
P819
P820
P821
P822
P823
P825
P826
P827
P828
P829
P830
P831
P832
P833
MONDAY
TUESDAY
WEDNESDAY
SUNDAY
Tools: catheters, sources, mapping, navigators (Catheter ablation / except atrial fibrillation)
Initial experience with a new image integration module designed for reducing radiation exposure during electrophysiological ablation
procedures
P848
O. Cano Perez, P. Alonso, J. Osca, A. Andres, M.J. Sancho-Tello, J. Olague, A. Salvador, L. Martinez-Dolz (Valencia, ES)
A novel tool for mapping multiple rhythms from a single mapping procedure
P849
L. Ptaszek, B. Moon, F. Sacher, P. Jais, S. Mahapatra, M. Mansour (Boston and Minneapolis, US; Bordeaux-Pessac, FR)
Catheter ablation of ventricular tachycardia in the presence of an old endocavitary thrombus: the role of intracardiac echocardigraphy P850
P. Peichl, D. Wichterle, R. Cihak, B. Aldhoon, J. Kautzner (Prague, CZ)
(W) P851
Omnipolar ablation catheter technology with unique capacity for beat by beat conduction velocity and direction display
D.C. Deno, R. Balachandran, D. Morgan, S. Masse, K. Nanthakumar (St. Paul, US; Toronto, CA)
Distinct and wide variations exist in the morphology of the cavo-tricuspid isthmus:utility of real-time intracardiac echocardiography. P852
K. Hisazaki, K. Kaseno, N. Amaya, D. Aoyama, M. Yokokawa, T. Morishita, K. Ishida, K. Arakawa, H. Uzui, H. Tada (Fukui, JP)
Results (Catheter ablation / except atrial fibrillation)
Waiting time after cavo-tricuspid isthmus ablation for typical atrial flutter and long term procedural success
P853
S. Marchandise, C. Scavee, C. Barbraud, C. De Meester, M.C. Gonzalez, C. Goesaert, Y. Reis-Pinheiro, J.B. Le Polain De Waroux (Brussels, BE)
P854
Success and limitation of epicardial VT ablation procedures in a large single centre cohort
M. Roos, A. Schade, K. Nentwich, J. Krug, P. Halbfass, P. Mueller, G.A. Szoelloesi, T. Deneke (Bad Neustadt a.d. Saale, DE)
83
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
Ablation of frequent pvc in primary prevention patients meeting criteria for icd implant. safety and appropriateness of withholding
the implant.
D. Penela, J. Acosta, L. Aguinaga, L. Tercedor, J. Fernandez-Armenta, D. Andreu, P. Sanchez, J. Brugada, L. Mont, A. Berruezo
(Barcelona and Granada, ES; Argentina, AR)
Contact force-guided versus contact force-blinded catheter ablation of typical atrial flutter: a prospective study.
S. Venier, J.G. Andrade, M. Dubuc, K. Dyrda, P. Guerra, P. Khairy, B. Mondesert, L. Rivard, B. Thibault, L. Macle (Montreal, CA)
Outcomes after multiple catheter ablations of ventricular tachycardia in patients with structural heart disease
B. Dinov, C. Stevanello, A. Bollmann, S. Rolf, P. Sommer, G. Hindricks, A. Arya (Leipzig, DE)
Ablation of tachyarrhythmias in early childehood
S. Krivolapov, R. Batalov, S. Popov, L. Svintsova, I. Kovalev (Tomsk and Moscow, RU)
Primary & Secondary prevention (Sudden cardiac death and implantable defibrillators)
Effect of Non-sustained ventricular tachycardias burden on electrical therapies among ICD patients with left ventricular dysfunction.
J. Jimenez-Candil, P. Perdiguero, E. Garcia-Piney, J. Morinigo, J. Hernandez Hernandez, A. Martin, P.L. Sanchez (Salamanca, ES)
Primary prevention in ischemic cardiomyopathy in Brazil: should we really do this?
G. Peixoto, M.S. Rocha, S.F. Siqueira, M.M. Lensi, S.A.D. Nishioka, R.A. Teixeira, W.A. Hueb, L.A. Machado Cesar, R. Costa, M. Martinelli
(Sao Paulo, BR)
Newly detected atrial arrhythmic episodes in single lead ICD with atrial sensor and early clinical interventions triggered by remote
monitoring
V. Calzolari, M. Crosato, L. De Mattia, P. Squasi, M. Mastropietro, A. Tronchin, D. Giacopelli, Z. Olivari (Treviso and Milan, IT)
The impact of age on clinical outcomes patients with primary prevention ICD/CRT-Ds
D.G. Wilson, H.M. Zeljko, G. Leventopoulos, A. Yue, P.R. Roberts, P.J. Roderick, J.M. Morgan (Southampton, GB)
P855
P856
P857
P858
P859
P860
P861
P862
P865
P866
P867
P868
P869
Leads (Pacing)
The evaluation of tricuspid regurgitation following implantation of right ventricular septal and apex pacing leads by 3D echocardiography P870
T. Hirai, T. Nakagomi, K. Mamiya, K. Okamoto, K. Iwase, M. Niwa, K. Miki, N. Suzuki, T. Tanaka (Okazaki, JP)
Activation of coagulation cascade in patients with implantable devices
P871
M. Sepsi, P. Scheer, G. Chlupova, T. Novakova, J. Spinar (Brno, CZ)
Indications & Results (Pacing)
Long-term follow-up of transvenous cardiac pacing in children: single-center experience in 161 patients
B. Kircanski, N. Radovanovic, P. Stojanov (Belgrade, RS)
Acute transitory atrio ventricular blockage in African; consider sickle cell anemia
P.H. Gacon (Dijon FR)
84
P872
P873
P874
P875
Syncope
Early repolarization in unexplained syncope
S. Loebe, J. Kornej, A. Arya, H. Hindricks, A. Bollmann, D. Husser (Leipzig, DE)
The role of QT intervals in prognosis of syncope of unknown origin
A. Fotoglidis, C. Papadopoulos, N. Fragakis, E. Pagourelias, D. Tanos, V. Skeberis, P. Kyriakou, V. Vassilikos (Thessaloniki, GR)
Mechanism (Basic Science in Arrhythmias)
Right ventricular diastolic dysfunction in children with WPW syndrome: invasive hemodynamic study
I.A. Khamnagadaev, S.A. Termosesov, M.A. Shkolnikova, L.S. Kokov, I.L. Ilich, R.S. Garipov, Y. Volkova (Moscow, RU)
Acute right ventricular apex pacing with an altered activation pattern reduces electrical parameters but does not modify torsade
de pointes incidence in the anesthetized chronic complete AV-block dog
A. Dunnink, R. Varkevisser, A. Bossu, S.C. Wijers, A. Oros, V.J.A. Bourgonje, T.R.G. Stams, H.D.M. Beekman, M.A. Vos (Utrecht, NL)
P880
P881
P882
P883
P884
P885
P886
WEDNESDAY
P879
TUESDAY
MONDAY
SUNDAY
P887
P888
P889
P890
P891
P892
85
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
Expression of miRNAs and morphological changes in myocardium of patients with atrial fibrillation
M.V. Eremeeva, T.V. Sukhacheva, A.G. Ibragimova, V.S. Rudomanova, V.A. Vaskovskiy, A.S.H. Revishvili (Moscow, RU)
Genetics (Basic Science in Arrhythmias)
Spectrum of long qt gene mutations in the republic of ireland.
D.P. Moran, S. Touhy, B. Noonan, J.O.O.neill, D. Ward, C. Mcgorrian, A. Green, S.A. Lynch, W. Reardon, J. Galvin (Dublin, IE)
Cardiomyopathies associated with mutations in SCN5A gene
E. Zaklyazminskaya, A. Revishvili, I. Pronicheva, A. Shestak, S. Dzemeshkevich (Moscow, RU)
P894
P895
P896
Monitoring tools
Results of clinical testing of a cloud computing based ambulatory ecg monitoring and arrhythmia detection system
I. Crozier, D. Hooks, M. Daly, I. Melton, C. Cruickshank, K. Morgan, L. Minarsch (Christchurch, NZ)
P897
86
P893
P898
P899
P900
P901
P902
P903
P904
P905
P906
P907
P908
P909
P910
P911
P912
SUNDAY
Remote monitoring
ICD therapies in the era of remote monitoring : follow-up of 881 patients with a very low rate of inappropriate therapies
P. Jacon, N. Pellet, A. Martin, H. Rekik, J.J. Ndjessan, F. Dujenet, P. Defaye (Grenoble, FR)
MONDAY
TUESDAY
WEDNESDAY
87
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
88
11:00 - 12:30
Poster Session
POSTER AREA
Posters must be set up between 08:00 - 08:30, removed between 18:00 - 18:30, to be on display between 08:30 - 18:00.
The presenter should be available by the poster (11:00-12:30) in order to discuss the research with the audience.
Heart failure
Circadian rhythms in ECG parameters in mice with and without heart failure.
L.A. Gottlieb (Koebenhavn N, DK)
Remodeling of distinct sodium channel pools in the murine failing heart.
M. Rivaud (Amsterdam, NL)
Adverse Remodelling of the Cardiac Conduction System (CCS) in Heart Failure Could be the Result of Up and Down Regulation of
MicroRNAs.
J. Yanni (Manchester, GB)
Electrical remodelling in heart failure
M. Liu, G.B. Shi, H. Liu, S.C. Dudley (Providence, US)
Identification of two native Nav1.5 phosphorylation sites as potential determinants of the increased late Na+ current in heart failure
S. Burel, F. Coyan, M.R. Meyer, C.F. Litchi, J.H. Brown, F. Charpentier, J.M. Nerbonne, R.R. Townsend, L.S. Maier, C. Marionneau
(Nantes, FR; Saint Louis, Galveston and San Diego, US; Regensburg, DE)
Pacemaker-induced cardiomyopathy in the sheep: RVA but not RVOT pacing results in a heart failure cellular phenotype
G. Kirkwood, M. Lawless, C. Pearman, E. Radcliffe, A.W. Trafford (Manchester, GB)
The association between tenascin-c and nt-proBNP levels and arrhythmia prevalence in heart failure
C. Ozmen, A. Deniz, O.S. Deveci, C.E. Caglayan, A.I. Celik, I. Yildiz, P. Ozmen Yildiz, M. Demir, M. Kanadasi (Adana and Osmaniye, TR)
Pharmacology
Effect of ethanol on inward rectifier potassium current sensitive to acetylcholine in rat atrial myocytes and on expressed Kir3.1/3.4
channels.
Z. Horakova (Prerov, CZ)
A Novel, Potent, and Selective Inhibitor of Cardiac Late Sodium Current Reduces Transmural Dispersion of Repolarization and
Suppresses Experimental Arrhythmias.
S. Rajamani (Fremont, US)
Paradoxical effects of IKs blockade during nNOS inhibition.
J. Bernardi (Milan, IT)
Mode of action of TMYX on the pacemaker activity of freely moving mice.
C. Piantoni (Milan, IT)
Effects of the Traditional Chinese Medicine drug TMYX on action potential parameters of SAN cells.
M. Paina (Milan, IT)
Molecular aspects of ivabradine binding to hHCN4 and hHCN1 channel pores.
A. Bucchi (Milan, IT)
DIfferent lidicaine, nifedipine and oubaine sensitivity SAN cells in rabbit and mouse.
A. Golovko (Syktyvkar, RU)
Rabbit and mouse sino-auricular node cells with similar maximal upstroke velocity of the potential exhibit different sensitivity to
lidocaine, nifedipine and ouabain.
E. Lebedeva (Syktyvkar, RU)
Pharmacological analysis of transmembrane action potential's morphology in the spontaneously beating heart of ascidia Styela rustica
in vitro.
A. Golovko (Syktyvkar, RU)
Selective pharmacologic block demonstrates contribution of L-type Cav1.3 calcium channel over the full diastolic depolarization
phase of cardiac pacemaker cells.
P. Mesirca (Montpellier, FR)
Inhibition of the inward rectifier current IK1 by PA-6 restores sinus rhythm in goats with atrial fibrillation, but does not induce
ventricular arrhythmias in dogs with chronic AV block
M.A.G. Van Der Heyden, R. Varkevisser, Y. Ji, A. Bossu, D. Opacic, J. Beekman, S. Yang, M. Wang, S. Verheule, M.A. Vos (Utrecht and
Maastricht, NL; Lawrence, US)
Molecular determinants of dronedarone inhibition of the hERG K+ channel
Y. Zhang, C. Colenso, C. Dempsey, J. Hancox (BRISTOL, GB)
P913
P914
P915
P916
P917
P918
P919
P920
P921
P922
P923
P924
P925
P926
P927
P928
P929
P930
P931
P934
P935
P936
P937
P938
P939
P940
P941
TUESDAY
P942
P943
P944
P945
P946
WEDNESDAY
P933
MONDAY
P932
SUNDAY
Effect of ethanol on inward rectifier potassium current sensitive to acetylcholine in rat atrial myocytes and on expressed Kir3.1/3.4
channels
Z. Horakova, P. Matejovic, J. Hosek, M. Simurdova, J. Simurda, M. Bebarova (Brno, CZ)
Multiple ion channel pharmacology screening at physiological temperature using the CytoPatch automated patch-clamp platform
O. Scheel, J. Eisfeld, S. Frech, B. Amuzescu, S. Wierschke, J. Kudolo, T. Knott (Rostock, DE)
P947
P948
P949
P950
P951
P952
P953
P954
89
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
90
P955
P956
P957
P958
P959
P960
P961
P962
P963
P964
P965
Poster Session
POSTER AREA
Poster session 4
Posters must be set up between 13:30 - 14:00, removed between 18:00 - 18:30, to be on display between 14:00 - 18:00.
The presenter should be available by the poster during the break (15:30 to 16:30) in order to discuss the research with the audience.
P968
P969
P970
P971
P972
P973
P974
WEDNESDAY
P967
TUESDAY
P966
MONDAY
SUNDAY
14:00 - 18:00
P975
P976
P977
P978
P979
P980
P981
P982
91
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
Esophagus temperature monitoring during cryoballoon ablation on left atrium using deflectable probe and fixed sensor probe
P983
A. Kobori, Y. Sasaki, T. Yamane, K. Kim, N. Ehara, M. Kinoshita, S. Kaji, Y. Furukawa (Kobe, JP)
Robotic navigation system nullifies the benefit of general anesthesia during pulmonary vein isolation: results from a randomized
single-center study.
P984
A. Dello Russo, S. Conti, G. Fassini, M. Casella, E. Russo, F. Pizzamiglio, L. Cipolletta, G. Vettor, G. Del Giorno, C. Tondo (Milan, IT)
Early ablation in paroxysmal atrial fibrillation demonstrates significant benefit in atrial function and reverse remodelling: a study
with 3D strain
P985
M. Agelaki, J. Grapsa, D. Dawson, C. Papadopoulos, A. Katsivas, P. Nihoyannopoulos (London, GB; Athens, GR)
Apixaban is a safe alternative to uninterrupted warfarin during catheter ablation of atrial fibrillation
P986
K.R. Nilsson, B. Pye, A. Lorrain, J. Murrow (Augusta, US)
Redo-ablations of atrial fibrillation: procedural characteristics depending on the choice of cryoenergy or radiofrequency ablation
as the first line therapy
P987
V. Galand, D. Feneon, N. Behar, A. Behaghel, M. Fournet, J.C. Daubert, P. Mabo, D. Pavin, R.P. Martins (Rennes, FR)
Head-to-head comparison of contact-force sensing catheters: the same benefit on catheter ablation of paroxysmal and persistent atrial
fibrillation?
P988
R.A. Providencia, Z. Khoueiry, A. Bouzeman, P. Sousa, S. Combes, N. Combes, S. Boveda, J.P. Albenque (Toulouse, FR)
The incidence and characteristics of right phrenic nerve stimulation from right pulmonary veins
P989
Y. Hama, Y. Matsudo, T. Kuwahara, M. Yamamoto, T. Himi (Kisarazu and Yokosuka, JP)
NMARQ survey: results of using a novel irrigated multielectrode mapping and ablation catheter for atrial fibrillation ablation
P990
N. Vitulano, A. Di Monaco, F. Quadrini, F. Troisi, G. Katsouras, V. Caccavo, T. Langialonga, M. Grimaldi (Acquaviva Delle Fonti, IT)
Non-fluoroscopic navigation system in atrial fibrillation ablation: reducing reference displacement using active fixation lead.
P991
R. Salgado Aranda, J. Garcia Fernandez, J. Martin Gonzalez, S. Mayordomo Gomez, J. Monedero Campo, M. Alvarez Calderon,
A. Mateos Perez (Burgos, ES)
Figure-of-eight suture for vascular hemostasis in fully anticoagulated patients after atrial fibrillation catheter ablation
P992
U. Lakshmanadoss, R. Khalid, I. Kutinsky, B. Williamson, W. Wong, D.E. Haines (Royal Oak and Rochester, US)
Pulmonary vein anatomy and nadir temperature during cryoballoon ablation for atrial fibrillation.
P993
J. Baran, R. Piotrowski, A. Sikorska, T. Krynski, S. Stec, P. Kulakowski (Warsaw and Rzeszw, PL)
Atrial fibrillation cycle length measured in a 12-lead surface ECG predicts intracardiac AF cycle length prior to ablation procedure (W) P994
J. Luker, A. Sultan, D. Schreiber, T. Plenge, S. Willems, D. Steven (Cologne and Hamburg, DE)
Age-specific incidence of recurrent atrial fibrillation and clinical events after catheter ablation in patients with paroxysmal atrial
fibrillation
(W) P995
M. Takigawa, A.T. Takahashi, T.K. Kuwahara, K.O. Ohkubo, K.Y. Yamao, E.N. Nakashima, N.J. Nakajima, K.T. Takagi, K.H. Hirao, M.I. Isobe
(Suita, Osaka and Yokosuka, JP)
Surgery & Pacing (Atrial Fibrillation)
Predictors of pocket hematoma occurrence in patients on uninterrupted oral anticoagulation undergoing cardiac implantable
electronic device procedures
F. De Sensi, G. Miracapillo, L. Addonisio, M. Breschi, T. Infusino, S. Severi (Grosseto and Catanzaro, IT)
P996
Tools: catheters, sources, mapping, navigators (Catheter ablation / except atrial fibrillation)
Comparison of pulmonary vein isolation guided by remote magnetic navigation in patients with paroxysmal atrial fibrillation using
an irrigated gold-tip and a classical irrigated catheter
P997
R. Prisecaru, L. Riahi, Y. De Greef, D. Stockman, P. Van Den Heuvel, B. Schwagten (Antwerp, BE)
Endoscopically detected esophageal thermal lesions are related to the use of esophageal intraluminal temperature probe: Results
from atrial fibrillation ablation using a novel irrigated multipolar abl
P998
T. Deneke, P. Halbfass, P. Mueller, P. Fochler, M. Roos, R. Schmitt, G. Christopoulos, A. Szoelloessi, J. Krug, K. Nentwich
(Bad Neustadt a.d. Saale, DE)
Irradiation of the operator and the patient during radiofrequency ablation of common atrial flutter using three different settings
of angiography system
P999
M. Granier, X. Brunet, J. Greffier, A. Zedira, J.P. Beregi, P. Messner, P.F. Winum (Nimes, FR)
Cavotricuspid isthmus ablation using a catheter equipped with mini electrodes on the 8mm tip: a prospective comparison with an 8mm
dumbbell shape tip catheter and an 8mm tip cryothermal catheter.
P1000
J. Iwasawa, S. Miyazaki, N. Ichihara, T. Takagi, H. Nakamura, H. Taniguchi, H. Hachiya, Y. Iesaka (Tsuchiura, JP)
P1001
Characterization of very low voltage/scar areas in patients with left atrial flutter by high density voltage maps
P.F. Cruz, S. Castrejon Castrejon, E. Falconi, M. Arceluz, R. Delgado, M. Ortega, O. Salvador, J.L. Merino Llorens (Madrid, ES)
92
P1003
P1004
P1005
P1006
P1007
P1009
P1010
P1011
External Defibrillators
Wearable cardioverter defibrillator reduces implantation rate of ICD in patients with high risk for life-threatening cardiac arrhythmias
A.M. Sinha, E. Martens, A. Wystrach (Hof, DE)
P1014
Subcutaneous ICD
The subcutaneous implantable defibrillator:global experience in an high volume ICD lead extraction centre
S.M. Viani, G. Zucchelli, E. Soldati, L. Paperini, L. Segreti, A. Di Cori, A. Boem, D. Levorato, G. Branchitta, M.G. Bongiorni (Pisa, IT)
P1015
Devices (Pacing)
Developing a new classification and grading system for pocket hematoma after CIED procedures
F. De Sensi, S. Severi, G. Miracapillo, K.E.J. Airaksinen (Grosseto, IT; Turku, FI)
Tricuspid regurgitation associated with pacemaker lead an underestimated problem.
A. Rydlewska, A. Zabek, K. Boczar, J. Lelakowski, B. Malecka (Krakow, PL)
Stability of pacing indices in cardiac transplant patients
T. Farid, A.R. Moser, B. Austin, A. Magalski, A. Wimmer (Kansas City, US)
Two years experience after decentralization of pacemaker follow-up visit to local especialty care centres using remote transmission.
J.J. Ferrer Hita, A. Rodriguez Gonzalez, R.A. Juarez Prera, P. Jorge Perez, F. Bosa Ojeda, M.J. Garcia Gonzalez, E. Gonzalez Cabeza,
B. Mari Lopez, C. Mendez Vargas, I. Laynez Cerdena (Santa Cruz de Tenerife, ES)
WEDNESDAY
TUESDAY
P1008
MONDAY
Primary & Secondary prevention (Sudden cardiac death and implantable defibrillators)
Effectiveness of extracorporeal life support for patients with cardiogenic shock due to intractable arrhythmic storm
S. Le Pennec-Prigent, R.P. Martins, C. Chabanne, B. Lelong, J.C. Daubert, C. Leclercq, P. Mabo, E. Flecher (Rennes, FR)
Predictive model of the probability of sudden cardiac death of the patients with dilated cardiomyopathy
T. Vaikhanskaya, T.M. Kaptsiukh, T.V. Kurushka, O.P. Melnikova, A.V. Frolov (Minsk, BY)
Quality of life, biomarkers and ICD indications in patients with a wearable cardioverter/defibrillator - preliminary results of
a prospective trial with 1 year of follow-up
D. Duncker, Y. Kirste, S. Hohmann, T. Koenig, F. Zauner, H. Oswald, C. Veltmann (Hannover, DE)
Role of NT-proBNP in the assessment of clinical outcome and prediction of arrhythmic events
E. Menardi, A. Vado, G. Rossetti, M. Landolina, A. Castro, R. Massa, M. Sassara, A. Kheir, M. Malacrida, L.M. Biasucci (Cuneo, Crema,
Rome, Alessandria, Viterbo, Ponte San Pietro and Milan, IT)
P1002
SUNDAY
P1016
P1017
P1018
P1019
93
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
Leads (Pacing)
Do quadripolar transvenous LV leads have advantages at the time of de novo CRT-D implantation?
(W) P1020
C.G. Wollmann, K. Thudt, P. Vock, H. Mayr (St. Polten, AT)
Utility and safety of temporary pacing using active-fixation leads and externalized re-usable pacemakers in transcatheter aortic valve
implantation and other conditions requiring short-term pacing
P1021
S. Schwarz, A. Kypta, S. Hoenig, J. Kammler, K. Saleh, T. Lambert, H. Blessberger, V. Gammer, A. Nahler, C. Steinwender (Linz, AT)
Indications & Results (Pacing)
Long-term follow up of pacemaker implantation through a persistent left superior vena cava, a safe approach?
M.T. Lopez Lluva, J. Jimenez Diaz, J.J. Gonzalez Ferrer, N.G. Uribe Heredia, J. Benezet Penaranda (Ciudad Real, ES)
Patients with atrio-ventricular blocks qualified for pacemaker implantation seem to be more frequent exposed on frailty syndrome
A. Mlynarska, R. Mlynarski, M. Sosnowski, K.S. Golba (Katowice, PL)
Long-term follow-up of patients with cardiac implantable electrical devices implanted in childhood
M. Sasov, V. Illikova, E. Balazova, P. Margitfalvi, M. Svetlosak, R. Hatala (Bratislava, SK)
LBBB is incomplete in the majority of patients with HF due to systolic LV dysfunction: a simple intraprocedural demonstration
D.-A. Radu, C.N. Iorgulescu, S.N. Bogdan, E. Ene, A. Nastasa, G. Malaescu, R.G. Vatasescu (Bucharest, RO)
Technical and imaging aspects (Resynchronisation therapy)
Initial experience implanting a new intravenous coronary sinus lead with an active fixation mechanism for cardiac resynchronization
therapy.
R. Matia Frances, A.H.Madrid, J. Rubio, A. Miracle, G. Sanchez-Huete, E. Franco, J. Moreno, J.L. Zamorano (Madrid, Valladolid and
Mostoles, ES)
Biventricular pacing reduces coronary flow velocity reserve in the left anterior descending artery compared with baseline rhythm
in patients with chronically implanted CRT devices
S.B.L. Claridge, Z. Chen, T. Jackson, J. Behar, K. Assress, M. Lumley, R. Williams, J. Bostock, D. Perera, C.A. Rinaldi (London, GB)
Modifying quadripolar left ventricular pacing vectors impacts ventricular activation times in cardiac resynchronisation therapy
T.A. Jackson, S. Claridge, J. Behar, R. Razavi, C.A. Rinaldi (London, GB)
P1022
P1023
P1024
P1025
P1026
P1027
P1028
94
P1039
P1040
P1041
P1042
P1045
Monitoring tools
The diagnostic quality of the new injectable telemedically cardiac monitor Reveal LINQ.
M. Christoph, J. Mayer, C. Wunderlich, Y. Huo, M. Forkmann, J. Salmas, M. Pohl, T. Gaspar, C. Piorkowski (Dresden, DE)
P1046
P1047
P1048
WEDNESDAY
TUESDAY
MONDAY
P1038
SUNDAY
Syncope
The role of beta-blocker treatment in reducing the incidence of fast-VT related syncope in ICD patients with left ventricular
dysfunction: Results from a multicenter study.
J. Jimenez-Candil, I. Anguera, J. Fernandez-Portales, J. Morinigo, J. Hernandez, E. Garcia-Piney, P. Perdiguero, P.L. Sanchez (Salamanca,
L'Hospitalet de Llobregat, Barcelona and Caceres, ES)
Vasovagal syncope patient eligibility for prevention of syncope trials IV and V: a single center evaluation
T. Kus, E. Tewfik, B. Huang, R.S. Sheldon, G. Becker, M. Sturmer (Montreal and Calgary, CA)
P1049
P1050
P1051
P1052
P1053
P1054
P1055
95
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
96
Long runs of non-sustained ventricular tachycardia predict serious arrhythmic events in patients with non-ischemic heart failure
M. Pimentel, A. Zimerman, D. Chemello, V. Giaretta, M. Andrades, D. Silvello, L.I. Zimerman, L.E. Rohde (Porto Alegre, BR)
Impact of a wireless probe on ultrasound-guided venous cannulation in the electrophysiology lab: reduction of unsuccessful attempts
and accidental arterial punctures
D. Rodriguez Munoz, E. Franco Diez, G. Lumia, T. Segura De La Cal, A. Carbonell San Roman, R. Matia Frances, A. Hernandez-Madrid,
J. Moreno Planas, J.L. Zamorano Gomez (Madrid, ES)
P1056
P1057
Anticoagulation
Predicting intracranial bleeding risk in unselected patients with atrial fibrillation: comparison of several bleeding risk scores.
P1058
L. Fauchier, A. Banerjee, I. Lagrenade, N. Clementy, D. Angoulvant, A. Bernard, D. Babuty, G.Y.H. Lip (Tours, FR; Birmingham, GB)
Patient-related factors and the quality of oral anticoagulant therapy with vitamin K antagonists for stroke prevention in atrial fibrillation P1059
M. Polovina, J. Savic, M. Vukicevic, G. Mitic, T. Potpara (Belgrade and Novi Sad, RS)
Remote monitoring
Successive monitoring with seven-day Holter and episodic ECG recorder with automatic transtelephonic ECG transmission for
asymptomatic atrial fibrillation in patients with cryptogenic stroke
V. Bulkova, D. Goldemund, Z. Houzarova, M. Novak, S. Sobotkova, D. Kovarikova, L. Ondraskova, J. Gandalovicova, M. Fiala (Brno, CZ)
Registries and surveys
Effect of high-grade atrioventricular block complicating STEMI in the contemporary era
F. Cordeiro, P. Magalhaes, S. Leao, A. Baptista, C. Ferreira, A. Ferreira, P.S. Mateus, J.I. Moreira (Vila Real, PT)
P1060
P1061
Main Session
ROMA
SUNDAY
08:30 - 10:00
The session proposal aims to providing an update on the management of patients with atrial fibrillation (both catheter ablation as rhythm control
strategy and AV nodal ablation as rate control strategy) and concomitant LV dysfunction.
Atrial fibrillation ablation in patients with left ventricular hypertrophy
C. Blomstrom-Lundqvist (Uppsala, SE)
Long term outcome of AF ablation in patients with left venticular systolic dysfunction.
F. Gaita (Turin, IT)
Current indications for AV node ablation in CRT recipients with atrial fibrillation.
L. Mont (Barcelona, ES)
Biventricular or right ventricular pacing only in the setting of the ablate-and-pace approach?
M. Brignole (Lavagna, IT)
08:30 - 10:00
How-to Session
1062
1063
1064
1065
NAPOLI
08:30 - 10:00
1066
1067
1068
1069
Main Session
TORINO
WEDNESDAY
Installation of facilities.
G. Luzzi (Bari, IT)
Optimal training.
C. Butter (Bernau/Berlin, DE)
Patient selection.
C. Love (New York, US)
Complication management.
M.G. Bongiorni (Pisa, IT)
TUESDAY
MONDAY
08:30
08:52
09:15
09:37
1070
1071
1072
1073
1074
97
MONDAY
SUNDAY
08:30 - 10:00
Symposium
PALERMO
08:30 - 10:00
1075
1076
1077
1078
Symposium
GENOVA
WEDNESDAY
TUESDAY
08:30 - 10:00
Symposium
1079
1080
1081
1082
1083
1084
1085
1086
BOLOGNA
98
Implementing results of lead extraction registry to improve quality of care - need for a European registry?
M.G. Bongiorni (Pisa, IT)
Device registries - can reported complication rates be trusted?
R. Kirkfeldt (Aarhus, DK)
Experience from the ICD and pacemaker registry in UK - has quality of care improved?
D. Todd (Liverpool, GB)
Can registries be used to improve CRT response rates?
M. Stahlberg (Stockholm, SE)
Device registries - financial implications.
G. Boriani (Bologna, IT)
1087
1088
1089
1090
1091
Symposium
FIRENZE
SUNDAY
08:30 - 10:00
This session will provide insights into greater understanding of reflex syncope, its pathophysiology,outcome and differential diagnosis.
Syncope and falls in older people.
J.-J. Blanc (Brest, FR)
Tales of the fainting heart: genes and biomarkers
A. Fedorowski (Malmo, SE)
New interrpretation of a positive tilt test
R. Sutton (Monte Carlo, MC)
Adenosine sensitive syncope: a distinct clinical entity?
J.-C. Deharo (Marseille, FR)
08:30 - 10:00
1092
1093
1094
1095
Symposium
VENEZIA
MR imaging before ablation contributes to risk stratification and planning of the procedure. The session will provide a translational view on
contemporary MR imaging, the contribution of structural myocardial substrates to arrhythmogenesis, and potentially useful integrated real-time
imaging with ablation in this setting
08:30 - 10:00
Symposium
1096
1097
1098
1099
BARI
WEDNESDAY
TUESDAY
08:30
08:52
09:15
09:37
MONDAY
08:30
08:52
09:15
09:37
To discuss issues in daily life that affect the quality of life of patients living with a device
08:30
08:52
09:15
09:37
Sport for ICD patients: how much and how to programme the device.
L. Hinterbuchner (Salzburg, AT)
What can we offer patients in patient teaching programmes?
U. Walfridsson (Linkoping, SE)
Resuming sexual life after a device implantation.
T.M. Norekval (Bergen, NO)
ICD shocks, what do people feel.
S.S. Pedersen (Odense, DK)
1100
1101
1102
1103
99
MONDAY
SUNDAY
08:30 - 10:00
Symposium
CAGLIARI
08:30 - 10:00
1104
1105
1106
1107
AGORA
WEDNESDAY
TUESDAY
Each speaker will present and discuss their research during the session.
After the session finishes each speaker will have a dedicated screen next to the Agora in the Abstract Discussion Zone in order to further
discuss and display their presentation and facilitate in-depth dialogue with interested parties.
08:30 The outcomes of patients with lead extraction without subsequent device re-implantation
1108
M. Al-Hijji, O. Yousefian, D. Hodge, S. Hebsur, K. Lewis, M.J. Ackerman, V. Pretorius, P. Friedman, U. Birgersdotter-Green, Y.M. Cha
(Rochester and San Diego, US)
08:39 Single sheath lead extraction, a single center experience of more than 1800 lead extractions
1109
T.M. Knutsen, P. Vanberg, T. Steen, P.T. Skretteberg, Z. Kamal, E.S. Platou (Oslo, NO)
08:48 Conductor externalization and failure rate of the Linox lead
1110
L. Roten, F. Noti, A. Lam, N. Klossner, J. Seiler, H. Servatius, A. Medeiros-Domingo, N. Van Tran, J. Fuhrer, H. Tanner (Bern, CH)
08:57 Lead-dependent infective endocarditis the role of factors predisposing to its development in an analysis of 414 clinical cases
1111
A. Polewczyk, W. Jachec, A. Tomaszewski, W. Brzozowski, M. Janion, A. Kutarski (Kielce, Zabrze and Lublin, PL)
09:06 Transvenous lead extraction in octagenarians.
1112
E.V. Dovellini, L. Giurlani, P. Corsi, A. Michelucci, N. Carrabba, A. Santini, D. Antoniucci (Florence, IT)
09:15 Favorable outcome of gram-negative bacteremia in patients with a cardiovascular implantable electronic device
1113
J. Shimotakahara, N. Yagi, J. Nakazato, T. Miyagi, T. Takahashi, M. Wake, K. Hirata (Uruma, JP)
09:24 The role of the coagulation system in the development and prognosis of syncope in patients with hypertrophic cardiomyopathy. 1114
G.A. Shakaryants, M.V. Kozhevnikova, V.Y.U. Kaplunova, E.V. Privalova, I.S. Chekneva, N.V. Khabarova, Y.N. Belenkov (Moscow, RU)
09:33 Impact of age and medications on risk of recurrent syncope in patients with suspected neurally-mediated syncope
1115
N.R. Petix, A. Del Rosso, V. Guarnaccia, A. Zipoli (Empoli, IT)
09:42 Changes of brain desaturation during head-up tilt test in teenagers with vasovagal syncope
1116
A.Z. Pietrucha, B.J. Pietrucha, M. Wnuk, I. Bzukala, O. Kruszelnicka, E. Konduracka, A. Rudzinski, J. Nessler (Cracow, PL)
09:51 Outcome of patients with early repolarization after an episode of syncope
1117
M. Le Bloa, F. Sacher, J.B. Gourraud, P. Maury, C. Leclercq, D. Babuty, D. Klug, J. Mansourati, M. Haissaguerre, V. Probst
(Bordeaux, Nantes, Toulouse, Rennes, Tours, Lille and Brest, FR)
100
Moderated Posters
POSTER AREA
WEDNESDAY
A higher prevalence of early repolarization and its characteristics on electrocardiogram in patients with epilepsy
P1118
K. Hayashi, R. Kohno, N. Akamatsu, Y. Oginosawa, Y. Otsuji, H. Abe (Kitakyusyu and Fukuoka, JP)
The relationship between J wave and ventricular tachycardia during Takotsubo cardiomyopathy
P1119
Y.S. Baek, M.J. Lee, J.H. Park, J.W. Yoon, S.W. Kwon, S.D. Park, S.H. Shin, S.I. Woo, J. Kwan, D.H. Kim (Incheon, KR)
Prevalence of early repolarization in congenital long QT syndrome. A combination of early and delayed repolarization
P1120
P. Maury, M. Audoubert, R. Chauvel, J.B. Gourraud, A. Rollin, A. Duparc, P. Mondoly, C. Cardin, F. Sacher, V. Probst (Toulouse,
Bordeaux and Nantes, FR)
Early repolarization pattern: a marker of increased risk in patients with catecholaminergic polymorphic ventricular tachycardia P1121
E. Tulumen, E. Schulze-Bahr, S. Zumhagen, B. Stallmeyer, B.M. Beckmann, S. Kaab, C. Wolpert, B. Rudic, C. Veltmann,
M. Borggrefe (Mannheim, Mnster, Munich, Ludwigsburg and Hannover, DE)
Persistence of identical ECG pattern and prevalence of depolarization and repolarization markers in asymptomatic young
individuals with incidentally found prominent J-wave over a period of 4 years.
P1122
E. Simeonidou, C. Michalakeas, S. Kastellanos, C. Varounis, C. Dai, J. Lekakis (Athens, GR)
Early repolarisation is associated with sudden death in hypertrophic cardiomyopathy
(W) P1123
G. Mellor, N. Sheikh, K. Prakash, M. Papadakis, S. Sharma, E.R. Behr (London, GB)
Relationship between J-wave and vagal activity in the patients who do not have structural heart disease
P1124
Y.S. Baek, J.H. Park, J.W. Yoon, M.J. Lee, S.D. Park, S.W. Kwon, S.H. Shin, S.I. Woo, J. Kwan, D.H. Kim (Incheon, KR)
Electrical remodeling in patients with iatrogenic left bundle branch block
P1125
E.B. Engels, T.T. Poels, P. Houthuizen, P. De Jaegere, K. Vernooy, F.W. Prinzen (Maastricht, Eindhoven and Rotterdam, NL)
Utility of T-wave-alternans during night time for risk assessment in patients with Brugada-type electrocardiogram
P1126
S. Sakamoto, M. Takagi, J. Kakihara, Y. Hayashi, A. Doi, M. Yoshiyama (Osaka, JP)
Maximal T-wave alternans site on the 12-lead Holter ECG correlates with the late gadolinium enhancement distribution
on cardiac MRI in hypertrophic cardiomyopathy
P1127
N. Sakamoto, N. Sato, E. Sugiyama, A. Minoshima, Y. Tanabe, T. Takeuchi, Y. Kawamura, N. Hasebe (Asahikawa, JP)
TUESDAY
MONDAY
Moderated Posters must be set up between 08:00 and 08:30, removed between 12:30 and 13:00 and be on display from 08:30 until 12:30. The
presenter should be present throughout the coffee break (10:00 - 11:00) in order to discuss the poster.
The following abstracts were chosen for their high quality and will be discussed during the Moderated Poster session animated by two
chairpersons between 10:00 - 11:00. Each presenter will have 5 minutes to present and discuss their research in front of the audience and the
chairpersons
SUNDAY
10:00 - 11:00
101
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
102
11:00 - 12:30
Special Session
MILANO
Live session
Chairpersons: To be announced; G. Hindricks (Leipzig, DE)
Case 1
Accurate CT scan anatomy and CARTO mapping with Stereotaxis catheter
Merging CT and CARTO map, PV mapping with Lasso catheter;
Ablation of PV antrum utilizing the VISITAG CARTO feature
Validation of bidirectional VP isolation (pacing and Adenosin).
Case 2
Indication to the procedure
General setup (general anesthesia, TEE monitoring)
Choice and sizing if the appropriate device
Post procedure evaluation and patient follow up
11:00
11:00
11:00 - 12:30
Main Session
1128
1129
ROMA
The session proposal aims to providing an update on post ablation management of atrial fibrillation patients and methods used to reduce
recurrences.
11:00
11:22
11:45
12:07
1130
1131
1132
1133
Debate Session
TORINO
Devices may not be forever? Can ongoing ICD or CRT therapy become unnecessary?
Chairpersons: J.C. Daubert (Rennes, FR); I. Goldenberg (Ramat Gan, IL)
EHRA Member session
Device track
11:00 - 12:30
Symposium
1134
1135
1136
1137
1138
1139
1140
1141
1142
1143
PALERMO
WEDNESDAY
TUESDAY
11:00
11:15
11:30
11:35
11:40
11:45
12:00
12:15
12:20
12:25
MONDAY
There is ongoing debate if an initiated CRT D therapy really needs to include an ICD over time . There is evidence to suggest that CRT may
be hazardous in patients with narrow QRS. How do we deal with patients already implanted? Could interruption of ongoing ICD therapy in
responders to CRT be considered? Listen to the debate by experts in the field.
SUNDAY
11:00 - 12:30
1144
1145
1146
1147
103
MONDAY
SUNDAY
11:00 - 12:30
TUESDAY
GENOVA
WEDNESDAY
Symposium
Symposium
1148
1149
1150
1151
BOLOGNA
11:00 - 12:30
Symposium
1152
1153
1154
1155
1156
FIRENZE
104
1157
1158
1159
1160
Symposium
VENEZIA
SUNDAY
11:00 - 12:30
This translational study will provide experimental understanding for the specific contribution of the right ventricle to arrhythmogenesis under
various conditions. Clinical perspectives will be given, particularly in relation to antiarrhythmic treatment.
RV versus LV electrophysiology in cardiac remodelling.
D. Dobrev (Essen, DE)
Exercise-related RV arrhythmias and the effect of physical deconditioning.
M. Papadakis (London, GB)
Lessons from arrhythmogenic ventricular cardiomyopathy: electrical and structural phenotypes.
F. Duru (Zurich, CH)
The RV after repair of congenital heart defects, and catheter-based antiarrhythmic treatment.
S. Ernst (London, GB)
11:00 - 12:30
Symposium
1161
1162
1163
1164
BARI
Describe and discuss monitoring of arrhythmias and discover ways to improve practice
11:00 - 12:30
Special Event
1165
1166
1167
1168
CAGLIARI
WEDNESDAY
State of the art: 50 years with in-hospital telemetry monitoring and what is ahead of us?
B.J. Drew (San Francisco, US)
Non-cardiac patients a challenge to existing telemetry guidelines.
P.A.F.M. Doevendans (Utrecht, NL)
Dedicated monitor watchers is it really necessary?
J. Tagney (Bristol, GB)
Comparison of two teaching methods for cardiac arrhythmia interpretation among nursing students.
T. Xanthos (Athens, GR)
TUESDAY
11:00
11:22
11:45
12:07
MONDAY
11:00
11:22
11:45
12:07
New approach for anti-bradycardia pacing: left ventricular septum pacing by transvenous approach through the inter-ventricular
septum.
1169
K. Vernooy (Valkenburg Aan De Geul, NL)
11:22 A method and system for vector analysis of lectrocardiogram in assessment of risk of sudden cardiac death (SCD) due to
arrhythmogenic right ventricular dysplasia/cardiomyopathy by quantifying micro scars (i.e. bites) in three dimensional
vector loops.
1170
I. Vranic (Belgrade, RS)
11:45 Through-needle intracardiac echocardiography for transseptal puncture using a novel optical pulse-echo ultrasound technique.
1171
M.C. Finlay (London, GB)
12:07 EHRA Inventors Award Winner announcement.
1172
F.W. Prinzen (Maastricht, NL)
105
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
106
11:00 - 12:30
AGORA
Molecular pathology and therapy of arrhythmias: novel insights from experimental studies
Chairpersons: C. Wolpert (Ludwigsburg, DE); M. Eldar (Ramat-Gan, IL)
Each speaker will present and discuss their research during the session.
After the session finishes each speaker will have a dedicated screen next to the Agora in the Abstract Discussion Zone in order to further
discuss and display their presentation and facilitate in-depth dialogue with interested parties.
11:00
11:09
11:18
11:27
11:36
11:45
11:54
12:03
12:12
12:21
Satellite Symposium
ROMA
SUNDAY
12:45 - 13:45
Learn how to optimise and improve the response of cardiac resynchronisation therapy by selecting the right candidates, applying the right tools
and techniques during implantation and the use of dedicated algorithms that improve hemodynamics while adapting to the individual patient.
Introduction.
M. Meine (Utrecht, NL)
Selection of CRT candidates: Which patients benefit most?
J.G.F. Cleland (London, GB)
Latest tools for successful CRT implantation.
M. Biffi (Bologna, IT)
AdaptivCRT: Dynamic left ventricular pacing to improve response.
N. Clementy (Tours, FR)
Conclusions and discussion.
A. Auricchio (Lugano, CH)
Satellite Symposium
1184
1185
1186
1187
PALERMO
12:45
13:05
13:25
12:45 - 13:45
1188
1189
1190
Satellite Symposium
WEDNESDAY
An increasing number of CIED are implanted every year. With an aging patient population and increased complexity of the device and leads, the
infection rates are also outgrowing implant rates. In this session, you will hear of the CIED infection problem, how to prevent it and ways to treat
those patients.
TUESDAY
12:45 - 13:45
1183
MONDAY
12:45
12:50
13:05
13:20
13:35
GENOVA
1) Learn how high resolution mapping technology enables accurate diagnosis and evaluation of cardiac arrhythmias.
2) Learn how high resolution ablation technology allows for precise localisation of ablation targets in complex arrhythmias.
3) Learn how high resolution ablation technology enables lesion assessment during ablation.
4) Learn how high resolution mapping technology contributes to a tailored ablation strategy in patients indicated for ventricular tachycardia
ablation.
12:45
13:05
13:25
1191
1192
1193
107
MONDAY
SUNDAY
12:45 - 13:45
TUESDAY
WEDNESDAY
BOLOGNA
Introduction.
A. Curnis (Brescia, IT)
Vector selection and programming based on electrical conduction.
D.O.Donnell (Victoria, AU)
Clinical evidence demonstrating benefits of MultiPoint Pacing CRT.
A. Kloppe (Bochum, DE)
Management of Non-Responders with MultiPoint Pacing.
Z. Calovic (Belgrade, RS)
Q & A.
12:45 - 13:45
108
Satellite Symposium
Satellite Symposium
1194
1195
1196
1197
1198
VENEZIA
1 in 14 Patients require arrhythmia intervention: Remote Patient Management with the Wearable Cardioverter Defibrillator
Sponsored by ZOLL
Chairpersons: J. Sperzel (Johannesberg, DE); J.-C. Deharo (Marseille, FR)
This program will discuss how the Wearable Cardioventer Defibrillator provides protection from Sudden Cardiac Death with a connection
to your patients changing cardiac condition through the Online Patient Data Management System. Arrhythmic events captured and provide
actionable insights and the opportunity to modify the treatment path for WCD patients.
12:45
12:55
13:10
13:25
Introduction.
Discussion of the utility of remotely managed patient clinical and diagnostic markers to effect better outcomes.
J. Steffel (Zurich, CH)
Overview of the online patient management system and clinical scenarios for its use in treating patients in addition
to shocking VT/VF.
O. Przibille (Frankfurt, DE)
Panel discussion / Q&A.
1199
1200
1201
1202
Symposium
ROMA
14:00 - 15:30
Main Session
1203
1204
1205
1206
NAPOLI
To learn about how to prevent and treat TAVI induced conduction abnormalities and arrhythmias.
14:00 - 15:30
Main Session
1207
1208
1209
1210
TORINO
WEDNESDAY
TUESDAY
14:00
14:22
14:45
15:07
MONDAY
14:00
14:22
14:45
15:07
SUNDAY
14:00 - 15:30
Practical issues for having an effective CRT in the lab without complications
14:00
14:22
14:45
15:07
1211
1212
1213
1214
109
MONDAY
SUNDAY
14:00 - 15:30
Symposium
GENOVA
14:00 - 15:30
Symposium
1215
1216
1217
1218
BOLOGNA
WEDNESDAY
TUESDAY
European registries for atrial fibrillation ablation - can outcomes and reported complication rates be trusted?
J. Brugada Terradellas (Barcelona, ES)
The use of periprocedural anticoagulation therapy for patients undergoing atrial fibrillation ablation - results of a European
snap shot survey.
T. Potpara (Belgrade, RS)
The use of patient self assessment questionnaires for educational purposes - experience from a European atrial fibrillation
anticoagulation survey.
A.H. Madrid (Madrid, ES)
14:54 First report from the Thoracoscopic epicardial/hybrid Atrial Fibrillation Ablation Registry (TehAFAR) of EHRA.
L. Pison (Maastricht, NL)
15:12 Atrial fibrillation and device registries - of clinical use in daily clinical practice?
W. Amara (Le Raincy-Montfermeil, FR)
14:00 - 15:30
1220
1221
1222
1223
FIRENZE
Postural orthostatic tachycardia syndrome, inappropriate sinus tachycardia and vasovagal syncope: toward a consensus on diagnosis
and therapy
Chairpersons: R. Sutton (Monte Carlo, MC); H. Haouala (Tunis Montfleury, TN)
14:00
14:22
14:45
15:07
110
Symposium
1219
1224
1225
1226
1227
Symposium
VENEZIA
14:00 - 15:30
1228
1229
1230
1231
Symposium
BARI
MONDAY
14:00
14:22
14:45
15:07
SUNDAY
14:00 - 15:30
14:00 - 15:30
1232
1233
1234
1235
CAGLIARI
Full protection from drug-induced torsade de pointes-like arrhythmias by an allosteric Ikr-modulatory mechanism in rat
ventricular monolayers
J. Liu, Z. Yu, J.P. Van Veldhoven, A.P. Ijzerman, D.A. Pijnappels, L.H. Heitman, A.A. De Vries (Leiden, NL)
Is left atrial fibrosis quantified using late Ggadoadolinium enhancement magnetic resonance imaging a specific attribute of atrial
fibrillation?
O. Aparina, O. Stukalova, N. Mironova, E. Butorova, D. Parkhomenko, S.P. Golitsyn (Moscow, RU)
14:30 Creating new trans-species types of myocytes by forced fusion between cardiomyocytes and fibroblasts to counteract
arrhythmias: breaking boundaries with muscular mixtures
S.F. Askar, E.C.A. Nyns, M.C. Engels, M.J. Schalij, W. Jangsangthong, Z. Neshati, A.A.F. De Vries, D.A. Pijnappels (Leiden, NL)
14:45 Conduction disorders in orthotopic heart transplantation: risk factors and clinical relevance
S. Ferretto, E. Tafciu, I. Giuliani, T. Bottio, G. Feltrin, A. Gambino, A. Angelini, S. Iliceto, G. Gerosa, L. Leoni (Padua, IT)
15:00 Value of the frontal QRS-T angle for diagnosis and prognosis in patients with symptoms suggestive of acute myocardial
infarction
T. Reichlin, R. Twerenbold, R. Abaecherli, C. Sticherling, S. Osswald, C. Mueller (Basel, CH)
15:15 Positive chronotropic action of liraglutide on isolated rabbit hearts is not mediated by the beta-adrenergic pathway
A. Porta Sanchez, P. Lai, M. Kusha, S. Masse, M.A. Azam, J. Asta, K. Viswanathan, N. Jackson, K. Nanthakumar (Barcelona, ES;
Toronto, CA)
WEDNESDAY
14:00
14:22
14:45
15:07
TUESDAY
Leading experts are discussing diagnosis and treatment of cardiac arrhythmias in female patients
1236
1237
1238
1239
1240
1241
111
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
14:00 - 15:30
AGORA
It's not all about ablation: electrophysiological insights from left atrial intervention
Chairpersons: M. ONeill (London, GB); M. Duytschaever (Gent, BE)
Each speaker will present and discuss their research during the session.
After the session finishes each speaker will have a dedicated screen next to the Agora in the Abstract Discussion Zone in order to further
discuss and display their presentation and facilitate in-depth dialogue with interested parties.
14:00
14:09
14:18
14:27
14:36
15:30 - 16:30
EHRA General Assembly
112
Special Event
1242
1243
1244
1245
1246
1247
1248
1249
1250
1251
FIRENZE
Moderated Posters
POSTER AREA
16:30 - 18:00
Special Session
P1252
P1253
P1254
P1255
P1256
P1257
P1258
P1259
P1260
P1261
WEDNESDAY
Capture thresholds and pacing impedances of LV pacing vectors in a large quadripolar CRT-D post approval study
R. Corbisiero, D.T. Martin, S.L. Beau, S. Allison, D. Schleinkofer, T.G. Farazi, S. Zhang, M. Cao (Browns Mills, Burlington,
Little Rock, Huntsville, Fort Wayne, Sunnyvale, Sylmar and Rosemead, US)
Chronic performance of 10 pacing vectors available with a novel quadripolar left ventricular lead compared to bipolar leads
in the MORE CRT trial
G. Boriani, S. Connors, B. Lemke, W. Mullens, Z. Kalarus, J. Osca Asensi, P. Raatikainen, D. Schmitz, L. Calo, C. Leclercq
(Bologna and Rome, IT; St. John's, CA; Ludenscheid and Essen, DE; Genk, BE; Zabrze, PL; Valencia, ES; Tampere, FI; Rennes, FR)
Acute haemodynamics and left ventricular mechanical dyssynchrony improving with multisite left ventricular pacing via
quadripolar lead.
P. Alonso Fernandez, J. Osca Asensi, O. Cano Perez, A. Andres Lahuerta, V. Miro Palau, J. Sanz Sanchez,
M.J. Sancho-Tello De Carranza, J. Olague De Ros (Valencia, ES)
Long term effects of a short-spaced left ventricular quadripolar lead: results from the Per4mer study
M. Ziacchi, D. Saporito, G.L. Morgagni, E. De Maria, F. Quartieri, M. Bertini, M. Zardini, M. Luzi, G. Boriani, M. Biffi (Bologna,
Rimini, Macerata, Carpi, Reggio Emilia, Ferrara, Parma and Ancona, IT)
Quadripolar LV leads are associated with fewer replacements and deactivations than bipolar LV leads in CRT-P
M.P. Turakhia, G.B. Forleo, J. Prillinger, C. Kumar, Y. Nabutovsky, M.R. Gold (Palo Alto, Sunnyvale, Sylmar and Charleston, US;
Rome, IT)
The quadripolar left ventricular lead allows due to basal stimulation an optimized more steady left ventricular activation
D. Mijic, Z. Karosiene, H. Bogossian, B. Lemke, M. Zarse (Ludenscheid, DE)
A new approach to check the left ventricle capture in biventricular devices. Results from DREAM (cardiac resynchronization
therapy device left capture confirmation through an Electrograms analysis Mod
M.S. Baccillieri, D. Ambroso, P. Turrini, E. Dalla Vecchia, R. Verlato (Camposampiero, PD and Marano Vicentino (VI), IT)
A new transvenous active fixation lead provides more options for stable targeted left ventricular lead placement
S. Faerestrand, H. Keilegavlen, T. Hovstad (Bergen, NO)
Failure of optimization algorithm to shorten QRS duration in patients with cardiac resynchronization therapy
D. Wichterle, R. Polasek, H. Jansova, J. Cerny, P. Kucera, K. Sedlacek, J. Kautzner (Prague and Liberec, CZ)
Multi-point pacing in cardiac resynchronization therapy: optimization and effect on QRS
G. Di Stolfo, G. Forleo, L. Santini, M. Giammaria, D. Ricciardi, G. Senatore, A. Curnis, A. Vado, E. Bertaglia, F. Zanon
(San Giovanni Rotondo, Rome, Turin, Ciri (Turin), Brescia, Cuneo, Padua and Rovigo, IT)
TUESDAY
MONDAY
Moderated Posters must be set up between 13:30 and 14:00, removed between 18:00 and 18:30 and be on display between 14:00 and 18:00.
The presenter should be present throughout the break (15:30 - 16:30) in order to discuss the poster.
The following abstracts were chosen for their high quality and will be discussed during the Moderated Poster session animated by two
chairpersons between 15:30 - 16:30. Each presenter will have 5 minutes to present and discuss their research in front of the audience and the
chairpersons.
SUNDAY
15:30 - 16:30
MILANO
Recorded session
Chairpersons: M. Hocini (Pessac, FR); P. Della Bella (Milan, IT)
16:30
17:15
1262
1263
113
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
16:30 - 18:00
Symposium
Stroke prevention for atrial fibrillation Europe, Far East or USA, nice or not?
Chairpersons: U. Birgersdotter-Green (La Jolla, US); P. Kirchhof (Birmingham, GB)
Atrial Fibrillation track
16:30
16:52
17:15
17:37
16:30 - 18:00
1264
1265
1266
1267
Symposium
NAPOLI
New devices for heart failure - when, which device and in whom
Joint session with the Heart Failure Association
Chairpersons: C. Leclercq (Rennes, FR); G.S. Filippatos (Athens, GR)
Joint Session
Pacing track
16:30
16:48
17:06
17:24
17:42
16:30 - 18:00
1268
1269
1270
1271
1272
Symposium
TORINO
114
ROMA
1273
1274
1275
1276
1277
Symposium
PALERMO
International CRT implantation practice: are we in Sync? Rationale for the CRT Survey II a HFA EHRA initiative
Chairpersons: C. Linde (Stockholm, SE); M. Gasparini (Rozzano, IT)
Device track
Comparison of International Guidelines for CRT Implementation.
C. Normand (Stavanger, NO)
CRT Survey II: Objectives, design and organisation.
K. Dickstein (Stavanger, NO)
What predicts response: patient selection, implantation technique or follow-up?
C. Stellbrink (Bielefeld, DE)
International benchmarking; what does it tell us and why is it important?
A.K. Gitt (Ludwigshafen, DE)
16:30 - 18:00
Symposium
1278
1279
1280
1281
GENOVA
Practical session, interactive where ECGs are presented and discussed with the audience
Case 1.
S. Viskin (Tel Aviv, IL)
Case 2.
J.L.R.M. Smeets (Nijmegen, NL)
Case 3.
J. Brugada Terradellas (Barcelona, ES)
Case 4.
B. Belhassen (Tel Aviv, IL)
16:30 - 18:00
1282
1283
1284
1285
Symposium
BOLOGNA
WEDNESDAY
16:30
16:52
17:15
17:37
TUESDAY
MONDAY
16:30
16:52
17:15
17:37
SUNDAY
16:30 - 18:00
1286
1287
1288
1289
1290
115
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
16:30 - 18:00
FIRENZE
Case 1: 82 year-old hypertensive man has cognitive impairment, recurrent syncope and falls, LBBB: what is next, tilt testing,
injectable loop recorder, empirical pacemaker, or nothing of the above?
A. Ungar (Florence, IT)
Panel discussion & questions from the audience.
S.M. Rafla (Alexandria, EG); B. Goronja (Banjaluka, BA)
Case 2: 82 year-old woman has CAD, STEMI 3 yrs ago, EF 40%, 2 syncopes without prodromes while watching TV,
5-sec pause during carotid sinus massage: what would you recommend, EPS, PM, ICD, or nothing of the above?
H. Abe (Kitakyushu, JP)
Panel discussion & questions from the audience.
S.M. Rafla (Alexandria, EG); B. Goronja (Banjaluka, BA)
Case 3: 82 year-old man lives independently has DCM, NYHA II, EF 25%, PM dependent, PM at ERI: what would you
recommend, replacement with PM, ICD, or CRT?
G. Baron Esquivias (Sevilla, ES)
Panel discussion & questions from the audience.
S.M. Rafla (Alexandria, EG); B. Goronja (Banjaluka, BA)
16:30 - 18:00
Symposium
1291
1292
1293
1294
1295
1296
VENEZIA
Sinus node dysfunction: how can basic science improve clinical management?
Chairpersons: R. Sutton (Monte Carlo, MC); E. Nof (Tel Hashomer, IL)
Basic and genetic track
Sinus node dysfunction is a common cause of syncope. Mechanisms and genetic determinants of sinus node dysfunction will be presented and
discussed with respect to their impact on patient management.
16:30
16:52
17:15
17:37
16:30 - 18:00
Symposium
1297
1298
1299
1300
BARI
Leading female experts are going to discuss alternative current treatment approaches for complex arrhythmias followed by their own practical
approaches.
16:30
16:52
17:15
17:37
116
1301
1302
1303
1304
CAGLIARI
1306
1307
1308
1309
1310
AGORA
16:30
16:39
16:48
16:57
17:06
17:15
17:24
17:33
Micra Transcatheter Pacing System: early performance assessment to demonstrate safety for pacemaker dependent patients
L. Mont, D.G. Benditt, G.Z. Duray, P. Ritter, D. Reynolds, T. Sheldon, V. Laager, J. Hayman, K. Stromberg (Barcelona, ES;
Minneapolis, Oklahoma City and Mounds View, MN, US; Budapest, HU; Bordeaux, FR)
Micra delivery system perforation risk assessment
M. Bonner, A. Steingisser, A. Jamous, P. Mcdonnell (Minneapolis and Santa Rosa, US; Galway, IE)
Permanent His bundle pacing in patients with advanced AV block: feasibility and long term follow-up
P. Vijayaraman, A. Naperkowski, G. Dandamudi, K.A. Ellenbogen (Wilkes Barre and Richmond, US)
Clinical benefit of right ventricular mid-septal pacing: 3 years follow-up data of a large consecutive patients cohort
G.H. Mairesse, M. Raepers, A. Moscato, E. Mauel, R. Campagnolo, A. Bartholome, Y. Ernst, B. Marchand (Arlon, BE)
Reversal of chronic right ventricular pacing induced adverse structural and electrical remodeling by permanent
his bundle pacing
P. Vijayaraman, G. Dandamudi, K.A. Ellenbogen (Wilkes Barre and Richmond, US)
Cardiovascular and non-cardiovascular adverse events in sinus node disease and AV block with a ventricular pacing
minimization mode versus standard DDD: A substudy from the ANSWER randomized trial
M. Stockburger, S. Boveda, J. Moreno, A. Da Costa, R. Hatala, J. Brachmann, C. Butter, J. Garcia Seara, M. Rolando, P. Defaye
(Berlin, Coburg and Bernau bei Berlin, DE; Toulouse, Saint-Etienne and Grenoble, FR; Madrid and Santiago de Compostela, ES;
Bratislava, SK; Saluggia, IT)
Complications following cardiac implantable electronic device procedures: results from a 6-month prospective registry
R. Costa, C.M.M. Albertini, T.S. Kawauchi, I.C. Maurino, G. Melo, L.B.O. Alves, E.S. Crevelari, A.I. Fioreli, M. Martinelli, K.R. Silva
(Sao Paulo, BR)
Effect on late clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve implantation.
J. Fernandez-Pastor, J.L. Pena-Hernandez, A. Munoz-Garcia, C. Medina-Palomo, A. Ruiz-Salas, A. Barrera-Cordero,
E. De Teresa-Galvan, F.J. Alzueta-Rodriguez (Malaga, ES)
1311
1312
1313
1314
WEDNESDAY
Each speaker will present and discuss their research during the session.
After the session finishes each speaker will have a dedicated screen next to the Agora in the Abstract Discussion Zone in order to further
discuss and display their presentation and facilitate in-depth dialogue with interested parties.
TUESDAY
16:30 - 18:00
1305
MONDAY
16:30 Esophageal temperature monitoring during atrial fibrillation ablation: sensitivity of a conventional probe to detect significant
temperature increases
R. Delgado, E. Falconi, A. Burgos, R. Olivares, M. Arceluz, P.F. Cruz, O. Salvador, M. Ortega, J. Caro, J.L. Merino (Madrid, ES)
16:45 Are the results of cryoballoon ablation more reproducible regards midterm success of paroxysmal atrial fibrillation ablation?
Comparative data vs. radiofrequency from a Multicentric National Survey.
S. Boveda, P. Defaye, D. Pavin, J.P. Cebron, F. Anselme, R.A. Providencia (Toulouse, Grenoble, Rennes, Nantes and Rouen, FR)
17:00 Fibrosis architecture predicts atrial fibrillation recurrences after ablation
P. Gal, C.F. Pacchia, A. Morris, J. Cates, G. Kaur, A. Elvan, N.F. Marrouche (Zwolle, NL; Salt Lake City, US)
17:15 Long- term follow- up after left ventricular endocardial resynchronisation therapy: mortality and thromboembolic complications
Z. Kis, A. Arany, G. Gyori, A. Mihalcz, A. Kardos, C.S. Foldesi, I. Kassai, T. Szili- Torok (Budapest, HU; Rotterdam, NL)
17:30 Predictors of LAA thrombi in patients with atrial fibrillation and Low CHA2DS2-VASc score
S. Nedios, T. Seewoester, E. Koutalas, J. Kornej, S. Rolf, A. Arya, P. Sommer, D. Husser, G. Hindricks, A. Bollmann (Leipzig, DE)
17:45 Electrophysiological insights into site of infra-nodal AV block: lessons from permanent His bundle pacing
A. Naperkowski, G. Dandamudi, K.A. Ellenbogen, P. Vijayaraman (Wilkes Barre and Richmond, US)
SUNDAY
16:30 - 18:00
1315
1316
1317
1318
117
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
118
16:30 - 18:00
17:42
17:51
Prognostic implication of heart failure with preserved and reduced ejection fraction in patients requiring pacemaker
implantation
A. Mizukami, Y. Matsue, Y. Naruse, S. Kowase, K. Kurosaki, M. Suzuki, A. Matsumura, A. Nogami, K. Aonuma, Y. Hashimoto
(Kamogawa, Yokohama and Tsukuba, JP; Groningen and Leiden, NL)
Optimized pacing mode for hypertrophic cardiomyopathy. the impact of ECG-fusion during pacing.
D. Penela, F. Burgos, R. Evertz, J. Roca, M. Sitges, R. Villuendas, R. Brugada, L. Mont, J. Brugada, A. Berruezo (Barcelona and
Girona, ES)
AGORA
1319
1320
Poster Session
POSTER AREA
Poster session 5
Posters must be set up between 08:00 - 08:30, removed between 12:30 - 13:00, to be on display between 08:30 - 12:30.
The presenter should be available by the poster during the coffee break (10:00 to 11:00) in order to discuss the research with the audience.
P1321
P1322
P1323
P1324
P1325
TUESDAY
P1326
WEDNESDAY
MONDAY
SUNDAY
08:30 - 12:30
119
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
120
Efficay and safety of first line cryoablation strategy to treat paroxysmal atrial fibrillation: a large cohort of data derived from
real world multicentric experience.
P1338
C. Tondo, C. Ardito, L. Padeletti, L. Leoni, D. Catanzariti, S. Porcellini, A. Curnis, L. Sciarra, R. Verlato, G. Arena (Milan, Florence, Padova,
Rovereto, Paderno Dugnano, Brescia, Rome, Camposampiero and Massa, IT)
Predictors for obtaining favorable results after catheter ablation for patients with post-operative atrial tachycardia
P1339
T. Mishima, I. Nakajima, M. Wada, K. Ishibashi, K. Miyamoto, H. Okamura, T. Noda, T. Aiba, S. Kamakura, K. Kusano (Osaka, JP)
Radiofrequency ablation of atrial fibrillation: comparison of success rate of circular ablation vs point-by-point ablation with contact
force in paroxysmal and persistent atrial fibrillation
P1340
R. Rosso, Y. Levi, S. Viskin (Tel Aviv, IL)
Radiofrequency af ablation with a new multipolar irrigated catheter (nMARQTM): acute and short-term results and impact on
postablation silent cerebral ischemia
P1341
C. Raimondo, E. Ebrille, R. De Vito, D. Caponi, M. Anselmino, F. Ferraris, P. Di Donna, F. Halimi, F. Gaita, M. Scaglione (Turin, Siena and
Asti, IT; Le Chesnay, FR)
Distribution and periprocedural management of different anticoagulation regimen in patients undergoing catheter ablation for atrial
fibrillation in a high volume center
P1342
T. Lin, A. Rillig, J. Pleman, C.H. Heeger, A. Metzner, S. Mathew, E. Wissner, F. Ouyang, K.H. Kuck, R.R. Tilz (Hamburg, DE)
Safety and efficacy of single stage atrial fibrillation ablation and left atrial appendage occlusion
(W) P1343
R. Colleran, C. Mc Cann, J. Galvin, I.P. Casserly, B. Glover, T. Keelan, K. Walsh (Dublin, IE)
Reduction of fluoroscopy exposure during atrial fibrillation ablation using a novel fluoroscopy image integrated 3-dimensional
electroanatomical mapping system
P1344
Y. Huo, M. Christoph, M. Forkmann, M. Pohl, J. Mayer, J. Salmas, J. Sitzy, C. Wunderlich, C. Piorkowski, T. Gaspar (Dresden, DE)
Is it necessary to eliminate adenosine triphosphate induced non-pulmonary vein foci after pulmonary vein and superior vena cava
isolation?
P1345
Y. Hama, Y. Matsudo, T. Kuwahara, K. Kamishita, M. Yamamoto, T. Himi (Kisarazu and Yokosuka, JP)
Rhythm control for persistent atrial fibrillation patients contributes to the improvement of exercise tolerability.
P1346
R. Matsuoka, T. Hirose, S. Warita, M. Kaneda, R. Watanabe, M. Ishiguro, H. Yagasaki, S. Tanihata, M. Arai, T. Noda (Gifu, JP)
Hybrid therapy for persistent atrial fibrillation
P1347
G. Bencsik, A. Benak, M. Kohari, J. Szilagyi, G. Klausz, A. Makai, R. Pap, L. Saghy (Szeged, HU)
P1348
Gastroesophageal reflux disease is not more frequently in patient with paroxysmal atrial fibrillation ablation
M. Floria, O. Barboi, C. Rezus, M. Grecu, C. Cijevschi Prelipcean, G.H.E. Balan, V.L. Drug (Iasi, RO)
Alignment of periprocedural left atrial rotational angiography with electro-anatomical mapping using sensors on an esophageal
temperature probe is highly accurate and decreases radiation dose
P1349
P. Vanduynhoven, I. Romero, P. Koopman, L. Herbots, J. Vijgen (Hasselt, BE; Eindhoven, NL)
P1350
Robotic navigation system versus manual pulmonary vein isolation: a novel ablation annotation algorithm.
A. Dello Russo, G. Del Giorno, S. Conti, G. Vettor, L. Cipolletta, G.M. Fassini, M. Casella, E. Russo, F. Pizzamiglio, C. Tondo (Milan, IT)
Tools: catheters, sources, mapping, navigators (Catheter ablation / except atrial fibrillation)
Improving anatomical definition in pulmonary vein isolation with 3D rotational angiography without the need for mapping.
K. Morrice, E. Silva, G. Bardhaj, P. Peytchev, P. Geelen, T.J.R. De Potter (Aalst, BE)
The Isochronal map of non-contact mapping system is useful to distinguish the right or left outflow tract origin of idiopathic
ventricular arrhythmias
K. Miyazawa, M. Ueda, M. Ishimura, T. Kajiyama, N. Hashiguchi, Y. Kobayashi (Chiba, JP)
Impact of intracardiac echocardiography on electrical storm ablation
F. Turreni, A. Castro, M.L. Loricchio, M. Mercurio, F. Messina, G. Altamura (Rome, IT)
Performance of a non-invasive mapping system (ECVUE) for pre-procedural and intra-procedural mapping to guide ablation
in patients with congenital heart disease: a step further.
K. Roy, F.P. Gomez, D. Valerone, I.S. Horduna, L. Mantziari, J.R. Clague, S. Ernst (London, GB)
Predictive accuracy of contactless magnetocardiographic mapping to detect ischemic heart disease
D. Brisinda, A.R. Sorbo, A. Venuti, F. Fioravanti, R. Fenici (Rome, IT)
(W) P1351
P1352
P1353
P1354
P1355
P1356
P1357
P1363
P1364
P1366
WEDNESDAY
Subcutaneous ICD
Learning curve associated with implantation of the totally subcutaneous implantable defibrillator: results from a pooled analysis
of 882 patients from the ide study and effortless registry
P1369
T.F. Brouwer, R.E. Knops, D.A. Theuns, L.V.A. Boersma, R. Weiss, P. Neuzil, P. Lambiase, A.R. Leon, P.W. Jones, M. Burke (Amsterdam,
Rotterdam and Nieuwegein, NL; Columbus, Atlanta, Minneapolis and Chicago, US; Prague, CZ; London, GB)
Eligibility to subcutaneous implantable cardioverter-defibrillator: relationship with ECG suitability in different physiologic conditions P1370
A. Corzani, M. Ziacchi, M. Biffi, I. Diemberger, C. Martignani, A. Marziali, A. Mazzotti, G. Massaro, C. Rapezzi, G. Boriani (Bologna, IT)
TUESDAY
P1365
Devices (Pacing)
Interference resistance of pacemakers and defibrillators to 60 Hz electric fields.
K.M. Dyrda, D.H. Nguyen, M. Plante, A. Turgeon, D. Goulet, R. Kavet, P. Khairy, B. Thibault, G. Ostiguy (Montreal and Varennes, CA;
Palo Alto, US)
A new algorithm for multi-point pacing in cardiac resynchronization therapy: feasibility from a multicenter experience
M. Giammaria, L. Santini, G. Forleo, D. Potenza, M. Del Greco, E. Pisano', L. Calo', G. Morani, G. Ansalone, F. Zanon (Turin, Rome,
San Giovanni Rotondo, Rovereto, Lecce, Verona and Rovigo, IT)
Comparison of variability of the paced QRS wave duration caused by right ventricular apex pacing and septal pacing in the cinical
situation
M. Tanaka, M. Oi, Y. Motohashi, K. Takahashi, E. Ko, K. Hanazawa, M. Toyofuku, M. Kitada, Y. Yutsuki, T. Tamura (Wakayama, JP)
Single and dual chamber device implantation totally without the use of fluoroscopy.
E. Kropotkin, E.A. Ivanitskiy (Krasnoyarsk, RU)
MONDAY
Primary & Secondary prevention (Sudden cardiac death and implantable defibrillators)
Safety and efficacy of implantable cardioverter-defibrillator programming with long detection interval and high rate cutoff in
secondary prevention population.
Y. Hayashi, M. Takagi, J. Kakihara, S. Sakamoto, A. Doi, M. Yoshiyama (Osaka, JP)
Epicardial fibrosis detected with delayed enhancement imaging is more prevalent in patients with nonischemic dilated cardiomyopathy
receiving an ICD for secondary prevention.
S. Pedretti, S. Vargiu, P. Pedrotti, A. Roghi, M. Lunati (Milan, IT)
The incidence of appropriate therapies following device replacement in primary prevention ICD patients: is improvement in systolic
function a predictor?
W.F. Mcintyre, C.M. Seifer (Winnipeg, CA)
Incidences of ventricular tachyarrhythmias and mortality in patients with ischemic versus non-ischemic left ventricular dysfunction
and implantable cardioverter-defibrillators
M. Tham, S.K. Kumar, J. Chan, P.L. Chia (Singapore, SG; Melbourne, AU)
SUNDAY
Non invasive programmed stimulation as a predictor of arrhythmia recurrences after catheter ablation of ventricular tachycardia
P1358
F. Baratto, G. Paglino, M. Yamase, G. Santagostino Baldi, A. Radinovic, P. Vergara, T. Oloriz, P. Della Bella (Milan, IT)
J-point elevation as a predictor of malignant ventricular arrhythmia triggered by premature ventricular contractions with right
bundle brunch block and superior axis
P1359
Y. Munetsugu, M. Kawamura, Y. Kobayashi (Tokyo, JP)
Catheter ablation without the use of fluoroscopy in pediatric patients
P1360
M. Jan, K. Rupar, T. Prolic Kalinsek, U. Mazic, D. Kuhelj, B. Gersak (Ljubljana, SI)
Efficacy of a systematic endo and epicardial access in patients with ischemic heart disease who undergo a first ventricular tachycardia
ablation
P1361
M. Izquierdo De Francisco, J.M. Sanchez-Gomez, A. Ferrero De Loma-Osorio, A. Martinez Brotons, C. Nunez, J. Nunez, A. Belver,
A. Pelaez, J. Chorro, R. Ruiz Granell (Valencia and Castellon, ES)
Focal radiofrequency ablation for macroreentrant left atrial tachycardias
P1362
P.F. Cruz, S. Castrejon Castrejon, M. Arceluz, O. Salvador, E. Falconi, M. Ortega, R. Delgado, J.L. Merino Llorens (Madrid, ES)
P1371
P1372
P1373
P1374
121
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
Leads (Pacing)
Lead-extractions, the zwolle experience with the evolution mechanical sheath
P.P.H.M. Delnoy, O.A. Witte, A. Adiyaman, A. Ghani, J.J.J. Smit, A.R. Ramdat Misier, A. Elvan (Zwolle, NL)
Middle term outcomes after left ventricular epicardial lead implantation.
V. Cousin, C. Marquie, G. Fayad, W. Escande, L. Wissocque, S. Boule, S. Kacet, D. Klug (Lille, FR)
Indications & Results (Pacing)
Routine His bundle pacing (HBP) can be a clinical reality: Incremental improvement in HBP outcomes with procedural experience
A. Naperkowski, S.A. Worsnick, A. Pugazhendhi, G. Dandamudi, P. Vijayaraman (Wilkes Barre, US)
The predictor of hospitalization from heart failure after permanent right venticular apical pacing in patients with acquired high-grade
atrioventricular block and normal left ventricular function
J. Sohn, Y.S. Lee, J.Y. Choi, K.S. Kim, H.S. Park, S.W. Han, Y.N. Kim (Daegu, KR)
Leadless (Pacing)
Is transcatheter delivered pacing suitable for all adult sizes and ages?
L.V.A. Boersma, P. Ritter, G.Z. Duray, C. Steinwender, K. Soejima, O. Razali, S. Liu, J.H. Hudnall, V. Laager, D. Reynolds
(Nieuwegein, NL; Bordeaux, FR; Budapest, HU; Linz, AT; Tokyo, JP; Kuala Lumpur, MY; Mounds View, MN and Oklahoma City, US)
P1376
P1377
P1378
P1379
122
P1375
P1383
P1384
P1385
P1386
P1387
P1388
P1389
P1390
P1391
P1392
P1393
Monitoring tools
Use of a patient-activated external event recording system in diagnosing the clinical arrhythmia in patients with palpitations and
normal 48h holter ECG.
P. Attanasio, M. Huemer, A.S. Parwani, H. Boldt, W. Haverkamp, A. Wutzler (Berlin, DE)
P1399
P1400
P1401
P1402
P1403
WEDNESDAY
P1398
TUESDAY
P1397
MONDAY
SUNDAY
P1404
P1405
P1406
P1407
P1408
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
124
Cardiac MRI after ventricular tachyarrhythmias increases diagnostic precision and reduces the need for family screening for
inherited cardiac disease
P. Marstrand, A. Axelsson, N. Vejlstrup, H. Bundgaard, J. Theilade (Copenhagen, DK)
Left atrial appendage sizing for percutaneous occlusion with Amplatzer cardiac plug: a multumodality imaging approach
X. Iriart, W. Selmi, Z. Jalal, J.B. Thambo (Bordeaux-Pessac, FR)
Anticoagulation
The effects of aging on coagulation fibrinolytic system and endothelial impairment
A. Ochi, T. Adachi, K. Inokuchi, Y. Onishi, Y. Munetsugu, T. Onuki, N. Watanabe, Y. Minoura, M. Kawamura, Y. Kobayashi (Tokyo, JP)
Percutaneous left atrial appendage occlusion. clinical indications, management and follow up in a referral center
P. Mazzone, F. Guarracini, N. Trevisi, D. Regazzoli, F. Melillo, A. Marzi, N. Sora, E. Agricola, M. Oppizzi, P. Della Bella (Milan, IT)
Remote monitoring
Impact of remote monitoring system for congenital heart disease patients
T. Nishimura, D. Takeuchi, T. Manaka, K. Toyohara, M. Shoda, T. Nakanishi (Tokyo, JP)
P1411
(W) P1412
P1413
P1414
P1415
Poster Session
POSTER AREA
Poster session 6
Posters must be set up between 13:30 - 14:00, removed between 18:00 - 18:30, to be on display between 14:00 - 18:00.
The presenter should be available by the poster during the break (15:30 to 16:30) in order to discuss the research with the audience.
P1418
P1419
P1420
P1421
P1422
WEDNESDAY
TUESDAY
P1417
MONDAY
SUNDAY
14:00 - 18:00
125
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
Morphological predictors of effective chemical ablation of marshall vein for atrial fibrillation
P1434
Y. Sasaki, A. Kobori, Y. Furukawa (Kobe, JP)
Safety and feasibility of excluding fluoroscopy imaging during catheter ablation of atrial fibrillation
P1435
A. Bulava, M. Eisenberger, J. Hanis (Ceske Budejovice, CZ)
Left atrial reverse remodeling prevents recurrence of atrial fibrillation after catherter ablation of persistent atrial fibrillation
P1436
Y. Kagawa, E. Fujii, S. Fujita, M. Ito (Tsu, JP)
Safety of warfarin and novel oral anticoagulants in atrial fibrillation ablation
P1437
M. Fujimoto, T. Ikeda, K. Okeie, M. Yamamoto (Toyama, JP)
Application of electrogram dyssynchrony to guide catheter ablation of persistent atrial fibrillation: acute and long term effect
P1438
P. Kuklik, B. Schaeffer, B.A. Hoffmann, D. Schreiber, J.M. Moser, R.O. Akbulak, A. Sultan, J. Luker, D. Steven, S. Willems (Hamburg, DE)
Effect of pulmonary vein anatomy and pulmonary vein diameters on outcome of cryoballoon aatheter ablation for atrial fibrillation P1439
E. Guler, G. Babur Guler, G.G. Demir, F. Kizilirmak, H.M. Gunes, M.O. Omaygenc, B. Cakal, F. Kilicaslan (Istanbul, TR)
Magnetic and contact-force sensing catheters have similar orientation during circumferential pulmonary vein isolation: lessons
from bipolar electrogram morphology analysis
(W) P1440
D.G. Latcu, A. Ayari, S.S. Bun, A. Errahmouni, N. Saoudi (Monaco, MC)
The different effect of anticoagulation during catheter ablation of atrial fibrillation according to preablation oral anticoagulant.
P1441
J.Y. Kim, S.H. Kim, I.G. Song, T.S. Kim, J.H. Kim, S.W. Jang, M.Y. Lee, T.H. Rho, Y.S. Oh (Seoul, KR)
Radiation-free pulmonary vein isolation in patients with atrial fibrillation and a patent foramen ovale
P1442
S. Knecht, C. Sticherling, A. Muehl, T. Reichlin, N. Pavlovic, S. Osswald, M. Kuehne (Basel, CH)
Catheter ablation of atrial fibrillation: three-dimensional transesophageal echocardiography provides an acceptable image quality
for analysing the individual pv anatomy prior to an ablation procedure
P1443
K. Kettering, F. Gramley, S.V. Bardeleben (Frankfurt and Mainz, DE)
High output pace capture methodology has poor sensitivity for identifying the location of conduction gaps in the wide
circumferential ablation line during pulmonary vein isolation
P1444
S. Pollak, G. Monir, E. Bassily, J. Pepe (Orlando, US)
Surgery & Pacing (Atrial Fibrillation)
Myocardial 123I-MIBG scintigraphy in assessing of the cardiac radiofrequency denervation effectiveness
Y. Saushkina, V. Evtushenko, A. Evtushenko, S. Minin, I. Efimova, Y. Lishmanov, K. Smishlyaev, O. Nasanova, V. Chernov, N. Efimova
(Tomsk, RU)
Tools: catheters, sources, mapping, navigators (Catheter ablation / except atrial fibrillation)
Safety of mapping in the sinus of valsalva region under intracardiac echocardiography guidance without angiography
K.C. El Tallawi, T. Feghali, M. Refaat, M. Khoury, B. Abi-Saleh (Beirut, LB)
A Novel, efficient method to identify gaps in cavo-tricuspid isthmus ablation line
P. Vijayaraman, C.A. Hadadi, A. Naperkowski, G. Dandamudi, K.A. Ellenbogen (Wilkes Barre and Richmond, US)
Zero fluoroscopy direction: going back to 3d mapping system origin
A. Pani, F. Ruffa, G. De Vito, R. Brambilla, C. Gerosa, A. Vincenti, G. Rovaris, S. Negroni, S. Foresti, D. Malaspina (Lecco, Monza
and Milan, IT)
An early negative deflection of the bipolar electrogram predicts the site of origin of premature ventricular contractions
G. Epicoco, A. Sorgente, H. Ali, G. Bonitta, S. Foresti, G. De Ambroggi, C. Balla, M.M. Ciccone, P. Lupo, R. Cappato
(Bari and San Donato Milanese, IT)
Optimization of left atrial catheterization by selective transseptal puncture. A single center experience.
A. Radinovic, P. Mazzone, F. Guarracini, A. Marzi, N. Sora, P. Della Bella (Milan, IT)
Indications (Catheter ablation / except atrial fibrillation)
Validation of standard and new criteria for the differential diagnosis of narrow QRS tachycardia in children and adolescents
K.J. Deutsch, S.M.S. Stec, P.K. Kukla, A.M. Morka, M.J. Jastrzebski, A.B. Baszko, M.P. Pitak, J.S. Sledz, M.M. Mazij, L.S. Szydlowski
(Kielce, Rzeszow, Gorlice, Krakow, Poznan, Wroclaw and Katowice, PL)
Impact of cavotricuspid isthmus morphology on procedural success rate of cryo- or radiofrequency ablation of cavotricuspid
dependent atrial flutter
S. Saygi, H. Bastani, C. Wredlert, M. Jensen-Urstad (Stockholm, SE)
Results (Catheter ablation /except atrial fibrillation)
Accessory pathway induced asynchrony in children: ablation as healing treatment for heart failure.
G. Sarquella Brugada, A. Berruezo, S. Cesar, C. Bautista, L. Marzo, J. Brugada (Esplugues de Llobregat, ES)
Experience of catheter ablation accessory pathways in children Ebstein's anomaly
E. Artukhina, A.S.H. Revishvili (Moscow, RU)
126
P1445
P1446
P1447
P1448
P1449
P1450
P1451
P1452
P1453
P1454
Devices (Pacing)
Examination about the influence that difference in the sensing filter properties gives to the record of the intracardiac wave pattern.
Y. Goseki, Y. Yazaki, K. Takarada, A. Yamashina (Tokyo, JP)
Effect of non-apical right ventricular pacing for left ventricular function
A. Baimbetov, K. Ergeshov, S. Anartayev, K. Bizhanov (Almaty, KZ)
Predictors of super response to cardiac resynchronization therapy
T. Segura De La Cal, R. Matia, A. Hernandez Madrid, E. Franco, J. Moreno, D. Rodriguez, C. Lazaro, J.L. Zamorano (Madrid, ES)
Ultrasound-guided axillary venous puncture for implantable cardiac devices is a safe technique with a short learning curve
S.S. Bun, M. Eljamili, D.G. Latcu, A. Errahmouni, T. Delassi, N. Saoudi (Monaco, MC)
Procedural safety and long-term follow-up after pacemaker implantation in nonagenarians
A. Loirat, D. Feneon, A. Behaghel, N. Behar, A. Le Helloco, P. Mabo, J.C. Daubert, C. Leclercq, R.P. Martins (Rennes, FR)
Indications & Results (Pacing)
Combined score using clinical, electrocardiographic and echocardiographic parameters to predict outcome after cardiac
resynchronization therapy
A. Bernard, L. Fauchier, S. Marechaux, A. Guiot, A. Reynaud, F. Schnell, C. Leclercq, P. Mabo, E. Donal (Tours, Lille and Rennes, FR)
Use of clinical follow-up and pacemaker memories to define predictors of complete atrio-ventricular block or sudden death after
balloon-expandable transcatheter aortic valve implantation.
G. Viart, F. Anselme, E. Durand, A. Savoure, N. Auquier, H. Eltchaninoff (Rouen, FR)
P1460
P1461
P1462
P1463
P1464
P1465
WEDNESDAY
P1459
TUESDAY
Primary & Secondary prevention (Sudden cardiac death and implantable defibrillators)
Mechanism of shock prevention using high rate detection in primary prevention ICD therapy
F. Eberhardt, H. Bonnemeier, T. Kleemann, J. Brachmann, S. Fischer, F. Birkenhauer, J.O. Schwab (Cologne, Kiel, Ludwigshafen Am Rhein,
Coburg, Quedlinburg, Eschborn and Bonn, DE)
Ventricular stimulation for the risk stratification of sudden cardiac death in non-ischemic dilated cardiomyopathy patients: old tools
never die; they just fade away
E. Kanoupakis, J. Fanourgiakis, E. Kallergis, H. Mavrakis, M. Vernardos, K. Roufas, S. Petousis, M. Touloupaki, P. Vardas (Heraklion, GR)
Risk stratification of ventricular tachycardia in post-infarct patients with left ventricular ejection fraction>35%: usefulness of
myocardial infarction scar assessment by magnetic resonance imaging
N. Hammache, D. Voilliot, B. Brembilla-Perrot, F. Odille, M. Andronache, D. Mandry, N. Girerd, E. Aliot, N. Sadoul, C. De Chillou
(Vandoeuvre les Nancy, FR)
Impact of prolonged QRS duration and severe left ventricular dysfunction as a predictor of appropriate implantable
cardioverter- defibrillator therapy
N. Matsumoto, M. Ogawa, T. Yasuda, J. Morii, Y. Nagata, Y. Hitaka, S. Imaizumi, A. Matsunaga, K. Saku (Fukuoka, JP)
Evaluating myocardial injury during ICD implantation using the upper limit of vulnerability versus standard defibrillation t
hreshold testing
S. Hebsur, J. Hunter, K. Lewis, J.C. Hsu, G. Feld, U. Birgersdotter-Green (San Diego, US)
MONDAY
SUNDAY
P1466
P1467
P1468
P1469
P1470
P1471
P1472
127
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
Ongoing need for cardiac pacing in a contemporary cohort of orthotopic heart transplant patients through one year of follow-up
T. Farid, A.R. Moser, B. Austin, A. Magalski, A. Wimmer (Kansas City, US)
Technical and imaging aspects (Resynchronisation therapy)
The influence of left ventricular midwall fibrosis on torsional mechanics. The implications for CRT.
R.J. Taylor, F. Umar, E.L.S. Lin, A. Ahmed, W.E. Moody, W. Mazur, B. Stegemann, J.N. Townend, R.P. Steeds, F. Leyva (Birmingham, GB;
Cincinnati, US; Maastricht, NL)
More favorable electrical and mechanical reverse remodeling after cardiac resynchronization therapy with quadripolar versus
conventional bipolar lead
S.J. Park, K.J. Chun, K.M. Park, Y.K. On, J. Huh, J.S. Kim (Seoul, KR)
Configuration of coronary veins in target area for cardiac resynchronization according to the systolic function
R. Mlynarski, A. Mlynarska, K.S. Golba, M. Sosnowski (Katowice, PL)
Intra-procedural correlation of potential anatomic sites for LV lead placement and RV-LV measurement
A. Schricker, G. Feld, J. Hsu, K. Lewis, J. Hunter, U. Birgersdotter-Green (San Diego, US)
Indications & Results (Resynchronisation therapy)
Two new electrocardiographic intra- and interventricular dyssynchrony criteria improve cardiac resynchronization therapy outcome
prediction
A. Vereckei, M. Kiss, Z.S. Szelenyi, E. Zima, V. Kutyifa, B. Merkely (Budapest, HU)
Multipoint pacing acutely induces better hemodynamics and QRS narrowing compared to conventional BiV.
F. Zanon, E. Baracca, G. Pastore, L. Marcantoni, D. Lanza, C. Fraccaro, L. Roncon, D. Cavazzini, S. Aggio, F.W. Prinzen (Rovigo and
Adria (RO), IT; Maastricht, NL)
Correlation between clinical response to cardiac resynchronization therapy and changes in frequency spectra of the first heart sound
recorded with an endocardial acceleration sensor
D. Kiblboeck, H. Hoellinger, E. Zeindlhofer, A. Winter, G. Eisserer, L. Pilgerstorfer, P. Siostrzonek, J. Reisinger (Linz, AT)
The jurdham procedure for endocardial cardiac resynchronization therapy: medium term follow-up.
L. Delgado Elias, A. Negrete, A. Trainini, N. Lopez Cabanillas, J. Trainini, A. Fischer, S. Worley, M.S. Palacio, B. Elencwajg
(Buenos Aires, AR; Cali, CO; New York and lancaster, US)
Compound parameters of electrical propagation at implant identify target regions and areas of avoidance during cardiac
resynchronization therapy
S. Ross, E. Kongsgaard, T. Edvardsen, T. Haaland, L.O. Gammelsrud, T. Fischer, R. Skaardal, H.H. Odland (Oslo, NO)
Pulmonary vascular resistence and transpulmonary gradient in non-responders to CRT
T. Minarik, M. Fedorco, M. Taborsky (Ostrava and Olomouc, CZ)
Different ventricular arrhythmic outcome of cardiac resynchronization therapy-defibrillators in women
A. Quesada Dorador, F. Arteaga, R. Romero-Villafranca, J. Martinez-Ferrer, L. Perez-Alvarez, J. Alzueta-Rodriguez, J. Garcia-Gerrero,
J.G. Martinez, X. Vinolas, J. Porres (Valencia, Alava, A Corua, Malaga, Badajoz, Alicante, Barcelona and San Sebastian, ES)
Gender differences in CRT patients with surgically implanted epicardial leads
L. Chen, H. Fu, S. Wong, Y. Cha, U. Birgersdotter-Green, V. Pretorius (San Diego and Rochester, US)
Lead management - extractions and recalls
High recurrence rate of device-related adverse events following transvenous lead extraction procedure in CRT patients
F. Regoli, M.G. Bongiorni, R. Rordorf, M. Santamaria, L. Segreti, V. De Regibus, G. Conte, M. Caputo, C. Klersy, A. Auricchio
(Lugano, CH; Pisa, Pavia and Campobasso, IT)
Immediate reimplantation after the extraction of infected cardiac implantable electronic devices (CIED)
C. Salazar Ramirez, E. Gutierrez Carretero, A. De Alarcon Gonzalez (Malaga and Sevilla, ES)
Syncope
Safety and tolerability of tilt testing and carotid sinus massage in the oldest old.
G. Rivasi, M. Rafanelli, G. Toffanello, A. Ceccofiglio, F. Tesi, N. Marchionni, A. Ungar (Florence, IT)
Pause-dependent differences in RAAS activation in patients with vasovagal syncope.
J. Gajek, D. Zysko (Wroclaw, PL)
Evaluation of military personnel at a dedicated syncope Center
A. Naimushin, S. Laufer, M. Abu Hadba, D. Bar Lev, M. Glikson (Ramat Gan, IL)
Mechanism (Basic Science in Arrhythmias)
Regional variation in ostial myocardial dimensions predicts sites of acute reconnection after left atrial appendage electrical isolation
S. Panikker, R. Virmani, F. Kolodgie, J. Jarman, L. Mantziari, S.K. Haldar, J.P. Foran, V. Markides, T. Wong (London, GB; Gaithersburg, US)
128
P1473
P1474
P1475
P1476
P1477
P1478
P1479
P1480
P1481
P1482
P1483
P1484
P1485
P1486
P1487
P1488
P1489
P1490
P1491
P1493
P1494
P1495
P1496
P1497
P1498
P1499
P1500
P1501
P1502
WEDNESDAY
TUESDAY
Monitoring tools
Long-term monitoring of respiratory rate in patients with heart failure: the multiparametric heart failure evaluation in implantable
cardioverter defibrillator patients (MULTITUDE-HF) Study
G.B. Forleo, L. Santini, M. Campoli, V. Ribatti, M. Malavasi, A. Scaccia, M. Menichelli, M. Lovecchio, G. Carreras, S. Valsecchi
(Rome, Viterbo, Sora, Frosinone, Milan and Rieti, IT)
MONDAY
P1492
SUNDAY
Innervation relationship between cardiac ganglionated plexi and atria analyzed by neuronal tracing in canine hearts
L. Lee, M.J. Cha, Y.J. Cho, E.K. Choi, S.E.I.L. Oh (Seoul, KR)
Inhibition of late INa suppresses the pro-arrhythmic but not the chronotropic effect of isoproterenol: comparison with a beta-blocker
A. Dhalla, H. Ling, L. Chi, L. Belardinelli (Fremont, US)
P1503
P1504
129
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
130
Anticoagulation
Acute procedural outcomes of percutaneous left atrial appendage occlusion (LAAO): a multicentre experience
P1509
T.R. Betts, M. Leo, P. Kanagaratnam, D. Hildick-Smith, O. Segal, D. Todd, D. Fox, C. Pepper, J. Foran, T. Wong (Oxford, London, Brighton,
Liverpool, Manchester and Leeds, GB)
Structured multidisciplinary approach ensures optimal anticoagulation therapy in patients with atrial fibrillation.
P1510
A.E. Albertsen, E.D. Monning, B.R.R. Nielsen, D.S. Moller (Viborg, DK)
Remote monitoring
Investigation on routine follow-up in heart failure patients with remotely monitored implanted cardioverter defibrillators systems
C. Hansen, C. Loges, F. Birkenhauer, C. Weiss (Gttingen, Bad Friedrichshall, Eschborn and Lneburg, DE)
P1511
P1512
Main Session
NAPOLI
08:30 - 10:00
Symposium
1513
1514
1515
1516
TORINO
Basic research has produced several novel, innovative approaches to antiarrhythmic therapy. New targets and strategies will be presented and
discussed in this session.
08:30 - 10:00
Main Session
1517
1518
1519
1520
PALERMO
WEDNESDAY
TUESDAY
08:30
08:52
09:15
09:37
MONDAY
08:30
08:52
09:15
09:37
SUNDAY
08:30 - 10:00
1521
1522
1523
1524
131
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
132
08:30 - 10:00
Symposium
GENOVA
The ECG is our daily "work horse. Although 110 years old new information about the value of the ECG continues to occur, requiring repeated
education to use the ECG optimally in our management of the cardiac patient. With the help of a voting system Dr. Farre and Dr. Wellens will test
your current knowledge and will go from there.
08:30 Discussants:.
J. Farre (Madrid, ES); H.J. Wellens (Maastricht, NL)
08:30 - 10:00
1525
AGORA
Each speaker will present and discuss their research during the session.
After the session finishes each speaker will have a dedicated screen next to the Agora in the Abstract Discussion Zone in order to further
discuss and display their presentation and facilitate in-depth dialogue with interested parties.
08:30 Biventricular, left ventricular only and multipoint pacing in CRT patients: an acute hemodynamic comparison.
F. Zanon, E. Baracca, G. Pastore, L. Marcantoni, D. Lanza, C. Picariello, L. Roncon, S. Aggio, P. Galasso, F.W. Prinzen (Rovigo, IT;
Maastricht, NL)
08:39 Optimizing the LV pacing site by means of electrical delay and LVdp/dtmax may predict the clinical outcome in CRT patients:
results of one year follow-up
F. Zanon, D. Lanza, C. Fraccaro, L. Marcantoni, E. Baracca, G. Pastore, C. Picariello, L. Roncon, S. Aggio, F.W. Prinzen (Rovigo, IT;
Maastricht, NL)
08:48 Validation of a simple risk stratification tool for patients implanted with cardiac resynchronization therapy: the valid-crt
risk score
M. Gasparini, C. Klersy, C. Leclercq, M. Lunati, M. Landolina, A. Auricchio, M. Santini, G. Boriani, A. Proclemer, F. Leyva
(Rozzano, Pavia, Milan, Rome, Bologna and Udine, IT; Rennes, FR; Lugano, CH; Birmingham, GB)
08:57 Safety and outcome of left ventricular endocardial pacing: the 12 months results of the alternate site cardiac resynchronization
(ALSYNC) study
J.M. Morgan, M. Biffi, L. Geller, F. Ruffa, C. Leclerq, S. Tung, B.E.W. Gerritse, Z. Yang, R. Yee, P. Jais (Southampton, GB;
Bologna and Lecco, IT; Budapest, HU; Rennes and Bordeaux, FR; Vancouver and London, CA; Maastricht, NL; Minneapolis, US)
09:06 Cardiac re-synchronization therapy for infants with left bundle branch block caused by various etiologies.
H. Sakaguchi, Y. Hayama, A. Miyazaki, T. Hoashi, K. Kagisaki, H. Ohuchi (Suita, JP)
09:15 Positive response to cardiac resynchronization therapy reduces arrhythmic events after elective generator change in patients
with primary prevention CRT-D.
F.A. Sebag, N. Lellouche, M.D.O.neil, M. Wright, C. Leclerq, C.A. Rinaldi (Rennes and Creteil, FR; London, GB)
09:24 Association of apical rocking with long-term major adverse cardiac events in patients undergoing cardiac resynchronization
therapy
A. Ghani, P.P.H.M. Delnoy, A. Adiyaman, J.P. Ottervanger, A.R. Ramdat Misier, J.J.J. Smit, A. Elvan (Zwolle, NL)
09:33 Prognostic value of epicardial strain amplitude at CRT left ventricular pacing site
A. Laish-Farkash, V. Khalameizer, E. Fishman, A. Costa, Y. Shmayahu, A. Katz (Ashkelon and Rosh Haayin, IL)
09:42 Biventricular pacing increases left anterior descending artery flow by increasing the dominant backward-travelling
decompression (suction) wave in patients with left bundle branch block.
S.B.L. Claridge, Z. Chen, T. Jackson, J. Behar, M. Lumley, K. De Silva, R. Williams, J. Bostock, D. Perera, C.A. Rinaldi (London, GB)
09:51 Impact of collagen turnover markers on echocardiographic response and mortality after CRT-D implantation in TRUST-CRT
study population
A. Sokal, R. Lenarczyk, O. Kowalski, K. Mitrega, S. Pluta, J. Stabryla-Deska, Z. Kalarus (Zabrze, PL)
1526
1527
1528
1529
1530
1531
1532
1533
1534
1535
Moderated Posters
POSTER AREA
Characterization of the endocardial component of ventricular tachycardia reentrant circuits by postpacing interval
electroanatomical mapping
P1536
O. Salvador, S. Castrejon, D. Filgueiras-Rama, M. Arceluz, E. Falconi, F. Cruz, C. Vazquez, R. Delgado, M. Ortega, J.L. Merino
(Madrid, ES)
Selective atrial vagal denervation guided by spectral mapping to treat advanced atrio-ventricular block.
P1537
E. Rivarola, C. Hardy, D. Hachul, E. Sosa, M. Scanavacca (Sao Paulo, BR)
Performance of the SA-VA difference to differentiate atrioventricular nodal reentrant tachycardia from atrioventricular
tachycardia in a large cohort
(W) P1538
F. Akerstrom, M.A. Arias, F.J. Garcia-Fernandez, M. Pachon, R. Salgado, A. Puchol, L. Rodriguez-Padial (Toledo and Burgos, ES)
Is epicardial approach routinely required to the ablation of ventricular tachycardias in patients with non-ischaemic
cardiomyopathy?
P1539
G. Santagostino, T. Oloriz, F. Baratto, N. Trevisi, P. Della Bella (Milan, IT)
Critical progressive activation delay after premature stimulation is associated with polymorphic ventricular tachycardia
in non-ischemic cardiomyopathy: results from the Leiden NICM study
P1540
J. Venlet, S.R.D. Piers, S.F.A. Askar, G.F.L. Kapel, M. De Riva Silva, H.M. Siebelink, M.J. Schalij, D.A. Pijnappels, K. Zeppenfeld
(Leiden, NL)
Arrhythmogenic substrate characterization in patients with arrhythmogenic right ventricular cardiomyopathy undergoing
ventricular tachycardia ablation
P1541
C. Bisceglia, S. Kirubakaran, J. Silberbauer, T. Oloriz, N. Trevisi, F. Baratto, P. Della Bella (Milan, IT)
Arrhythmia substrate characterization in relation to survival and long-term outcomes of catheter ablation of ventricular
tachycardia in nonischemic dilated cardiomyopathy
P1542
B. Dinov, A. Schratter, V. Schirripa, L. Fiedler, A. Bollmann, S. Rolf, G. Hindricks, A. Arya (Leipzig, DE)
Number of beats in the transition zone with fixed SA interval determines accessory pathway location in atrioventricular
reentrant tachycardia
(W) P1543
F. Akerstrom, M.A. Arias, M. Jensen-Urstad, M. Pachon, P. Insulander, A. Puchol, L. Rodriguez-Padial (Toledo, ES; Stockholm, SE)
Atrial fibrillation after radiofrequency catheter ablation of atrial tachyarrhythmias in adult patients after surgical repair
of congenital heart disease
P1544
T. Noda, M. Wada, I. Nakajima, K. Ishibashi, K. Miyamoto, H. Okamura, T. Aiba, S. Kamakura, K.F. Kusano (Suita, Osaka, JP)
Long-term outcome of intra-atrial reentrant tachycardia catheter ablation in adults with congenital heart disease.
P1545
R. Peinado, O. Salvador, A.E. Gonzalez, J. Ruiz-Cantador, A. Vega, D.H. Garcia, M.A. Gonzalez-Vasserot, J.L. Merino,
A. Sanchez Recalde, J.M. Oliver (Madrid, ES)
WEDNESDAY
TUESDAY
Moderated Posters must be set up between 08:00 and 08:30, removed between 12:30 and 13:00 and be on display from 08:30 until 12:30. The
presenter should be present throughout the coffee break (10:00 - 11:00) in order to discuss the poster.
The following abstracts were chosen for their high quality and will be discussed during the Moderated Poster session animated by two
chairpersons between 10:00 - 11:00. Each presenter will have 5 minutes to present and discuss their research in front of the audience and the
chairpersons
MONDAY
10:00 - 11:00
SUNDAY
133
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
11:00 - 12:30
Main Session
NAPOLI
11:00 - 12:30
Main Session
1546
1547
1548
1549
TORINO
11:00 - 12:30
Main Session
1550
1551
1552
1553
1554
PALERMO
Every electrophysiologist is confronted with these vexing questions. How to proceed in practice?
11:00
11:22
11:45
12:07
134
1555
1556
1557
1558
Symposium
GENOVA
SUNDAY
11:00 - 12:30
The ECG is our daily "work horse. Although 110 years old new information about the value of the ECG continues to occur, requiring repeated
education to use the ECG optimally in our management of the cardiac patient. With the help of a voting system Dr. Farre and Dr. Wellens will test
your current knowledge and will go from there.
Discussants:.
J. Farre (Madrid, ES); H.J. Wellens (Maastricht, NL)
11:00 - 12:30
1559
AGORA
11:27
11:36
11:45
11:54
12:03
12:12
12:21
The incidence of silent cerebral thromboembolism in catheter ablation for atrial fibrillation using novel oral anticoagulants
versus therapeutic warfarin
1560
A. Aso, T. Nakamura, M. Nishihara, T. Mori, K. Takenaka, K. Numaguchi, Y. Murasato, K. Hiyamuta (Fukuoka, JP)
Incidence and predictors of pericardial effusion during and immediately after catheter ablation of atrial fibrillation
1561
Y. Murakawa, A. Nogami, M. Shoda, K. Inoue, S. Naito, K. Kumagai, Y. Miyauchi, T. Yamane, N. Morita, K. Okumura (Kawasaki,
Tsukuba, Tokyo, Osaka, Maebashi, Fukuoka, Hachioji and Hirosaki, JP)
May a clinical assessment predict left atrial appendage thrombi presence in patients undergoing atrial fibrillation transcatheter
ablation? A large retrospective experience
1562
M. Anselmino, L. Garberoglio, S. Gili, A. Battaglia, S. Frea, W. Grosso Marra, M. Morello, D. Castagno, M. Scaglione, F. Gaita
(Turin and Asti, IT)
Risk of left atrial appendage thrombus in patients scheduled for ablation for atrial fibrillation beyond the CHA2DS2VASc score 1563
A.A. Sikorska, J. Baran, E. Pilichowska-Paszkiet, M. Sikora-Frac, T. Krynski, R. Piotrowski, S.M. Stec, B. Zaborska, P. Kulakowski
(Warsaw and Rzeszow, PL)
Higher incidence of esophageal lesions after atrial fibrillation ablation related to the use esophageal temperature probes.
1564
P. Mueller, F. Fochler, A. Szoelloesi, K. Nentwich, M. Roos, J. Krug, P. Halbfass, A. Schade, T. Deneke (Bad Neustadt an der Saale, DE)
The clinical course and management of periesophageal vagal nerve injury after catheter ablation of atrial fibrillation: lessons
from long-term follow-up.
1565
M. Terasawa, K. Satomi, Y. Iwasaki, K. Takarada, Y. Tsunoda, S. Takahashi, Y. Yazaki, Y. Goseki, K. Uno, A. Yamashina (Hachiouji
and Sapporo, JP)
Low vulnerability of the esophagus for electroporation ablation
1566
K.G.E.J. Neven, V.J.H.M. Van Driel, H. Van Wessel, R. Van Es, H.H. Fidder, A. Vink, P.A.F.M. Doevendans, F.H.M. Wittkampf
(Utrecht, NL)
Ablation of atrial fibrillation with uninterrupted NOAC treatment during ablation of atrial fibrillation is not associated with
severe peri- and postprocedural complications
1567
C. Wunderlich, M. Christoph, Y. Huo, M. Forkmann, T. Gaspar, J. Salmas, M. Pohl, J. Mayer, C. Piorkowski (Dresden, DE)
Feasibility and safety of apixaban as compared to rivaroxaban for periprocedural anticoagulation in patients undergoing
catheter ablation for atrial fibrillation
1568
A. Rillig, J. Plesman, T. Lin, C.H. Heeger, A. Metzner, E. Wissner, S. Mathew, F. Ouyang, K.H. Kuck, R.R. Tilz (Hamburg, DE)
The safety of catheter ablation for atrial fibrillation using open irrigation catheter in patients on chronic hemodialysis
1569
Y. Furukawa, T. Yamada, T. Morita, S. Tamaki, Y. Iwasaki, M. Kawasaki, A. Kikuchi, T. Kondo, M. Fukunami (Osaka, JP)
WEDNESDAY
11:00
11:09
11:18
TUESDAY
Each speaker will present and discuss their research during the session.
After the session finishes each speaker will have a dedicated screen next to the Agora in the Abstract Discussion Zone in order to further
discuss and display their presentation and facilitate in-depth dialogue with interested parties.
MONDAY
11:00
135
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
136
12:45 - 13:45
Special Event
NAPOLI
1570
1571
1576
1572
1573
1574
1575
Poster Session
POSTER AREA
Poster session 7
Posters must be set up between 08:00 - 08:30, removed between 12:30 - 13:00, to be on display between 08:30 - 12:30.
The presenter should be available by the poster during the coffee break (10:00 to 11:00) in order to discuss the research with the audience.
P1579
P1580
P1581
P1582
P1583
P1584
WEDNESDAY
TUESDAY
P1578
MONDAY
SUNDAY
08:30 - 12:30
137
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
A new concept: single shot isolation of the left atrial appendage using the 28mm cryoballoon
P1594
S. Bordignon, A. Fuernkranz, L. Perrotta, A. Kostantionu, B. Schullte-Hahn, B. Nowak, B. Schmidt, K.R.J. Chun (Frankfurt a.M., DE)
ICE assisted radiofrequency ablation of paroxysmal atrial fibrillation-modern standard in elderly patients
P1595
I. Skigin, I. Pyaterichenko, K. Shorokhov, E. Voytkovskaya, T. Elizarova, A. Abramov (Saint-Petersburg, RU)
Time-dependent development of respiratory acidosis during conscious sedation for pulmonary vein isolation
(W) P1596
R.F. Feurich, J.R. Ehrlich, A. Fink, G. Buerkle (Wiesbaden, DE)
High incidence of low esophageal temperatures during second generation cryoballoon therapy for atrial fibrillation
P1597
M.M.D. Molenaar, M.F. Scholten, T. Hesselink, Y.J. Stevenhagen, J.M. Van Opstal (Enschede, NL)
Pulmonary vein stenosis after pulmonary vein isolation using duty-cycled unipolar/bipolar radiofrequency ablation guided by
intracardiac echocardiography
P1598
S. Asbach, F. Schluermann, L. Trolese, G. Pache, C. Bode, T. Krauss (Freiburg, DE)
Superior efficacy of pulmonary vein isolation with online contact force measurement persists after the learning period:
a prospective case control study
P1599
M. Wolf, J.B. Saenen, W. Bories, H.P. Miljoen, C. Vrints, A. Sarkozy (Antwerp, BE)
The coronary sinus is an important extra-PV substrate of paroxysmal atrial fibrillation: evidence from serial inducibility testing
P1600
M. Namdar, P. Gentil-Baron, H. Sunthorn, H. Burri, D. Shah (Geneva, CH)
Does left atrial electroanatomical remodeling involve the P-wave to left appendage time determined by noninvasive transthoracic
echocardiography?
P1601
Y. Hori, S. Nakahara, N. Tsukada, A. Nakagawa, N. Nishiyama, T. Komatsu, S. Kobayashi, Y. Sakai, I. Taguchi (Koshigaya City, JP)
Incidence of dormant conduction after pulmonary vein isolation using second-generation cryoballoon: comparison with irrigated-tip
radiofrequency ablation
(W) P1602
I. Watanabe, Y. Okumuya, K. Takahashi, A. Hirayama (Tokyo, JP)
Incidence and characteristics of conduction gaps after pulmonary vein isolation using the endoscopic laser ablation system
P1603
A. Fuernkranz, M. De Lazzari, D. Dugo, S. Bordignon, L. Perrotta, J.K.R. Chun, B. Schmidt (Frankfurt/M, DE)
Long-term follow-up of ablation with multiple generations of duty-cycled phased radiofrequency ablation using a subcutaneous
monitoring device
P1604
G. Rovaris, E. Piazzi, S. De Ceglia, G. Zanotto, A. Vincenti (Monza and Legnago, IT)
Impact of two different linear ablation strategies (inferolateral vs. superoseptal mitral isthmus) on left atrial function in patients
with persistent atrial fibrillation
P1605
T. Daehne, M. Brunelli, M.-A. Secknus, A. Grosse, S. Raffa, A. Cima, A. Madaffari, M. Frommhold, J.C. Geller (Bad Berka, DE)
Impact of hypertension on anatomical change of left atrial wall and output needed for pulmonary vein isolation in patients
with atrial fibrillation
P1606
M. Kamioka, H.S. Suzuki, Y.M. Matsumoto, M.N. Nodera, T.K. Kaneshiro, Y.K. Kamiyama, Y.T. Takeishi (Fukushima, JP)
Surgery & Pacing (Atrial Fibrillation)
Atrial tachycardias occurring after surgical treatment of atrial fibrillation: Electrophysiological analysis and ablation strategies
R. Krausova, D. Wichterle, P. Peichl, J. Kautzner, J. Pirk (Prague, CZ)
Long-term outcomes after surgical ablation for atrial fibrillation in patients with continuous heart rhythm monitoring devices
T. Hanke, U. Stierle, P. Ziegler, B. Graf, S. Klotz, H.-H. Sievers, E. Charitos (Luebeck, DE; Minneapolis, US)
Endocardial vs epicardial ablation of atrial fibrillation: effectiveness and left atrial flutter incidence
A. Chasnoits, D. Goncharik, O. Kovalenko, V. Halianishcha, V. Sevrukevich, A. Zigalkovich, V. Barsukevich, L. Plaschinskaya, A. Savchenko,
A. Mrochek (Minsk, BY)
Tools: catheters, sources, mapping, navigators (Catheter ablation / except atrial fibrillation)
First experience with CARTOUNIVUTM used in combination with the nMARQ multipolar circular ablation catheter in atrial
fibrillation ablation
S. Varanasi, S.H. Chin, S. Siddiqui, G.S. Chu, S.H.W. Man, R. Somani, A.J. Sandilands, P.J. Stafford, G.A. Ng (Leicester, GB)
Cryoablation of typical AVNRT: younger age and administration of bonus ablation favor long-term success
P. Pieragnoli, A. Paoletti Perini, L. Checchi, G.C. Carrassa, P. Carrai, A. Michelucci, L. Padeletti, G. Ricciardi (Florence, IT)
Catheter ablation within the aortic sinus cusp for ventricular arrhythmia-A safety distance between the tip of ablation catheter
and coronary artery ostium
E. Nakano, T. Harada, Y. Takagi, M. Yamada, M. Takano, T. Furukawa, Y. Akashi (Kawasaki, JP)
Indications (Catheter ablation / except atrial fibrillation)
Implementation of maximum voltage gradient technique for ablation of typical atrial flutter with zero-fluoroscopy approach.
S.M.S. Stec, K.J. Deutsch, D.K. Karbarz, B.P. Pasicka, M.K.S. Klank-Szafran, J.S. Sledz, M.M. Mazij, B.L. Ludwik, A.K. Kusak, J.S. Spikowski
(Rzeszow, Kielce, Radom, Wroclaw and Szczecin, PL)
138
P1607
P1608
P1609
P1610
P1611
P1612
P1613
P1615
P1616
P1617
P1618
P1619
P1621
P1622
WEDNESDAY
Leads (Pacing)
Feasibility, safety, and acute hemodynamic effect of a new approach for anti-bradycardia pacing: left ventricular septum pacing
by transvenous approach through the inter-ventricular septum
M. Mafi Rad, Y. Blaauw, J.G.L.M. Luermans, M. Janssen, H.J. Crijns, F.W. Prinzen, K. Vernooy (Maastricht, NL)
TUESDAY
P1620
MONDAY
Primary & Secondary prevention (Sudden cardiac death and implantable defibrillators)
Is defibrillator back-up always needed at the end of service life of CRT-D? Insights from the DECODE registry.
M.L. Narducci, E. Menardi, P. Ferrari, F. Quartieri, C. La Rosa, G. Stabile, M. Zoni Berisso, V. Carinci, M. Malacrida, F. Zanon
(Rome, Cuneo, Bergamo, Reggio Emilia, Taranto, Naples, Genoa-Sestri Ponente, Bologna, Milan and Rovigo, IT)
Serum markers of collagen turnover predict future shocks in ICD recipients with dilated cardiomyopathy on optimal treatment
J. Fanourgiakis, E. Kanoupakis, E. Kallergis, H. Mavrakis, M. Vernardos, G. Mpantouvakis, A. Daskalakis, G. Chlouverakis, P. Vardas
(Heraklion, GR)
Primary prevention implantable cardioverter defibrillator: is battery replacement always needed?
G. Dell'era, A. Degiovanni, E. Occhetta, A. Magnani, S. Gavazzoli, L. Plebani, P. Marino (Novara, IT)
High event rates support application of SCD HeFT criteria for primary prevention of sudden death in a multi-ethnic asian heart failure
cohort
R. Cherian, P. Kojodjojo, D. Singh, W.T. Yeo, S.C. Seow, T.W. Lim (Singapore, SG)
Occurrence of supra-ventricular and ventricular arrhythmias in a current implantable cardioverter defibrillator population:
preliminary observations from the things registry
D. Giorgi, V. Calvi, M. Bertini, V. Carinci, M. Iori, G. Bolognesi, M. Pastore, E. De Maria, D. Grassini, M. Biffi (Lucca, Catania, Ferrara,
Bologna, Ravenna, Piacenza, Fidenza, Carpi and Milan, IT)
P1614
SUNDAY
P1625
P1626
P1627
P1628
P1629
P1630
139
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
Post-procedural heart rate reduction predicts need for permanent pacemaker implantation after transcathether aortic valve
implantation in patients with atrial fibrillation
G. Portugal, M. Oliveira, A. Abreu, L. Patricio, D. Cacela, P.S. Cunha, A. Lousinha, R. Ramos, S. Almeida, R. Ferreira
(Lisbon and Vila Franca de Xira, PT)
Exercise training improves functional capacity in pacemaker users
G. Peixoto, E.G.D. Licariao, D. Lobo, C.E. Negrao, P.A. Oliveira, R.A. Teixeira, S.A.D. Nishioka, S.F. Siqueira, R. Costa, M. Martinelli
(Sao Paulo, BR)
Technical and imaging aspects (Resynchronisation therapy)
Optimization of coronary sinus lead placement by means of Right-to-Left Delay reduces QRS width and improves clinical outcome
of cardiac resynchronization therapy
D. Solari, R. Carpi, F. Di Lorenzo, D. Oddone, P. Donateo, R. Mureddu, M. Brignole (Lavagna, IT)
How does scar affect the potential benefit of triventricular pacing over conventional CRT?
P.R. Huntjens, J. Walmsley, P. Bordachar, S. Ploux, F.W. Prinzen, T. Delhaas, J. Lumens (Maastricht, NL; Bordeaux-Pessac, FR)
The effect of atrioventricular and ventriculo-ventricular delay optimisation on ventricular activation times
T.A. Jackson, S. Claridge, J. Behar, R. Razavi, C.A. Rinaldi (London, GB)
The ability of preoperative cardiovascular magnetic resonance imaging to identify optimal target sites for transvenous left
ventricular lead placement
A. Parikh, G.R. Hartlage, P.T. Strickland, E. Okene, F.M. Merchant, J.N. Oshinski, M.S. Lloyd (Atlanta, US)
Indications & Results (Resynchronisation therapy)
A combined electroanatomic activation and voltage map discriminates patients with right bundle branch block who profit from
cardiac resynchronization therapy
M. Zarse, H. Bogossian, A. Kloppe, D. Mijic, Z. Karosiene, H. Suleimann, F. Hasan, Q.S. Nguyen, J. Kolbe, B. Lemke (Ldenscheid, Bochum
and Luedenscheid, DE)
Fragmented-QRS after receiving cardiac resynchronization therapy was strongly associated with ventricular arrhythmias or
sudden cardiac death
M. Igarashi, H. Tada, H. Yamasaki, K. Kuroki, T. Machino, Y. Sekiguchi, Y. Noguchi, A. Nogami, K. Aonuma (Ibaraki, Fukui and Tsukuba, JP)
The impact of applied ECG criteria for diagnosing left bundle branch block on the outcome of cardiac resynchronization therapy
K. Gladisova, P. Margitfalvi, M. Sasov, P. Hlivak, H. Cerna, A. Vachulova, M. Svetlosak, L. Urban, V. Bernat, R. Hatala (Bratislava, SK)
Comparison of conventional biventricular and triple site pacing on acute hemodynamic response.
F. Zanon, G. Pastore, E. Baracca, L. Marcantoni, D. Lanza, C. Picariello, L. Roncon, S. Aggio, M. Rinuncini, F.W. Prinzen
(Rovigo, IT; Maastricht, NL)
Left ventricular endocardial stimulation in patients with atrial fibrillation using puncture of interventricular septum
Y. Karpenko (Odessa, UA)
P1632
P1633
P1634
P1635
P1636
P1637
P1638
P1639
P1640
P1641
140
P1631
P1645
P1646
P1647
P1648
P1652
P1653
P1654
P1655
P1656
P1657
P1658
P1659
P1660
WEDNESDAY
Monitoring tools
Usefulness of external long-lasting ECG monitoring for the diagnosis of unexplained syncope and palpitation: Results of the
SYNARR-FLASH study
E.T. Locati, M. Brignole, J.M. Ormaetxe, H. Tanner, M. Oliveira, M. Lopez-Gil, X. Sabate, N. Rivas, R. Willems, A. Moya
(Milan and Lavagna, IT; Bilbao, Madrid and Barcelona, ES; Bern, CH; Lisbon, PT; Leuven, BE)
P1651
TUESDAY
P1650
MONDAY
P1649
SUNDAY
Biomarkers of cardiovascular stress in assessment the left atrial remodeling in patients with ischemic chronic heart failure with atrial
fibrillation
D. Lashkul, V.D. Syvolap (Zaporizhzhya, UA)
Endomyocardial Biopsy from right ventricular in children with drug-refractory arrhythmias
E.S. Vasichkina, H.R. Poghosyan, L.B. Mitrofanova, R.B. Tatarsky, D.S. Lebedev (Saint Petersburg, RU; Yerevan, AM)
Symptomatic premature ventricular complexes are associated with left ventricular outflow tract time velocity integral.
J.Y. Kim, S.H. Kim, I.G. Song, T.S. Kim, J.H. Kim, S.W. Jang, M.Y. Lee, T.H. Rho, Y.S. Oh (Seoul, KR)
In the pigeon heart atrioventricular valve pacemaker myocytes are found exclusively in those sites where annulus fibrosus is present
V. Prosheva (Syktyvkar, RU)
P1661
P1662
P1663
P1664
141
WEDNESDAY
TUESDAY
MONDAY
SUNDAY
142
Occurrence of ventricular and supraventricular arrhythmias in patients with severe pulmonary hypertension is associated
with abnormal heart rate turbulence, an indicator of sudden cardiac death.
P. Bienias, M. Ciurzynski, O. Dzikowska-Diduch, Z. Rymarczyk, M. Roik, M. Kostrubiec, M. Kurzyna, A. Torbicki, A. Fijalkowska,
P. Pruszczyk (Warsaw, PL)
Others (Cardiac arrhythmias, non invasive)
Takotsubo cardiomyopathy associated with cardiac device implantation
T. Kondo, J. Miake, K. Ogura, M. Kato, K. Iitsuka, K. Yamamoto (Yonago, JP)
Study on ventricular arrhythmias in acute myocardial infarction
M.T. Rahman (Dhaka, BD)
Particular reaction of blood pressure in young elite athletes in exercise stress test
L. Makarov, N. Fedina, V. Komoliatova, D. Besportochny, I. Kiseleva (Moscow., RU)
ECG abnormalities in pericardial disease: association with arrhythmias and clinical signs
T. Kudaiberdiev, G. Imanalieva, K. Tilemanbetova (Bishkek, KG)
Anticoagulation
Improved clinical outcomes with the use of new oral anticoagulants in aged patients with atrial fibrillation
K.H. Lee, H.W. Park, N.S. Yoon, J.G. Cho, Y.K. Ahn, M.H. Jeong, J.C. Park, S.S. Kim (Gwangju, KR)
Clinical aspects in real life patients with atrial fibrillation and different oral anticoagulants
B. Lurina, M. Kovalova, G. Rancane, I. Sime, G. Dormidontova, E. Miglane, B. Tilgale, O. Litunenko, A. Lejnieks, O. Kalejs (Riga, Jelgava,
Ventspils, Liepaja and Daugavpils, LV)
Registries and surveys
Incidence and survival of out-of-hospital cardiac arrest in the swiss canton ticino
M. Caputo, R. Mauri, R. Burkart, C. Benvenuti, T. Moccetti, A. Del Bufalo, A. Gallino, C. Casso, C. Klersy, A. Auricchio (Lugano and
Breganzona, CH; Pavia, IT)
P1666
P1667
P1668
P1669
P1670
P1671
P1672
P1673
www.cardiostim.com
Invasive & Non-Invasive Electrophysiology - Catheter Ablation - Pacing & Debrillation - Heart
Failure - Cardiac Imaging - Angiogenesis & Genetics - Emerging Cardiovascular Technologies
Information:
Dr Philippe Ritter - CARDIOSTIM
E-mail: cardiostim@wanadoo.fr
Created by Jacques Mugica
Millions of people have atrial fibrillation this website can help to understand
www.afibmatters.org
Also available:
www.fibrillation-auriculaire.org
www.vorhofflimmern-zaehlt.org
www.fibrillazioneatriale.org
www.fibrilacion-auricular.org
SESSION BY TOPIC
NAME/PAGE NUMBER
Ablation track (Traditional ablation & Ventricular tachycardia ablation)........................................................................................................................................................................................................................................................18, 23, 30, 35, 63, 71, 77, 98, 103
Arrhythmias in athletes.....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................31, 134
Atrial Fibrillation track
(AF, AF ablation, Anticoagulation).........................................................................................................................................................................................................................................................................................................................................................17, 19, 22, 24, 29, 31, 34, 57, 62, 70, 76, 97, 102, 109, 114
Basic and genetic track
(Genetics & Basic Electrophysiology)........................................................................................................................................................................................................................................................................................................................................................................................18, 23, 30, 35, 58, 63, 78, 99, 105, 111, 116, 131
Device track
(ICD - CRT)............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................17, 23, 30, 34, 57, 62, 71, 76, 97, 100, 103, 109, 115, 134
Non invasive and eCardiology track
(ECG and eCardiology, Remote monitoring, ECG interpretation)..........................................................................................................................................................................................................................................19, 24, 31, 36, 58, 64, 72, 78, 110, 115, 132, 135
Nurses and Allied Professional track - (Nurse, Allied Professional, other)............................................................................................................................................................................................................................19, 25, 31, 36, 59, 64, 73, 78, 99, 105
Pacing track - (Cardiac Pacing, Lead management - extractions and recalls)....................................................................................................................................................................17, 22, 29, 34, 57, 62, 71, 73, 76, 97, 109, 114
Paediatric ...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................65, 73, 79
Pharmacology /cancer chemotherapy / Pregnancy.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................20, 25, 32, 37, 59
Registries and surveys..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................77, 98, 104, 110, 115
Satellite Symposia...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................27, 28, 61, 66, 67, 68, 81, 107, 108
Scientific documents and Guidelines...............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................114, 131, 134
Special events........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................38, 74, 105, 112, 136
Special sessions ..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................22, 29, 61, 69, 70, 75, 102, 113
Syncope..............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................99, 104, 110, 116
ESC Working Group on Cardiac Cellular Electrophysiology sessions............................................................................................................................................................................................................................................................18, 24, 31, 36, 48, 58, 63, 72, 77, 82
Young electrophysiologist / Women in electrophysiology....................................................................................................................................................................................................................................................................................................................................................................................................................................98, 104, 111, 116
Abstract sessions................................................................................................................................................................................................................................................................................................................................................................................................................................ 20, 26, 31, 37, 59, 65, 74, 80, 100, 106, 111, 112, 117, 132, 135
Moderated Poster sessions.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................21, 33, 60, 75, 101, 113, 133
Poster sessions............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................39, 42, 51, 82, 91, 119, 125, 137
145
146
Gadler F.: 63
Gaita F.: 18
Galal W.: 34
Gasparini M.: 115
Geelen P.: 133
Geller L.A.: 98
Giannessi C.: 19
Gizurarson S.: 99
Glikson M.: 109, 117
Goette A.: 24, 32, 62, 75
Gold M.R.: 62
Goldenberg I.: 65, 97, 103
Gomez A.: 24
Gorenek B.: 134
Grace A.: 77
Grimaldi M.: 27, 102
Guedon-Moreau L.: 64
Israel C.W.: 17
Jaarsma T.: 31
Janousek J.: 65
Jordaens L.: 30
Jubele K.: 111
Kalman J.M.: 64
Karpenko Y.: 71
Katz A.: 78
Kennergren C.E.H.: 76, 107
Khachatryan A.: 37
Khoury M.: 99
Kirchhof P.: 57, 114
Kourtellaris P.: 25
Kuck K.-H.: 27, 31, 38, 57, 66, 70, 109, 117, 131, 136
Kutyifa V.: 65, 104, 132
Lamp B.: 60
Larsen J.M.: 71
Le Heuzey J.-Y.: 58
Leclercq C.: 67, 98, 114
Lendeckel U.: 111
Levy S.: 57
Leyva-Leon F.: 61, 73
Linde C.: 111, 115
Lip G.Y.H.: 73, 109, 114
Lobban T.: 99
Lombardi F.: 19
Love C.: 71
Lunati M.: 68, 134
Luria D.: 97
Mabo P.: 17
Magalhaes L.: 31
Makaryan Y.S.: 20
Malik M.: 31, 58
Malmborg H.: 59
Manola S.: 131
Manolis A.S.: 134
Mansour A.H.: 78, 105
Mansourati J.: 33, 100
Marin F.: 114
Marquie C.: 108
Mavrakis I.: 21
Meine M.: 107
Merino J.L.: 22, 103, 133
Merkely B.: 71, 104
Metzner A.: 100
Mitkowski P.: 17
Mont L.: 63, 97
Morgan J.M.: 75
Morichelli L.: 73
Mudd J.: 64
Murgatroyd F.D.: 34, 57
Raffagnato P.: 25
Raviele A.: 76
Reddy V.: 29
Remme C.A.: 18
Revishvili A.S.: 36
Rienstra M.: 32
Rillig A.: 32
Ristic A.D.: 57
Ritter P.: 57, 105, 117
Romanov A.: 22
Rosenthal E.: 73
Roses Noguer F.: 79
Rostock T.: 97
Rueb N.: 80
Russo A.: 35
Okumura K.: 24
Oloriz T.: 77
Oneill M.: 76, 112
Oto A.: 116
Padeletti L.: 71
Papiashvili G.: 115
Pappone C.: 70
Piorkowski C.: 23, 28, 70
Platonov P.G.: 20
Ploux S.: 62
Poole J.: 59, 69
Porfili A.: 25
Potpara T.: 75
Pretorius V.: 22
Prinzen F.W.: 100, 105
Priori S.G.: 23, 110
Probst V.: 35
Proclemer A.: 98, 104
Walfridsson U.: 64
Wellens H.J.: 132, 135
Wolpert C.: 30, 106
Zaza A.: 72
Zeppenfeld K.: 37
Zizek D.: 34
Zupan I.: 23
Santini M.: 72
Sarkozy A.: 116
Scaglione M.: 135
Schalij M.J.: 20
Schilling R.: 62, 66
Schmidt G.: 19
Settergren M.: 109
Shen W.K.: 17, 104
Silberbauer J.C.: 61
Simmers T.A.: 27
Simonelli N.: 59, 99
Smith G.L.: 72
Sperzel J.: 97, 108, 117
Steinberg J.: 76
Stellbrink C.: 76
Sticherling C.: 30
Sutton R.: 110, 116
Vos M A.: 59
Vukmirovic M.: 131
SPEAKERS
NAME/INDEX NUMBER
SPEAKERS
NAME/INDEX NUMBER
Maack C.: 86
Maass A.H.: 42
Mabo P.: 614, 700
Madrid A.H.: 1221, 772
Maggioni A.P.: 193
Mahajan R.: 618
Mahnkopf C.: 1098
Malhotra A.: 1555
Malik M.: 251, 27, 92
Marijon E.: 1153
Marinskis G.: 5
Marrouche N.: 756
Martins R.P.: 138
Mastenbroek M.H.: 680
Maury P.: 702
Mazzone P.: 1129
Meine M.: 1183
Merino J.L.: 63, 64, 65, 1573
Merkely B.: 765
Metzner A.: 722
Michaud G.: 688
Mitsuhashi T.: 97
Mittal S.: 758
Mondesert B.: 1130
Monserrat L.: 608
Mont L.: 1064, 120, 142, 1556
Morgan J.M.: 1286, 143, 202, 204, 749, 750, 751
Morichelli L.: 38, 615
Morken I.: 168
Moya I Mitjans A.: 1227
149
SPEAKERS
NAME/INDEX NUMBER
Zabel M.: 74
Zaza A.: 156, 786
Zeppenfeld K.: 1275, 628
Zoni-Berisso M.: 1152
Zorzin A.: 37
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
Ronchi C.: 88
Roncon L.: 1526, 1527, P1479, P1580, P1640
Roos M.: 1564, 244, P462, P830, P854, P981, P998
Roque J.: P1417
Rordorf R.: P1486, P346, P354, P54
Rosa Alba Abellas-Sequellas R.A.A.S.: P486
Rosati F.: P1643, P471, P847, P975
Ross S.: P1482, P589
Rosset S.: 1174
Rossetti G.: P1011
Rossi P.: P394
Rossi S.: P1394, P366
Rossillo A.: P54
Rosso R.: P1340
Rosu R.: P1657
Roten L.: 1110, P1455, P287, P517
Roth N.: P263
Rothman K.J.: P536, P912
Rotondi F.: P903
Rottbauer W.: P185
Rouet R.: P433
Roufas K.: P1460
Rougier J.S.: P436
Rousseau-Plasse A.: P584
Rousso B.: P583
Roux J.F.: P1329
Rovaris G.: P1448, P1604
Rowland E.: P1586, P353
Roy D.: 810, P467, P498, P866
Roy K.: P1354, P474
Rozen G.: P1392
Rubio J.: P1026, P338
Rudic B.: 48, 579, 633, P1121, P865
Rudomanova V.S.: P893
Rudzinski A.: 1116
Ruehmkorf K.: P188
Ruf S.: 89
Ruffa F.: 1529, P1448
Ruidavet J.B.: 50
Ruiz Granell R.: P1361
Ruiz Guerrero L.: P514
Ruiz-Cantador J.: P1545
Ruiz-Salas A.: 1318
Ruocco A.: P384
Rupar K.: P1360
Russo E.: P1350, P307, P984
Russo M.S.: P327
Rutherford L.: P442
Rutigliano L.: 1179
Ruud M.: P965
Rychlak R.: P513
Rydlewska A.: P1017
Rymarczyk Z.: P1666
Ryu K.: P1381
Rzaev F.G.: P419
172
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
176
AUTHORS
NAME/INDEX NUMBER
AUTHORS
NAME/INDEX NUMBER
www.escardio.org/EHRA
The EHRA White Book 2015 was made possible with the aid of
an unrestricted educational grant from BIOTRONIK SE & Co. KG
www.cardiostim.com
Invasive & Non-Invasive Electrophysiology - Catheter Ablation - Pacing & Debrillation - Heart
Failure - Cardiac Imaging - Angiogenesis & Genetics - Emerging Cardiovascular Technologies
Information:
Dr Philippe Ritter - CARDIOSTIM
E-mail: cardiostim@wanadoo.fr
Created by Jacques Mugica